John A. Moran Eye Center university of utah health care

40 years of civil war... Will curing blindness

FOCUS bring peace? 2013

South Sudan Peace c ircle Moran advisory council

robert F bennett Wayne ImbrescIa Falls Church, Virginia John A. Moran Eye Center

John bloomberg claudIa s luttrell La Jolla, California Salt Lake City, Utah

reed brInton robert e marc, Phd Salt Lake City, Utah John A. Moran Eye Center

alan s crandall, md John a moran John A. Moran Eye Center Palm Beach, Florida

Ian cummIng randall J olson, md

2013 Jackson Hole, Wyoming John A. Moran Eye Center

steve deZII chase n Peterson, md Las Vegas, Nevada Park City, Utah

sPencer F eccles lynn Ward Salt Lake City, Utah John A. Moran Eye Center

gregory s hageman, Phd steve Wynn John A. Moran Eye Center Las Vegas, Nevada

alan hIrschFIeld norm a ZabrIskIe, md Jackson, Wyoming John A. Moran Eye Center at Moran Eye Center and on Twitter @MoranEyeCenter website: www.moraneyecenter.org. Follow us on Facebook For more information about Moran the Eye Center, visit our to Kaythanks also Spatafore and Garfield, Lori Designers. andtime talent to make publication this possible. Special patients, and researchers generously who contributed their employees, management, care health workers, physicians, thanks to many the A special hard working Moran Eye Center G Virginia Rainey, Editor, Writer Co Michael Yei, Manager Tara Kisow, Program Coordinator Julie Crandall, Project Coordinator AND I Lynn Ward, Executive Director Heidi Reid, Development Officer Pomeroy,Esther Communications Specialist Kirsten Mallik, Director of Development B.J. Fullmer, Administrative Assistant Tawnja Carballo, Development Specialist Linda Bult, Editor, Writer Ex Steve Brown, Communications Manager E 801-581-2352 City,Salt Lake UT84132 65 Mario Capecchi Drive John A.Moran Eye Center University of Utah Health Care, City, Salt Lake Utah 84132 PublicationOfficial the of John A. Moran Center Eye Requests express written consent of the publisher, stated.unless otherwise in whole or contained inpart, herein are prohibited without product themselves. Reproductions of articlesor photographs, representation therein, nor quality the or deliverability of the Moran Eye Center not does assume responsibility for any ©2013 John A.Moran Eye Center. The rights reserved. All Center, 65Mario Capecchi Drive, City, Salt Lake Utah 84132. sent to following: the Communications Manager, Moran Eye PHoTo Spatafore &Associates Printers Inc. City, Salt Lake Utah P Michael Schoenfeld Patrick Reddish Timmy O’Neill Brandee Michaelson Leitch Steve Ace Kvale W.Bryan Jones, PhD James Gilman, FOPS CRA, Laurel Dokos Brown Steve FOCUS NTERNATI DIT RINTING RAPHIC TERNAL NSULTANTS Lo oR GRAPH CAL for additional copies of publication this may be D

R o ESIGN o ELATI NAL UTREACH y

DIVISI

o NS T

oN EAM o F /Co o PHTHALM NTRIBUT o oLoG RS

y JoHN

. o M A. 79 72 68 66 64 62 56 54 48 46 44 42 41 40 38 36 34 32 27 24 22 19 18 13 10 8 4 2 30

Disease Childhood Rare about Theories

Charitable Saturday Surgery Day Day Surgery Saturday Charitable Back Comes Kindness of Bit Little Every ThreeGenerations of Giving Foundation D. Green Edith and Val A. Ophthalmologists Highlights Generous Donors Dedicated Volunteers, Friends, and Sight for Night YourSeeing Enemy inaNew Light Sudan South of Vision and Peace Today The Words of a Mother,the Miracles Chair the from Message National and InternationalPresentations 2012-2013 Contracts and Grants Research Published Research Grand Rounds Technology Commercialization and Clinical Trials Service and Leadership Industry 2012-2013 Awards and Honors, Appointments, 2012 Donors and Sanduk Ruit Moran’s Drs. Geoffrey Tabin Second Suns Skaggs Sam of Legacy Enduring Expanding, The Hope Fund David Kelby Johnson Clinics Community Service of Vision A Clear Clinic Continuity Resident Moran’s New 2013-2014 Fellows and Residents on Retinopathy of Prematurity Light New Shedding Prevailing Upend Researchers Moran Stop Pit Unexpected Andy’s Intellectual Intellectual Property/Patents 2012-2013 Diagnosis and Treatment of Uveitis Remission is Mission Our Research Team RAN E y E

2013 CENTER

Contents

out r ca patient education esea r each r c h r e 1 

F o c u s 1 2 0 1 3 F o c u s 2 2 0 1 3 sighT ofVisionandPeaceToday The Words ofa Message from theChair throughout the world. notonly life that mothersaid his changed his words the but lives of individuals countless point John can to live them. by eventually namesake, and Moran, and ourchief benefactor through them, recite them, life.on we’re lean we soon but When young, them, reject wemay navigate we mother? as her or his acompass mother’smillion Our as from act words words 13 48 and between that the heard by age of know you eight, the child average has Did the field. Here’s an example from our most recent mission to South Sudan. South to mission recent most our Here’sfrom field. the an example in doctors our from updates regular through restoration of sight miracles modern of word these We receive wait! cannot boy as a young him in Moran’s instilled John that mother today.vision but the future, Fulfilling the we in can—not as sometime blindness curable with individuals to many as sight bring we will comes, time that until future, near the in eye diseases blinding for cures and treatments discovering in role abig play will Center Eye Moran at the day.devoted I’mresearchers the every While confident programs charitable international and local our through out plays story yet profound simple Iwatch this awe in as programs. outreach our spotlight as we publication this for fitting especially feels I’ve it but told John’s times, many story mother’sby my love.” influenced is of life’s possibilities later, today, Even decades my vision many miracles. in these abelief me within planted my mother because is exists building this reasons of the One toward as strangers. well as to neighbors our kind being and sight, of restoration miraculous the beggar, of faith, power the blind of the bystories the touched particularly achild,” to as “As read me says. boy, my mother John tostories alittle my mind Iwas brought it blind, to the vision restore someday might that research out to carry dream his Dr. about told me Olson “When Young South Sudan patient will soon see again see soon will patient Sudan South Young m other, the University of Utah; CEO Moran Eye Center Eye Moran CEO Utah; of University Ophthalmology, of Division Chair and Professor MD, Olson, J Randall m iracles

miracles together under the dire circumstances of blindness.” of blindness.” circumstances dire the under together brought were Murle) and Nuer, (the Dinka, tribes opposing three all from the three tribes, resulting in tears from all.” from tears in resulting tribes, three the between hug agroup with concluded evening The lives. their change will surgeries sight-restoring the how to discuss peace in together gathered tribes warring the from leaders and families, their patients, points taught to John Moran by his mother. by his Moran to John taught points compass the navigating Sudan—that South successfully we are from evidence the in found be can achievements extraordinary most 2012; of for our one perhaps but accomplishments and growth our we highlight report, annual of this Eye Center. Moran appendix A. the In John of the anniversary year, twentieth the This we celebrate tribes. various the between situation improved the and of individuals lives the on effects extraordinary its about read can you issue, this in and, place take event extraordinary sight. of havethis nowWe watched gift the received had affiliation—who of tribal citizens—regardless Sudanese South fellow their with observance apeace in together came tribes warring of three leaders the where miracle It’s asecond peace. about about also is It Sudan. South countries, violent most of the world’sthe one and newest, in blindness cure treatable help to Center’scommitment Eye Moran five-year the about is issue in this story first Our Peace Six Day Four Day Three Day Journal entriesfromthe 2011 Sudan MD—South Tabin, Geoffrey MD, Crandall, Alan Dau, John MD, Williams, Lloyd offered post-operative care for patients in the blazing sun.” blazing the in patients for care post-operative offered others room, operating hot extremely the in hours endless spent some —Michael Yei, —Michael “The peace initiative was a huge success. Formerly blind blind Formerly success. ahuge was initiative peace “The

“The team completed 34 more cataract surgeries. While While surgeries. cataract more 34 completed team “The “The team completed 34 cataract surgeries. Patients Patients surgeries. cataract 34 completed team “The Moran International Division Manager Division International Moran John Dau and Randall J Olson, MD JOlson, Randall and Dau John l ost Boys c linic, South Sudan Peace Circle 2012 Circle Peace Sudan South s outh University of Utah University Eye Center Moran A. CEO, John of Ophthalmology Chair and Professor MD JOlson, Randall s udan:

F o c u s 3 2 0 1 3 Seeing Your Enemyina

before surgery before examined eyes his has Sudan South in patient A blind South Sudan sight-restoring surgicaloperationandacommitmenttopeace. aid havestruggledtodo?Theanswerliesinasimpleten-minute peacekeepers, diplomacy, andmillionsofdollarsininternational Center dotobringpeaceSouthSudanthatUnitedNations What canonemanandophthalmologistsfrom theMoranEye South Sudanese man needlessly blind from untreated cataract untreated from blind needlessly man Sudanese South Seeing Your Enemyina Dr. Crandall pledged to bring eye care Clinic. Boys Lost to Duk the forAfrica more than Moved adecade. by younger the man’s remarkable vision and tenacity, met John Dau. Dr. performing sight-restoring Crandallhad been missions inother of parts andmology Professor and Vice Senior Chair of Ophthalmologyat University the of Utah, In 2006,Moran’s Dr. Alan Crandall, Co-director of Division the of International Ophthal- Dr. Alan CrandallandJohnDau—SowingEarlySeeds ofPeace of Payuel. Duk to establish John the Dau Foundation inhis home Clinic Boys and Lost openDuk village the relocated who Boys 3,800 Lost to United the States. His compelled horric experiences him Sudan,” war the ed on foot over to 1,000 miles Ethiopia. John Dau is one of three leadersof displaced or orphaned children. ousands of children, those known as “Lost the of Boys 2005, 2.5million Sudanese war, werecivil inthe killed leaving more behind than 20,000 In 2011,South Sudan gained independence, but at adevastating 1983and price: between and nation. person cannot care for himor herself and is aphysical and nancial burden to family, village, Sudan, but becoming blind is an early death sentence—without ability the ablind to see, sighttheir restored with acommon eyesurgery. Everyday inSouth to survive life is astruggle living with blinding Tragically, eyediseases. vast the majority of individuals these could have ophthalmologists of country inthis ten million, resulting innearly one million of its citizens South Sudan is newest the world inthe country and one of poorest. the ere are literally no Hope andHeartbreak New Light Dr. Tabin, John Dau and Dr. Crandall, 2011 South Sudan mission 2011 Sudan South Dr. Crandall, and Dr. Dau Tabin,John South Sudan. In addition, Dau suggested that as away to miti- to Dau that out he would four carry more missions medical to 2011mission, the During Dr. Crandallmade acommitment A CommitmenttoPeace shortly aerkilled leaving. patients, Lonnie, had who his sight restored at clinic, the was that took lives the of 3,000individuals. Tragically, one of the just inavillage lence surfaced southeast 150miles of clinic the intotaken slavery. Aer team the le,awave of vio- intertribal people inanearby were and village 16children killed were heard ey them. daily gunre, and during stay, their 40 e Moran team reminded was also of around violence the all children,their under own their departed power. Skeptical patients, arrived who at clinic with the astick led by of gi the sight through cataract and trachoma operations. camp was asuccess. Two hundred forty-one people received turn.tion Despite at extreme every these conditions, eye the war zone to get to clinic. the ere and wasmalnutri- disease cut o without warning. Patients for walked days through a through and open entryways windows. would e electricity bats,allowed insects, snakes, and lizards to y and slither tures exceeding 105degrees, cinder the block operating room team In had humidity everexperienced. high with tempera- e rst eyecamp was achallenge anything unlike Moran the we persisted,” says Dr. Crandall. region. Twice we were turned of back because violence, but guards. " is was our actually third attempt to go into this to enter country, the but only under protection the of armed In 2011,aMoran December surgicalteam was nallyable without vision. for rst the time—others aer years and evendecades ing Murle, Nuer, leaders,gained sight—some and tribal Dinka were screened. At end the of week, the 227individuals, includ- risking safetyClinic, their for promise the of sight. 600 Over hungry, and sick Sudanese to Boy’s Lost miles the walked Wary of once other warring tribes, again hundreds of blind, Dr. Weber. over “greeted to 8,000miles be by alot of smiling faces,” said Weber. e team packed 2,000 pounds of own their equipment ophthalmologists Roger Furlong, Alan Crandall, and Charles summitpeace would become areality. e team included sion at Boy’s Lost the with hope Clinic that plan their for a teammedical from Moran arrived for asecond eyecare mis- Jump one ahead year 11,2012.Aeen-member to December Sight isaPrecious Thing leaders agreed to terms. the agreementpeace throughout region, the and many of tribal the state agencies spread also word the about clinic the and the eyecampthe and conditions the for nextand the one. Local and returned friends home and spread wonderful the of news given of gi the had who been sightthose and families their a shared eyecamp. With mandate, this aer clinic the ended, pledged to warringassemblethe tribes for together inpeace Moran team would not return to performeyesurgeries unless futuretie missions medical Dr. to peace; Crandallagreed. e gate South Sudan’s continuing warfare, Moran the team could

New Hope F  5     F  6     Peace are sitting inacircle under quiet the beauty of African the from and and warringleaders,friends, the their families tribes event: this as depicted byexperienced Patients who several circle.planned peace Imagine ifyou following the will, scene Near end the of eyecamp, the stage the for was set aspecial Drunk from Love is aprecious thing.” and occasionally stoppingeverything to hug eachother. Sight women, post-op, wander through camp the looking up at Michael Yei reported at “I time: the just watched two elderly is pretty incredible.” Moran International Division Manager ward emotion. But patients to see break out insong and hug said Dr. Weber. usually don’t “ ey show any kindof out- stoicsight—not is avery culture,” enemies. as “ is mortal other—for rst the time—as comrades, relishing of gi the removed during members week, the saw warring tribal each was profound. e experience As surgical bandages the were on. looks team Moran’s as medical 2012, ceremony, circle peace during relations improving discuss foreground) (right Dau John and leaders tribal Sudan South Miracles hearts,” earning himasincere round of applause. are on him,as he says to group, the “We want to disarmyour an eloquent manner. Areport from eld the says that eyes all ofall six-feet, eight-inches with acaptivating tall voice and When have all assembled, Dau stands up He to speak. is peoplethe of Jonglei State!” drunk—from love. You clearly can see that there is love among looked absolutely were likeandwere they they actually drunk, nation. way, this experience the Dau described “Patients other and tears ow embrace—now as they citizens of one Former enemies become kindredat smile souls. ey each circlethe that thoughts of war, hatred, and anger dissolve. e suddenof gi sight produces such overwhelming joy in whole light. new circle,facesofthe patients see they from ina other tribes children or grandchildren for rst the time. As across look they skies—many patients are sunset the or seeing facesof the their three tribal languages such as“Don’t move” translated into e Moran team needed key words mortal enemies.” ofsight—notas the gift as comrades, relishing time— other—for therst members saweach the week,warringtribal were removed during “As thesurgicalbandages Pre-op patients have achance to theirhearts.”“disarm clinics thatinclude peaceceremonies willbecomeayearly tradition thatspreads across all14statesinthatcountry, will sothateveryone the Moran teamisgone. Itisour visionthatinthenottoodistant future, eye care willbecomeself-sustainable inSouthSudan, andvision technicians. Itwon’t belongbefore theywill beabletotreat trachoma by themselvesandto train other SouthSudanesetodoso, longafter Two assistantsfromtheLostBoy’s Clinicrecently wenttoNairobi, Kenyaforophthalmic training to Sudanascertified and willreturn one daytheseclinicswillbestaffed andrunby the peopleofSouthSudan—andthegoodnewsis, thisprogramhasalready begun. outreach visionandtheofJohnDauFoundation isoneofself-sustainability. With continuedsupportfrommanywonderful people, it would take more than3,000years justtorestore theirsight.Fortunately, itwon’t take thatlong. A key component ofourinternational While thesefirstmissionsare important, withalmost onemillioncitizensofSouthSudanexperiencing blindnessyear afteryear, atthisrate region that hasbeencalledthe “Conflict Triangle.” 300 membersofmultipletribesfromtheextremely isolatedandneglected 2014. to SouthSudaninJanuary The goal istobringsightmore than A teamfromtheMoranoutathird Eyemission Centerispreparing tocarry ceremony andexperience totheirresidents. want Moran ophthalmologists tobringeye care missions andthepeace the firstsight-restoring peaceinitiative, leadersfromotherstatesnow success. oflong-term measure in terms After hearingthesuccessof in thepast60years. Like allpeaceinitiatives, thisonewilltake timeto The Sudanesepeoplehave experienced only15years ofrelative peace “DISARM THEIRHEARTS” AVision ofSustainability someone have who restored eyesights for is Bible… free inthe blind bypartially cataractrst Ihave time said, “ e heard of Police First Lieutenant Kong Lam from Uror County was who circle: participatedwho peace inthe report on 2012eyecamp the included remarks from patients for rst the inmany time years. AJohn Dau Foundation trip circle, arecent region inthe report said there peace has been 2012camp.the Yet, aer latest the eyemission and peace the ere have conicts inother of been parts South Sudan since Other Party Peace isPossibleWhenYou CanSeethe sengers for peace.” Now that we eachother, can see letus unite and become mes- declares, “Peace is possible you when other the canparty. see statement that feelings reects the ofpatients, the all awoman Hemembers of tribes. opens then all up discussion. the In a Dau continues to inspire, and his message felt is truly by circle peace the in participating patients Post-op “Patients looked peopleof clearlythatthere isloveamongthe were drunk,fromlove.You cansee theywere drunk—actuallythey and come to help open our eyes?” realthe God’s people. How leave can they families their behind brought here by John Dau are either sent or by are they God Nyaboth Tutdel from Ayod County said, “Americans were who trouble to neighbor the country.” for inJonglei peace State. Let’s stop our from thieves causing we eachother, can see letus unite and becomemessengers the Peace is possible you when other the canparty. see Now that that has happened to your youth to stop raiding other villages? eye sight was restored, you will not communicate miracle this Kuot Bol Elijah from Twic County East said, “For whose those hear of any conict again.” Nuer and Jiang are (tribes) now one people, and you never will and second the is time today, and are they doctors. Lou these Patients wait to have their eyesscreened Jonglei State!” absolutelylike —John Dau

2014 F  7     F  8     blindness and vision loss at home and around the world. world. the around and athome loss vision and blindness preventable cure to and treat mission of our part integral an are that programs outreach premiere brought fundraiser in funds much-needed to and local international support 22, June on 2013, Hotel, Held Moran’s Lake’s success. America atSalt a rousing Grand was gala Sight for Night Eye Center’s Moran annual A. John The donors, and sponsors, Thanks to astellar committee create aspecial evening to remember donors generous and friends, volunteers, Dedicated Moran doctors in South Sudan Night forSight savoring a privately catered south-of-the-border style dinner afterwards. dinner style south-of-the-border catered aprivately savoring and Bobcat, Intermountain from movers of earth suite afull operating and learning play, “sandbox” of a day grown-up in to join 20 for friends achance with Inside” Emmy-winning Bestor. composerKurt celebrated Kid Another “The opportunity with Trapp Mikel concert aprivate chef and with Party” World’s Dinner “The Best including items, one-of-a-kind many on bid Guests Himalayas. the in deep camps eye atsurgical teams medical Moran alongside to track working a private on cars race BMW to drive achance as varied as were opportunities Bidding auctions. silent and live with along dinner and reception elegant an for gathered guests abroad, and locally care Moran’s charity documented that photography large-format of stunning, panels Amid

and more than 530 guests, supportive

2013 or [email protected]. email at801-585-9700 Office Development Eye Center Moran sponsoring the next Night for Sight, please contact the in volunteering, attending, information or receiving about atwww.moraneyecenter.org. interested are you If Sight for Night about more learn and shorts video the See world. the around and Utah in work to outreach do resources and time volunteer who partners industry of our all and Moran from professionals to medical the thanks finally, asincere event. the And in participated Wasatch Front who entire Valley, Lake Salt the City, the Park and throughout leaders business and community to many the grateful We also are Crandall, co-directors of Moran’s International Division. Tabin Alan and Geoff to Drs. also Thanks evening. aspecial to such create tirelessly worked who committee volunteer the and Firmage, Carol Chair Event Warnock, Marva and John Chairs to Honorary our thanks Special countries. own their in surgeries restoring South Sudan, Indonesia, and Kenya to sight- perform Trinidad Tobago, Salvador, El and China, Bhutan, India, training doctors from Ethiopia, Tanzania, Ghana, Nepal, also are doctors Moran continents. five on countries fourteen in missions sight-restoring out carrying talents and time their donated ophthalmologists Eye Center Moran year, last Just world. the around and locally underserved, the for care medical of providing decades three spans that tradition aproud support money or of time Donors blindness. unnecessary to end effort of our part a critical is Sight for atNight volunteers or attends who Everyone book. the from passages touching read also Suns, Second seller best anticipated highly of the subject Tabin, Dr. surgeon the Geoffrey Moran Clinic. Boys Lost Duk the and Dau John with alliance an in Sudan South in out carrying is Moran that mission sight-restoration and peace five-year unprecedented the about learned Attendees Dr. Olson. Chair Randall Department and CEO by Moran speech inspiring an did as evening, the out rounded Moran’s efforts outreach illustrating films Short Marva Warnock; Event Chair Carol Firmage Carol Chair Event Warnock; Marva H ONORARY C HAIRS

John Warnock, Scott Murray, Murray, Scott Warnock, John Mark Miller, Dr. Randall JOlson Dr. Randall Miller, Mark

Julie Nester Gallery Molina Healthcare McAdams Ben Mayor Winston Lipman Legislative Insight Consulting LLC Photography Grant Justin FreeportWest Industrial Properties Fred and Christine Fairclough EnergySolutions JewelersBennion Table Sponsors Zions Bank Foundation Stewart SD Architects FFKR Foundation Eccles Doré Dolores S. and George John and Toni Bloomberg Sponsors Visionary OutdoorReagan Advertising Claudia Skaggs Luttrell Grand America Hotel Bamberger-Allen Health & Education Foundation Platinum Sponsors Warnock Marva and John Tanner O.C. Kelby Johnson of David memory in Johnson, A. Elizabeth of Murray MINI Grove of Pleasant BMW BMW of Murray Sponsors Presenting NIGHT FOR SIGHT SPONSORS THANK YOU TO OUR Dr. Geoff Tabin Dr. Geoff

F  9     10 F o c u s 2 0 1 3 moran eye center eye moran Four Major Awards Randall J Olson, MD built in2006,isdedicatedtoresearch. 210,000-square-foot MoranEyeCenter, And now, more thanhalfofthecurrent from onetooverfiftymemberstoday. managed facultythathasexpanded building oftwoeyecentersand During thistime,hehasdirected the Chief ofOphthalmologyeversince. at theUniversityofUtahandhasbeen person DivisionChiefinJune,1979, Services. Dr. Olsonstartedasaone- faculty in1977asDirector ofCorneal in NewOrleans,where he joined the Louisiana StateUniversityEyeCenter of FloridainGainesvilleandatthe attheUniversity fellowships incornea UCLA in1977ophthalmology;and (BA ’70,MD’73);hisresidency at schooling attheUniversityofUtah undergraduate trainingandmedical Dr. RandallJOlsoncompletedhis School ofMedicine Moran EyeCenter, UniversityofUtah and Visual Sciences,CEO,JohnA. Professor andChairofOphthalmology RANDALL JOLSON,MD,

of Medicine. offaculty Jules the Stein Eye Institute and School UCLA the trained, to share findings their withthe residents, fellows, and careers,their are who invited back to institute the where they to researchers clinical with outstanding research throughout June14,2013. California, School ofMedicineatUCLA,LosAngeles, Award, JulesSteinEyeInstitute,DavidGeffen The 44thAnnualJulesSteinPettitLectureship research, interest, and expertise. distinguished ophthalmologists are invited to share their Coston. Held at Annual the Resident and Alumni Meeting, contributions of founding ophthalmic surgeon Dr. Tullos O. This lectureship was established in honor the enormousof Oklahoma, OklahomaCity, Oklahoma,June8,2013. at theDeanMcGeeEyeInstitute,Universityof The 34thAnnualTullos O.CostonLectureship and insurgery patienthis lifetime of care. service is arole tradition inthe model established by Dr. Rich during students,medical interns, residents, or fellows. The recipient field of surgery, including teaching, advising, and mentoring has demonstrated exceptional and skill dedication inthe outstanding surgeon eachyear at University the of Utah who City, Utah,May23,2013. Award. Educator, UniversityofUtah,SaltLake The Dr. ClarkLoweRichDistinguishedSurgeon ophthalmology, education, and patient care. many accomplishments and years of contributions to at event. this This awardgiven was to Dr. Olson for his Dr. Olson guest and faculty was also keynote the speaker of Medicine,IowaCity, Iowa,May17,2013. Educator Award, UniversityofIowaCarverCollege The FourthAnnualDistinguishedOphthalmic received FOUR major accolades: awards, we’re to announce pleased that Dr. Olson recently universities, or other institutions. Adding to his many Dr. Olson has received an honor from his colleagues, Dr. JOlson. It Randall is alwayswe when hear that special our remarkable chair and CEO, professor and surgeon, supporters, and feel it friends is aprivilege to work with The Moran CenterEye faculty, staff, as aswell our patients, Dr. OlsonReceivesFourNewHonors HIGHLIGHTS This award recognizes one The PettitLecture is awarded

of the Researchtain Center, Ocular Chairman of ASCRS the Task Force, and an editor Pathology Laboratory at Moran the Eye Center, Co-director of Intermoun- the Dr. Mamalis is apracticing ophthalmic surgeon, Director of Ophthalmic the cataract surgery.” clear and uncorrected distance, intermediate, and near vision following techniques from to next beginning the the technological frontier inproviding explores and “history the future of IOL implantation and surgical traces His lecture, “Intraocular Evolution: Lens What aLong, Strange Trip it’s Been,” 2013, where Dr. Mamalis delivered Binkhorst the Lecture. Ophthalmic Administrators Symposium and Congress inSan Francisco, April, ogy. He was presented with award the at of ASCRS the and American Society segment syndrome, has established field inthe himas aleader of ophthalmol- Dr. Mamalis’ work, study inthe specializing and understanding of toxic anterior “significant contributionsscience the to and practice of ophthalmology.” J Olson was 2012recipient. the Binkhorst Medal winners are for selected their This award marks an unprecedented honor for Moran Center,Eye as Dr.Randall greatest tribute—the Binkhorst Medal of Honor, an award ofprominence. global ofreceived Cataract and American the Surgery’s Society Refractive (ASCRS) Dr. Nick Mamalis, Professor of Ophthalmologyat University the of Utah, has Moran’s SecondBinkhorstMedalWinner Unprecedented—Nick Mamalis, MD,Named

Journal of Cataract &Refractive Surgery. Balamurali K Ambati, MD, PhD, MBA Ophthalmologist Utah UtesTeam delivery systemsdelivery for eyediseases. several ing work inshowing what keeps cornea the clear and is developing novel drug procedures of cornea the and anterior segment of eye. the He conducts pioneer- keratoprosthesis extraction, ract LASIK, cornea), (artificial and complexother from schoolat medical age 17.He incornea transplants, is experienced cata- Dr. Ambati has distinction the of world's the being youngest person to graduate athletichead trainer. eyes. He would like to express his “special thanks” to Trevor Jameson, Utes’ the of wearing protective to goggles avoid foreign getting objects into or hitting the cation for athletes and coaching staff. cannotHe stress enoughthe importance Dr. Ambati provides also eyeinjuryprevention, eyetrauma, and edu- eyehealth that maydiseases they have.” tured chemical burns—and globes, performroutine eyeexams and treat any eye as athletes. the treat I’ll any injuries to front the of eyesuch the as scratches, rup- medicine, and Utes,” the says Dr. Ambati. “I care take of coaches and staff as well of Utah Utes inAugust 2012.“I’ve always interested been ineyetrauma, sports of Utah Health Center was appointed team ophthalmologist for University the and Adjunct Associate Professor of Neurobiology and Anatomy at University the Dr. Ambati, Bala Professor, Department of Ophthalmologyand Visual Sciences Team Ophthalmologist is AppointedtheOfficialUtahUtes Balamurali KAmbati,MD,PhD,MBA Medal Binkhorst

Nick Mamalis, MD 11 F o c u s 2 0 1 3 12 F o c u s 2 0 1 3 moran eye center eye moran

Identify Audacious Yingbin Fu, PhD Goals in Vision Goals inVision Research and Rehabilitation Challenge to Blindness Bavaria, Germany. at XVth the International Degeneration Retinal Symposium, Gögging, Bad Dr. Fu presented was also with “National the Eye Institute Travel Award” of sense word best the the and revolutionizes area this of science.” In 2012, man and CEO, John A.Moran Eye Center. This work truly is ‘audacious’ in prestigiousthis award,” and well-deserved said Dr. JOlson, Chair- Randall “It is an incredible honor for Moran the Eye Center and for Dr. Fu to receive cellular responses to environmental stresses. of any virtually human inherited whether or disease, resulting from applied be strategy could this also eye disease, to genetic the component disease-causing mutations early and before onset the of disease.” Beyond person’s genome at low cost, makes which it possible for us to catch medicine, italized has become more and more to sequence a practical and cure of human diseases,” Dr. Fu said. “As we enter eraof the person- “If is goal achieved, this impact the would enormous be prevention inthe target mutated DNA sequences. mutations inapatient to designed through of use specially the molecules (by delivered being safely and efficiently into the eye) any disease-associated submission: “Precise Editing Gene In Vivo” aims to permanently correct in Vision Research and Blindness Rehabilitation,” 2013.His winning Nationalthe Eye Institute (NEI)“Challenge to Identify Audacious Goals Center for Translational Medicine, was one of 10esteemed winners of Molecularsciences, Biology, and Director of Model Development, Moran Dr. Yingbin Fu, Assistant Professor of Neurobiology &Anatomy, Neuro- Identify AudaciousGoals” “Challengeto Yingbin Fu,PhD,Wins Dr. Yingbin Fu with Director of the National Eye Institute, Paul Sieving Paul Institute, Eye National the of Director with Fu Dr. Yingbin HIGHLIGHTS • Uveitis Surgery Correction • Vision Services • Cataract • Cornea specialties books. two and publications peer-reviewed forty than more has and laboratory research dynamic a maintains also Dr. Ambati issues. ophthalmic general as well as areas these in patients welcomes He eye. the of segment anterior and cornea the of procedures complex other and LASIK, cornea), thesis (artificial cataract extraction, keratopros- specializes in cornea transplants, MD, PhD, MBA, KAmbati, Balamurali Doctors in Alphabetical Order Alphabetical in Doctors (LASIK, Laser, Non-laser) and (LASIK, moran eye center eye moran

number of patients Dr. Olson is able to see, yet he continues to enjoy patient care visits on a regular basis. regular a on visits care patient enjoy to continues he see, yet to Dr.able is Olson patients of number Today Surgery States United the in surgeons the of one as selected was He techniques. transplantation corneal and ophthalmology, tele- complications, lens intraocular with dealing research in specializes He lecturer. aworldwide and publications professional 300 than more of Eye Center. author the is Dr. Moran A. Olson John the of • specialty Jo Randall CE Cataract Services o • Macular and Retinal Retinal and • Macular Biochemistry • Retinal Diseases • Vitreoretinal specialties detachments. retinal and retinopathy diabetic as such ders treatment of vitreoretinal disor and macular surgical dystrophies; prevention; inherited retinaland and treatment its in environment and nutrition of role the on phasis em special with degeneration specializes macular in age-related MD, PhD, SBernstein, Paul (LASIK, Surgery • Refractive Services • Cataract • Ophthalmology Comprehensive specialties outcomes. surgical cataract on focused is interest research current His lenses. intraocular and laser using surgery rection cor- vision and surgery, segment anterior cataracts, complex and routine of management surgical the on afocus with thalmology oph comprehensive in specializes MD, Barlow, William of the John A. Moran Eye of the John A. Center Degeneration Surgery and Laser, Non-laser) and lson, MD,lson, named Dr. Olson as one of 50 international opinion leaders. Time constraints limit the the limit constraints Time leaders. opinion international 50 of one Dr.as named Olson and External Eye Diseases External and o is the the is

PHTHALM in a peer survey conducted by by conducted survey apeer in - c - hair of the Department of of Department the of hair - • Glaucoma • Ophthalmology Comprehensive specialties syndrome. eye dry of management the in interest special a has also Dr. Chortkoff ophthalmology. comprehensive as well as glaucoma of treatment and management the on focuses MD, Chortkoff, Susan • Glaucoma Surgery • Cataract • Ophthalmology Comprehensive specialties world. developing the in surgery glaucoma and cataract include interests research His Thailand,Ghana,and Nepal. Haiti, Pohnpei, Guam, in worked has and ophthalmology international Dr. glaucoma. and cataracts of ment manage andthe surgical medical on afocus with ophthalmology comprehensive in specializes MD, JChaya, Craig c haya also has an interest in in interest an has also haya o L o o

Ophthalmology Times. Cataract and Refractive Refractive and Cataract Times. Ophthalmology phthalmology and Visual Sciences and and Sciences Visual and phthalmology

GISTS - • Glaucoma Services • Cataract specialties m of Director Sciences, Visual and of Department Vice Senior the is MD, SCrandall, Alan ion leaders. leaders. ion opin- international 50 of one as Today Surgery Refractive and by selected was and world, the throughout lectures Eye Center, Moran the at studies research clinical numerous in involved is He photocoagulation. cyclo laser and trabeculoplasty c Dr. cataracts. and glaucoma of management surgical and medical the on focuses He Moran’s InternationalDivsion. of Co-director and Division, randall has experience with with experience has randall oran’s Glaucoma and and Glaucoma oran’s 2013 15 best cataract cataract 15 best o phthalmology phthalmology c hair of the the of hair Cataract c

ceo ataract

- 13 F o c u s 2 0 1 3 14 F o c u s 2 0 1 3 • Neuro-ophthalmology specialty internet at http://novel.utah.edu. the on (NOVEL) Library Educational Virtual a Neuro-ophthalmology develop to Library Eccles Utah of University the and Society mology Neuro-ophthal- American North the with worked has She Disease. Graves’ and diplopia pain, eye and episodic vision loss, headaches papilledema, arteritis, temporal cerebri, ischemic optic neuropathy, pseudotumor thalmic disorders, neuro-oph- in differences gender include interests Her disease. brain or nerve optic to due be can which complaints visual complex treats and evaluates and ophthalmology neuro- in specializes She Society. Neuro-ophthalmology American North the of President aPast is MD, BDigre, Kathleen • Ophthalmology & • Oculoplastics • Neuro-ophthalmology specialties papilledema. of treatment and disease Graves’ of treatment include interests Her disorders. visual for treatments surgical and medical provides and brain, the to connects eye the how of study the ophthalmology, neuro- practices also She lifts. eyelid as such surgeries, aesthetic and eyelids, drooping recting cor- traumas, after eyes the around bones the of struction recon surgery—the orbital and oculoplastics both in specializes MD, Crum, Alison Facial Plastic Surgery Plastic Facial moran eye center eye moran

- • Ophthalmology Comprehensive specialty transplants. cornea and surgery cataract including America, Latin in mostly projects, eye tarian humani- 25 over conducted has Dr. Duffin California. in privateexperience practice of years 22 after Eye Center Moran the joined He diseases. eye external and cornea in specializing ophthalmology, comprehensive practices MD, Duffin, R Michael Strabismus • Adult Ophthalmology • Pediatric specialties and nasolacrimal duct obstruction. cataracts, childhood and infant of prematurity, retinoblastoma, esotropia, exotropia, retinopathy amblyopia, in interest special has He adults. and children both in strabismus of management and evaluation as well as children in impairments visual and diseases eye of range awide for care surgical and medical provides MD, CDries, David o

PHTHALM

• Ophthalmology Comprehensive specialty the world. sionals to countries throughout profes care eye sends program This Initiative. Vision Church Saints Latter-day of Christ Jesus of Church the on serve to asked was Hatch 2008, Dr. In fitting. lens contact in experience extensive has and ophthalmology of areas all in ence experi- and expertise provides MD, LHatch, Joseph • Glaucoma Services • Cataract specialties glaucoma. angle-closure for screening in used technology imaging thalmic oph an tomography, coherence optical of use the include interests research Dr. Goldsmith’s glaucoma. and cataracts of management cal surgi- and medical the on focuses Jason Goldsmith, MD, o L o

GISTS

- - • Pediatric and Adult Retinal Adult and • Pediatric specialty Hospital. Children’s Primary at Eye Center the and Utah of University the both c Eye Moran the at practice clinical retina adult and apediatric and center retina apediatric building now is She cases. retinal pediatric and adult manages and treats and surgery vitreoretinal in specializes She Retina. Pediatric of Director is MD, Hartnett, Elizabeth Mary • Ophthalmology Comprehensive specialty annual the at course ultrasound ocular the in instructor senior the is He sound. ultra ophthalmic in subspecialty a with surgery ocular and mology comprehensive practices ophthal- MD, PHarrie, Roger techniques. techniques. therapeutic and diagnostic in countries developing in doctors training trips, mostly humanitarian 20 than more made has Harrie Dr. meeting. Ophthalmology of enter. She performs surgery at at surgery performs enter. She Diseases and Surgery and Diseases m 2013 oran oran a merican e ye ye c enter at the the at enter a cademy cademy m oran oran - • Macular and Retinal Retinal and • Macular Surgery and Diseases • Retinal specialties degeneration. retinal and macular and retinopathy, diabetic ments, detach- retinal include interests surgical and clinical primary Her vitreous. and retina the of diseases surgical and medical in specializes Rachael Jacoby, MD, Strabismus • Adult Ophthalmology • Pediatric specialties strabismus. complicated and cataracts, pediatric disorders, craniofacial genetics, ocular prematurity, of retinopathy in interests special has He Disorders. o Pediatric of Division the of Chief is o Robert Degeneration phthalmology and and phthalmology moran eye center eye moran Hoffman, MD, Hoffman, e ye ye

m uscle

• Pediatric Ophthalmology • Pediatric Strabismus Pediatric and • Adult • Glaucoma Services • Cataract • Ophthalmology Comprehensive specialties strabismus. with adults and children to care surgical and medical provides also She disorders. lacrimal and glaucoma, amblyopia, cataract, eye diseases in children, including inherited and acquired of ment treat and diagnosis in specializes Kuo, MD, Annie • Neuro-ophthalmology Services • Cataract specialties sclerosis. multiple and neuritis, optic migraine, and photophobia these areas: giant cell arteritis, in research conducts also Katz Dr. movements. eye and vision affect that brain the of diseases and nerve optic the affect that diseases with patients evaluates prehensive ophthalmology. He com- and cataract, mology, neuro-ophthal- in specializes MD, PhD, JKatz, Bradley

o PHTHALM

- international opinion leaders. Today Surgery tive by selected was Mamalis Dr. inflammation. tive postopera- and lenses intra-ocular of area the in research performing o Intermountain the of Co-director also is He Pathologists. thalmic Oph- of Association American Surgery Refractive and Cataract of Journal Dr. ies. • Cornea Transplant Surgery Transplant • Cornea Surgery Correction • Vision Surgery • Cataract specialties keratoplasty. conductive and lenses, intraocular lasers, using correction vision and surgery, cataract transplantation, corneal of types all includes eye diseases. His expertise segment anterior and corneal of treatment surgical and medical the in specializes He Eye Bank. Lions the and Director Education Moran’s is MD, DMifflin, Mark • Ophthalmology Comprehensive Pathology • Ophthalmic Services • Cataract specialties surger ocular anterior other and cataract including ophthalmology clinical onpractice comprehensive his focuses He laboratory. the to submitted specimens all ates evalu- and Laboratory Pathology the of Director is MD, Mamalis, Nick (LASIK, Laser, Non-laser) and (LASIK, cular m edical Director of the Utah Utah the of Director edical r m and is a member of the the of amember is and esearch esearch amalis is the editor of the the of editor the is amalis Cataract and Refrac- and Cataract o L o c o enter and is is and enter as one of the 50 50 the of one as phthalmic phthalmic

GISTS - • Artificial Cornea • Artificial Inflammatory • Corneal and Surgery • Cataract Surgery Correction • Vision Transplant • Cornea specialties America. in Doctors of editions three last the in appeared has He surgery. rection cor- vision of risks and benefits the on spokesperson community a become has and procedures correction vision of avariety on country the around extensively Dr. eye. the of segment anterior and cornea the of procedures complex other and eye inflammatory diseases, LASIK, disorders, extraction, cataract corneal of management cornea), (artificial tation, keratoprosthesis transplan corneal in specializes He Divisions. Surgery Refractive and of Director the is MD, FACS, Moshirfar, Majid Eye Diseases Implants Intraocular CK) Intacs, IOL, Phakic LASEK, PRK, (LASIK, 2013 m oshirfar lectures lectures oshirfar m oran’s oran’s c ornea ornea Best Best - 15 F o c u s 2 0 1 3 16 F o c u s 2 0 1 3 • Cataract Services • Cataract • Ophthalmology Comprehensive specialties countries. developing in programs with collaborations training and teaching develop to works he where ophthalmology international in and outreach local in interest an has also Pettey Dr. fellows. and observers, tional cal residents, interna- students, medi of training and teaching the coordinates He surgery. segment anterior and cataracts, complex ophthalmology, comprehensive in specializes and Director Program Residency Moran’s is Pettey, Jeff MD, and • Oculoplastic specialty surgery. cosmetic facial and surgery, lacrimal eyelid blepharospasm, tumors, and orbital disorders, nerve optic disease, thyroid include interests research clinical His fractures. including bones, facial and system, periorbital tissues, the lacrimal eyelids, involving disorders of management the in expert an is FRC, FRCS, MD, CKPatel, Bhupendra Facial Plastic Surgery Plastic Facial moran eye center eye moran

- • Ophthalmology Comprehensive specialty ophthalmology. about more learning in interested are who residents and students medical teaching and patients treating Triage Clinic, Moran’s in working Eye Center. Dr. Tabin enjoys the at services mology ophthal- and comprehensive care vision general provides Tabin,Jean MD, Surgery Correction • Vision Services • Cataract specialties surgery. corneal and cataract improving includes research his of Part countries. developing in delivery care eye develop to Dr.care, Tabin working is refractive and cataract, corneal, providing Utah in work his to addition in and specialist, corneal is a He Division. International Moran’s of Co-director is MD, Tabin, Geoffrey (LASIK, Laser, Non-laser) and (LASIK,

o m

PHTHALM oran oran • Retinal Diseases and Surgery and Diseases • Retinal Infections Ocular • Uveitis, specialties Treatment Uveitis. of Foster, entitled, Dr. Stephen with C. subject, the on text definitive the of co-author is Dr. Vitale surgery. vitreoretinal and disease inflammatory and ogy dual training in ocular immunol with country the in people a few of one is He degeneration. macular age-related of pharmacotherapy the and disease, vascular retinal disease, inflammatory ocular of treatment the in systems delivery drug new and agents, therapeutic novel diseases, systemic of tions manifesta ocular include interests research His eye. the of diseases inflammatory and infections other and uveitis of treatment and diagnosis the in specializing West Intermountain the in thalmologists oph only the of one is He vitreous. and retina the of diseases with patients in specializes He Division. Uveitis Moran’s of Director is MD, TVitale, Albert Surgery and Disease • Retinal specialty trauma. segment posterior and holes, macular maturity, epiretinalmembranes, pre- of retinopathy retinopathy, vitreoretinopathy, diabetic erative prolif- retinalinclude detachment, interests surgical primary His ous. vitre- and retina the of diseases surgical and medical in specializes Dr. Teske Surgery. and Diseases Vitreoretinal of Director the is PTeske, MD, Michael o L o Diagnosis and

GISTS

- - - • Glaucoma • Comprehensive Ophthalmology specialties pressure mediated approaches. non-intraocular through glaucoma pathologies and approaching ocular for therapeutics of delivery sustained in is interest research Her therapies. pharmaceutical glaucoma for development drug and research clinical in specializes MD, MWirostko, Barbara • Neuro-ophthalmology specialty loss. vision unexplained and neuropathy, optic ischemic sion, hyperten intracranial idiopathic loss, vision episodic neuritis, optic papilledema, giant cell arteritis, diplopia, include interests Her disorders. these for treatment provides and disease, brain or nerve optic to due be can which complaints, visual complex ates evalu She brain. the to relates it as eye the of study mology—the specializing in neuro-ophthal- Neuro-ophthalmology, of Chief is EAWarner, MD,Judith 2013

- - • Glaucoma Services • Cataract specialties of glaucoma. genetics the in interest a research has He cataracts. and glaucoma of treatment surgical and medical the Vice the is MD, AZabriskie, Norm Strabismus Pediatric and • Adult Ophthalmology • Pediatric specialties nasolacrimal duct obstruction. and cataracts, developmental and infantile strabismus, amblyopia, of treatment and evaluation the includes expertise clinical Her strabismus. with children and adults as well as disease eye with children for care surgical and medical provides Marielle m of at Clinical Operations theA. John of tor oran oran moran eye center eye moran c e linical Services and Director Director and Services linical ye ye y c c oung, MD, oung, hair and and hair enter. He specializes in in enter. specializes He m edical Direc edical

- • Electrophysiology specialty function. pathway auditory brainstem and cortical, way, visual path- optic retinal, quantitate tests These potentials. evoked visually and multifocal electroretinograms, multifocal electro-oculograms, responses, brainstem auditory electroretinograms, full-field tials, visually including evoked poten- examinations provides Service c John the at Service of Director is PhD, JCreel, Donnell • Ophthalmology & • Oculoplastics • Neuro-ophthalmology specialties of papilledema. treatment and disease Graves’ of treatment include interests Her disorders. visual for treatments surgical and medical provides and brain, the to connects eye the how of study the mology, neuro-ophthal- practices also She lifts. eyelid as such surgeries, aesthetic and eyelids, drooping correcting traumas, after eyes the around bones the of struction recon surgery—the orbital and oculoplastics both in specializes MD, Crum, Alison enter. enter. Facial Plastic Surgery Plastic Facial o THER t he he e

lectrophysiology lectrophysiology e SPECIALTIES lectrophysiology lectrophysiology a

o . . NEW m oran oran

PHTHALM

CLINICAL e ye ye - • Counseling Related to Vision Loss to Vision Related • Counseling specialty Loss Program. Vision to Orientation the and groups, support referral services, information and crisis counseling, include program this in Services families. their and impairment visual with people for Program Support Patient mology-based ophthal- the of Director the is Lisa • Glaucoma Surgery • Cataract • Ophthalmology Comprehensive specialties world. developing the in surgery glaucoma and cataract include interests research His Thailand,Ghana,and Nepal. Haiti, Pohnpei, Guam, in worked has and ophthalmology international Dr. glaucoma. and cataracts of ment manage andthe surgical medical on afocus with ophthalmology comprehensive in specializes MD, JChaya, Craig

FACULT c o haya also has an interest in in interest an has also haya rd, PhD, LCSW,rd, y o L o

GISTS - • General Anesthesiology specialty delivery. drug and designs device medical new into research in involved be to continues He startups. company subsequent and design device medical in involved been has and neering engi- in abackground has also He surgery. after and during, before, patients ophthalmic for care anesthesia directs and provides Eye Center. Dr. Sakata Moran John the at Services thesia Anes- for Director Medical the is MD, JSakata, Derek N • Vascular Biology • Vascular specialty o of Professor Assistant Research MD, PhD, Wang, Haibo phthalmology & Visual Sciences. &Visual phthalmology EW R ESEARCH 2013 F

ACULT

a . . y 17 F o c u s 2 0 1 3 18 F      beat AMD. dad tosomedayhelp built areal desire inmy “…the teamatMoran him hope.” Patient SupportProgram, hervisionwasfineforyearsafterthat.” replaced.with hervisionandendeduphavingacornea ThankstoDrs.ManoSwartzAlanCrandallMoran’s at Moranbuiltareal desire inmydadtosomedayhelp beatAMD.Theygavehimhope.Mymomalsohadchallenges progression ofthedisease,theycouldn’t prevent it,”saystheirson,Val Green, ofParkCity, Utah.“Despitethat,theteam from ahighlysuccessfulcareer withTheCocaCola Company. “WhilethedoctorsatMoranwere abletohelpslowthe struck Mr. Green. Becausehisvisionwassocompromised, hecouldnolongerdriveandhadtotakeanearlyretirement The family’s relationship withMoranstretches backafewdecadeswhenage-related maculardegeneration (AMD)first where allpatientswhoenroll inMoran’s CenterforTranslational Medicine(CTM)research are welcomedandexamined. of inauguralchair-holder Dr. AlanCrandallandattheVal A.andEdithD.Green FoundationClinicalResearch Center, Every day, theGreens’ contributions generosity ofspiritthathascarriedonthroughthegenerations. Chair inOphthalmologyattheUniversity ofUtah in1997, itwaswitha When Val establishedtheirPresidential A.andEdithD.Green Endowed D. Green Val Edith and A. Theygave —Val Green their hands.’” have togo—there isnobetterplaceinthe country—soputyoureyes in I don’t hesitatetotellpeoplefacingvisionchallenges,‘this iswhere you relationship, soweallknowthatwhatevertheneedsare, theyare worthy. “When itcomestoMoran,”he says,“wehavealongandtrusting what’s goingon. a lotofresearch todo,andit’s importantthatthewholefamilyknows document someofourprojects. Ourcausesare fairlyeclectic,sothere’s grants board, andMatthew, theyoungest,isaphotographer whohelps sister Hollie,andhersonBrodie. Myoldestson,Aaron, isalready onthe thing, somyentire familyis involved,includingmywifeElizabeth, foundation uptogetherwiththeintentionofmakingitagenerational Front, andhewantedtoreally helppeoplehere,” henotes.“We setthe and Edith’s estate. “MydadlovedtheLaytonarea andtheWasatch who are makingadifference through thefoundation establishedbyVal The Greens’ legacynowthrives intheirchildren andgrandchildren impactophthalmiccare attheMoranEyeCenter—through thework Three Generationsof Val A.andEdithD.Green Foundation GIVING Every LittleBitofKindness He wastruetohisword—he workedhard andlovedwhathedid.” body exactlythesameway. AsfarasIcouldtell,hehadnoprejudice againstanythingotherthanstarkstupidity. “It wasn’t unusualtoreceive achickeninsteadofcash.Myfather’s philosophywasthathewouldtreat every- original St.Mark’s hospitalinSaltLakeCitywhere someofhisfather’s patientspaidhimonthebartersystem. As thesonofoneUtah’s firstophthalmologists,Dr. AlanS.Crandallrecalls accompanyinghisfathertothe Val Presidential A.andEdithD.Green EndowedChairinOphthalmology Dr. AlanS.Crandall honored astheInaugural Holder ofthe COMES BACK ophthalmology at U. the City to become aone-person division of ships. Dr. Olson returned to Salt Lake his own way for residencies and fellow- completing school, eachwent medical create over Aer next the few decades. interms wouldahead of they history the forged abond, but had what no idea lay Olson, MD. As students, medical two the where he rst met now-CEO J Randall Center beganat University the of Utah Dr. Crandall’s path to Moran the Eye Randall JOlson,MD History-making Friendshipwith and Surgery (2010). Refractive dent of of Cataract American the Society other notable honors, he is apast presi- Moran’s International Division. Among coma and Cataract, and Co-director of of Vice Senior Chair, Director of Glau- and humanitarian, he holds titles the surgeon, respected A highly educator, Endowed Chair inOphthalmology. and Edith D. Green Presidential as inaugural the holder of Val the A. to appointed his newly legacy position Dr. Crandallbrings arichand storied Chair inOphthalmology New Presidential Endowed comes back.” that.believe little Every kindness a big dierence long inthe Ireally run. little bit you can doto help can make his outlook remains same: the “Every interactions with patients and students, outreach at Moran or his day-to-day his pioneering work ininternational his father’s philosophy. Whether in Dr. Crandallhas always remembered

19 F      20 F      Dr. Alan S. Crandall S. Dr. Alan “ALL ITTOOKWAS ACALLFROMRANDYASKING METOJOINHIMBACKHERE,ANDTHAT WAS IT.” Willie Nelson’s Willie Christmas album. doctors. Ibrought myboomboxin,andwelistened to Ourdivision consistedofsixpeople,including three “I stillremember ourfirst Christmasparty. changed everything.” Today Moran inophthalmology. leader has become aglobal bit of luck. that e fact John A.Moran wanted also to give back and attach his name to our cause expand to become an international center for research. So, we grewwith alot of hard work and a Eventually, division the adepartment. became “Our was goal to deliver rst-rate care and to then that he was “not bow-tie the type.” growing of collection he which wearing started ties, bolo inPennsylvania once he gured out album.Christmas It was great.” Dr. Crandallsays felt he also more at home inUtah sporting his people, including three doctors. Ibrought my box boom in,and we listened to Willie Nelson’s it,” Dr. recalls remember Crandall. Istill our rst party. Christmas division Our consisted of six to him.“Allcalled it from took was acall Randy asking me to join himback here, and that was He says he enjoyed Ivy the but League, City Salt and Lake its mountain-ringed landscape still Meanwhile, Dr. Crandalljoined at faculty the Institute, Scheie the University of Pennsylvania. day period. Every year Every day since, period. we’ve gone werethey able to doinatwo-or three- surgeries. At time, the that was what slowly, with just ten to een cataract Kumasi, incentral Ghana. We started Anokye Teaching Hospital (KATH) in “We made contact with e Komfo and what see we can do. said, what heck, the let’s go over there of blindness caused by I cataracts. So treatments to help reverse epidemic the me about dire the for need schools and and she when came to back, she talked Africa,” he says. “She went to Ghana, out more about her family’s in history Richardson, read it and wanted to nd came out. “One of my patients, Gladys Haley’sAlex Roots book, selling best latebegan inthe 1970s,afew years aer International Outreach Program. It all Crandall unocially initiated Moran’s Among many other of acts giving, Dr. —Dr. AlanS. Crandall It wasgreat.” —Dr. AlanS.Crandall a dierence.” that I’m ahard worker, and I’m making “To me, it means recognize also they around world,” the Dr. Crandallsays. sphere—locallyblindness and inevery to spread Moran’s mission of curing stay on cutting the edge, and continue count on me to deliver excellent care, University of Utah feel that can they “I am honored that Greens the and the rstthe inhistory. time third-worldyear inseveral countries for dropped and is now decreasing every out that rate the of curable blindness has other heroic eorts, Dr. Crandallpoints other doctors.” of and these Because to go back to work dothe and to train herethem to Moran. are ey able then trained doctors their byalso bringing back. As we now doworldwide, we have great friendship and admiration he has for Dr. Crandall: Dr. sent Olson this email to all Moran employees. It shows the bigdifferenceinthelongrun.Ireallybelievethat.” littlebityoucandotohelp canmakea “Every CEO, JMEC Sincerely, RandallOlson,MD Alan, youare thebest!! for theJohnA.MoranEyeCenter! honor andthankingthisremarkable individualforallhehasdone Ophthalmology! Pleasejoinwithmeincelebratingthisdistinct the Val A.andEdithD.Green Presidential EndowedChairin of amazingserviceineveryaspecthiscareer, isnowofficially honor andpleasure toannouncethatAlanCrandall,afteryears Endowed ChairsattheUniversityofUtah.Well, itismydistinct a presidential endowedprofessor, whichisthehighestof that canbeawarded afacultymemberistobeappointedas but hadtowaituntilitwasofficial.Oneofthehighesthonors I havebeendyingtomakethisannouncementforquiteawhile, Dear FriendsandColleagues: —Dr. AlanCrandall Dr. Crandall in surgery in Dr. Crandall 21 F      Charitable Charitable Saturday SurgeryDay Maliheh Clinics in Salt Lake City and the People’s the City. and Park in Clinic City Lake Salt in Clinics Maliheh and Street fourth the at work Moran’s outreach through monthly diagnosed and screened been have 12 of whom many to welcome patients, specialist relations guest our and surgeons, nurses, fellows, residents, technicians, anesthesiologists, techs, scrub secretaries, including volunteers, 40 with up staffs Moran preparation, and of planning year, months each Saturday after one it. behind effort amonumental with service community established now an is students, medical fourth-year 2007 in by two Eye conceived Center, Moran the at Day originally Surgery Saturday Charitable at Moran’sneed own surgical facilities one special day each year. technicians, donate and staff to their provide services to surgery people in down the street. Close to home in Salt Lake City, Moran surgeons, medical Moran’s outreach Programs aim to reach around the world well as as and ripple through economies both international and local. that’s why Debilitating vision problems know no borders.they every population affect nurse, readies Leitha Harvey for surgery for Harvey Leitha readies nurse, post-op pre-and Johnston, Moran’s Cynthia they gave me back my vision.” “My gosh…everything is so position that I need help.” Ineed that position in a myself Ifind but Reservation, Indian the or Africa or Nepal from not like me. I’m someone for available was it Ididn’t think to cause. donate this to willing are who people the and here of workers team the for grateful I’m afew times. really just lines over Ihave to Icrossed that say coming! was one no that prayed and my left eye with to see my right Icovered so dark, after home to had come but hours, daylight to during went work I eye covered. one with daytime the in to drive see only Icould clients. of my names the out write and out and in me to had clock “Co-workers functioned: Leitha how is this Moran, at surgery to cataract get able was she time the By son. her with living and uninsured but employed is she cataracts, advanced from suffering four-year-old therapist massage Asixty- patients. deserving those of one was year, Harvey Last Leitha energized; Ihave anew lease on life—I’m just J. Katz and surgical team surgical and J. Katz Dr. Bradley standing; J. Sakata, Dr. Derek

surgery Day medical students, residents, and and residents, students, medical a unique foreducational opportunity provides homeless the for Clinic Street atFourth West, working Intermountain the for center ophthalmology demic aca- major only the is Moran Because 2013. October for day surgery asecond scheduled has Moran so capacity, the than greater is help for need the surprisingly, Not by insurance.” covered always not surgery elective an are cataracts did, she if Even insurance. health for enough make doesn’t but works, She Medicaid. or Medicare for 64, yet is qualify doesn’t “She clinics. atlocal year the throughout and Day Surgery on services his donates who surgeons of the one is and neuro-ophthalmology and surgery cataract in specializes who Moran’s MD, J. Katz, PhD, Bradley Isee,” patients of the many says of aprototype is Harvey “Mrs. bright. —Leitha Harvey I’m thrilled; I’m so grateful so grateful they gave me back my vision.” back gave me they grateful have a new lease on life—I’m on lease have anew just I I’m I’mbright. energized; thrilled; so is gosh…everything “My surgery. cataract to having reaction her about Harvey, Leitha says crying,” started “I at home.” of service Eye Center’sMoran mission the expands and surgeries perform to opportunity an residents gives also It marginalized. and uninsured the for need unmet an serves work Our care. eye need street the down right of people “plenty Clinic, Street Fourth atthe Eye Clinic Moran the for Director Medical the is and uveitis and diseases retinal in specializes T. MD, Nepal,” who Albert Vitale, says exotic to to travel sounds it “While eye care. needing patients 25 as many as for month per evening Tuesday one services volunteer vide pro- They see. necessarily not would they that pathology to see fellows

Leitha Harvey Leitha and Katz Dr. Bradley so so 23 F o c u s 2 0 1 3 24 F      AND can rise from, how you canstill come out of it.” to encountermay be necessary the defeats, so you canknow who you are, what you “You may encounter Unexpected S Pit Y’S many defeats, but you must not be defeated. In fact, it —Maya Angelou top Mike Nish, Andy Nish, and Moran’s and Dr. Bernstein Paul Nish, Andy Nish, Mike they nally sought treatment. Recalling Recalling treatment. sought nally they one,” other outI can’t of that see the Andy’s reply, jaw-dropping heard “cause and red?” “How so is eye come your asked, mother.”his Mike It wasn’t until “nor Nish, did Mike Andy’s dad, says it,” Ididn’t hear complain, he did “If to complain. reticence his and resilience youthful utterly of his combination a is not“How know?” Andy did question, obvious to the e answer help.fore he sought be- years two for almost injury vision catastrophic this with functioning been had Andy shocking, as Just Andy! did neither retina—and detached and hole amacular feat with this plished he accom- that know never you would Park, Motorsports Miller at pionship Cham- 2012the World Karting Junior in for place second line nish the cross Nish Andy fourteen-year-old Watching Ball of Dodge Game Innocent An

Andy in the winner’s circle winner’s the in Andy Karts poses a dierent kind of challenge. “We can ask other patients to lie face face to lie patients other “We ask can of challenge. kind adierent poses Karts races and wrestles, basketball, plays who person young active an with Dealing Care Tailoring Andy’s forever. eye Andy’s in stay will oil silicone and buckle escleral hole to close. the allowing place, in back retina the pushes and absorber ashock like acts which oil, silicone with Andy’s hole macula in the lled Dr. vitrectomy, Bernstein the aer weeks Several he explains. instrument,” actual one the is and in, source one alight puts in, uid “One pumps ports: three through to go in needles 25-gauge tiny used Bernstein Dr. pupil, Andy’s dilated through amicroscope through Looking tissue. scar and vitreous to remove the vitrectomy small-incision of-the-art astate he performed later, weeks Several it heals. until tear the toward eye of the middle the toward sclera the pushes and retina tension on the relieves Andy. is cue,” remarks apool with eye the in hit getting like “feels which eye, of the equator the around band, aplastic buckle, ascleral sewed rst To Dr. Andy’s eye, Bernstein heal Surgery severe,” Dr. says very Bernstein. are they occur, but they when children, in not common are trauma holes from “Macular object. at an directly looking when detail ne color and to see ability and vision for central responsible our is that retina of the part the is e macula degeneration. retinal and macular and biochemistry, retinal surgery, and diseases vitreoretinal in MD, PhD, specializes who Bernstein, S. Paul Eye specialist, Center’s Moran says world-renowned retinal challenging,” and complicated signicantly Andy’s made injury reaction tissue complex scar and macula, the in hole directly torn the retina, to the injury of the severity “ e Diagnosis eye. le his in vision all lost nearly Andy to where degenerated gradually injury the problem gone had the undetected, long and so ago was incident prior, the years but two because ball adodge with head side of the the in slammed been had Andy that realized they accidents, past “W that with an active teenager.” an with that down for aweek, but ithard is very to do

e can ask can e

other patients to lie face to patients face lie other —Dr. Paul Bernstein checkup with Dr. Bernstein with checkup apost-surgery getting Andy 25 F      moran eye center R ESEARCH TEAM 2013

The Nish family’s Royal Purple Streamliner

Balamurali K Ambati, Alessandra Angelucci, down for a week, but it is very hard to do that with an active teenager,” says Dr. Bernstein. “While Andy is a very good patient, he is MD, PhD, MBA MD, PhD still very limited in his activities. He always wants to know what he can do and when he can go back to sports…to car racing.” Professor of Ophthalmology Associate Professor, Ophthalmology and Visual Sciences and and Visual Sciences And car racing is in Andy’s blood. Among the land-speed racing community, the name Nish conjures instant recognition. Adjunct Associate Professor of specialty Terry Nish, Andy’s grandfather, and his three sons, Mike (Andy’s dad), Jeff, and T.J., often tout themselves as the world’s fastest Neurobiology and Anatomy Visual Cortex Circuitry and Function family, holding thirteen records set at the Bonneville Salt Flats—all four are in the 300 MPH Club. This year, the Nishes hope specialties ocular angiogenesis and corneal to break their own land-speed record, reaching 425 MPH in their “Royal Purple Streamliner.” It is Andy’s dream to follow in research their “racetracks.”

“When I get in the car, I’m completely focused,” says Andy. “I run the track through my mind. And when the green flag drops, it is reSearcH an adrenalin rush. I never feel scared; it is not a priority. I just want to beat anyone who is in front of me. But racing is not easy,” he explains. “The concentration is mentally and physically exhausting. You have to constantly think and strategize about a maneuver two laps ahead.” Andy wants to drive the Streamliner—a hot-rodder’s dream that goes over 400 mph. “That’s what I’ve wanted to do since I was two,” Andy grins. “Drive.” Yet, in treating an undaunted teenager The Race to Recovery Andy has endured several more who aspires to follow in his father’s is Longer than Expected, surgeries to remove scar tissue that tugs footsteps, who is as tough and resilient but the Driver Remains at his retina, and he has had a cataract as the 2500-horsepower Nitro Hemi Focused removed. Now, “the macular hole is engine that powers his family’s Royal “I thought I would have one surgery, closed, the retina is reattached, and Wolfgang B Baehr, PhD Paul S Bernstein, MD, PhD Paul Bressloff, PhD Donnell J Creel, PhD Purple Streamliner, and who has almost and it would be fixed,” says Andy. he has pretty good peripheral vision,” Professor and Director, Michael Director of Clinical Research Adjunct Professor, Research Professor, completely lost the vision of one eye— “My advice to other kids about having says Dr. Bernstein. “But Andy has lost 26 M. Wynn Center for Inherited and Associate Director of Ophthalmology and Visual Ophthalmology and Visual 27 the biggest challenge for Dr. Bernstein to stop the thing they are passionate central vision, which he will never Retinal Diseases; Ralph and Mary Research; Mary H. Boesche Sciences; Professor of Sciences may not be healing Andy’s eye. Indeed, about—stay as involved as much as completely get back.” “When I close my Tuck Professor of Ophthalmology Professor of Ophthalmology Mathematics specialty and Visual Sciences and Visual Sciences you can. Even though I can’t race yet, specialty electrophysiology F o c u s it may 2 0 1 3 be how to steward the transi- good eye, I can see your outline,” says specialties specialties modeling of Visual cortex F o c u s 2 0 1 3 tion of a feisty, driven adolescent as he I coached a five-year-old boy at the Andy. “But I can’t see detail.” Phototransduction, the Retinoid Vitreoretinal Diseases and evolves, through introspection, to adopt track and helped my little sister with Cycle, and Membrane Protein Surgery; Retinal Biochemistry; “I’m amazed every time Andy comes Transport in Photoreceptors; Macular and Retinal Degeneration a very mature, life-changing philoso- her championship race; I can’t wrestle in,” says Dr. Bernstein. “We just want Biochemistry, Molecular and phy—that he may have to reformulate yet, but Dr. Bernstein says I can be a Cell Biology him to have a very functional eye, very his dream. wrestling manager.” useful for the rest of his life.” “My dream is to race Formula One,” states Andy, “if I can’t do that, I’ll be involved in whatever way I can—I stay involved because I need to stay involved.”

Margaret DeAngelis, PhD Jeanne M Frederick, PhD yingbin Fu, PhD

Associate Professor of Ophthal- Research Associate Professor, Assistant Professor of Ophthal- mology and Visual Sciences Ophthalmology and Visual mology and Visual Sciences specialty Sciences specialties Genomic Convergent/Systems specialty Macular and Retinal Biology: approaches in an effort Retinal Cell and Molecular Biology Degeneration; Gene Therapy; to pinpoint disease causality in Phototransduction age-related macular degeneration, diabetic retinopathy, and rare ocular diseases. Andy in Kart #82 takes the lead 28 F o c u s 2 0 1 3 drug development physiology andmedicinefor for application inunderstanding Neurocircuitry; Metabolomics: Retinal Neurotransmission and bionic orbiological implants; sion viagene therapy andretinal the implications for rescue ofvi- intrinsic retinal circuitry, including how thosediseasesaffect the Retinal Degeneration Disorders: specialty Sciences Ophthalmology and Visual Professor, Assistant Research PhD WJones, Bryan Cell Biology Retinal Pigment Epithelial Ocular Development; specialties Sciences Ophthalmology and Visual Professor, Associate Fuhrmann,Sabine PhD Building bridesfromeseachtopatientcae sive sive of theOptic Nerve; Comprehen- Neuro-ophthalmology; Diseases specialties Sciences Visual and mology Professor, Ophthal Associate MD, PhD JKatz, Bradley Human Spectroscopy ofLiving specialty Physics Professor, Sciences; Research Ophthalmology and Visual Adjunct Professor, Werner Gellermann, PhD g o phthalmology andSurgery t issue g es f - Retinal Anatomy specialty mol (Emeritus), Professor PhD ETKolb, Helga reach Division Eye Center’s International Out- gists training underthe for international ophthalmolo- Orientation andSupportServices specialty mol (Emeritus), Ophthal- Professor LCSW Julia PhD,Kleinschmidt, tion; Retinal CellBiology of Age-related MacularDegenera- Pathways Involved intheEtiology The Genetics andAssessment of specialties for Translational Center Moran Director, Executive Sciences; Visual and thalmology Oph of Professor, Department Presidential Moran A. John PhD SHageman, Gregory ogy and Visual Sciences Visual and ogy Sciences Visual and ogy Medicine patient ca Ophthal- m oran

- Calcium Regulation; Glaucoma Retinal Neurobiology; specialties Sciences Visual and mology Associate PhD Krizaj, David Sciences Visual and Professor, Ophthalmology MD Hartnett, Elizabeth Mary Degeneration and Age-related Macular to Retinopathy ofPrematurity Retinal Angiogenesis Relating specialty Professor, Ophthal- Prosthetics Artificial Vision/Neural specialty Professor of Bioengineering Distinguished Sciences; Visual and Professor, Ophthalmology PhD ANormann, Richard reSearcH center eye moran with ocular tissues. modifications, and interactions designs, materials andsurface including different intraocular lens Ocular Biodevices Research specialty Center Research Ocular Intermountain Co-director Sciences; Visual and mology Professor, Associate Werner, MD,Liliana PhD Retinal Neurobiology specialty Sciences Visual Professor, PhD Tian, Ning Regeneration Retinal Neurogenesis and specialty Sciences Ophthalmology and Visual Professor, Associate PhD MLevine, Edward Ophthalmology and and Ophthalmology R Ophthal ESEARCH - Development Glaucoma; Drug andDevice specialties Sciences Visual and Professor, Ophthalmology Associate Adjunct Clinical MD MWirostko, Barbara Retinal Development, Glaucoma specialties Anatomy and Neurobiology Neuroscience; and Chair, of Professor Winder Lorna and George Sciences; Ophthalmology and Visual Adjunct Professor, Vetter,Monica PhD Inflammation Lens Research; Postoperative Ophthalmology; Intraocular Ocular Pathology; Comprehensive specialties Center Research Ocular Intermountain Co-director, Sciences; Visual and Professor, Ophthalmology MD Mamalis, Nick

TEAM 2013 and Retinal Diseases Cell BiologyofPhotoreceptors specialties Sciences Visual and mology Professor, Assistant y Jun and diabetic retinopathy tion, retinopathy of prematurity, in age-related maculardegenera- pathological neovascularization vessel growth implicated in Vascular Biology:abnormal specialty Sciences Visual and Ophthalmology of Professor Assistant Research MD, PhD Wang, Haibo Neurocircuitry; Metabolomics Retinal Neurotransmission and specialties Sciences Visual and Ophthalmology in Chair Endowed Presidential Hatch JeNeal and Cal Eye Center; Moran A. John mology, Ophthal- of Professor guised and Research of Director PhD EMarc, Robert ang, PhD ang, Ophthal- Distin- 29 F o c u s 2 0 1 3 30 F      tells you, ‘You know what, I’m going to become a homicidal maniac if you give me systemic steroids,’ won’t systemic me that.” do give you if Iprobably maniac you,tells ‘You ahomicidal I’m what, know to become going apatient “If personally,” and ocularly, continues. medically, he well, very patient the knowing tolerate. requires It cannot or can they to what and disease, to to patient, the their to individualized be needs therapy, approach the one “I’m any but against not akey diseases—this is concept—however that,” of do these Dr. can you remission stresses Vitale. a to induce just medications to unnecessary patient the don’t but subject need, you whatever “Use effects. side drug-induced significant any experience not does patient the that so medications to immunomodulatory how use about immunologist ocular or chemotherapist expert truly and atrained with collaborating includes This patient’s of the uveitis. cause underlying the intraocular inflammation—with no relapse.” The text stresses that physicians follow a comprehensive approach to diagnosing bookThe presents a unique philosophy: “Our mission is remission—a complete intolerance to chronic, even low-grade diseases.” 30 about is disease—it one not is disease,” Dr. says “Uveitis Vitale. underlying of an afeature as or by itself occur can It complexity. of its because to diagnose challenging be can “Uveitis disease: of the crux the is this And impairment.” visual to permanent eyeleads that the to damage structural ocular to the prevent control under adequately—to and inflammation the get effectively to uveitis treat and to adiagnosis make So, essential is it prime. productive their in people affects frequently it because significant is blindness that treated,” of impact adequately Dr. says “The being not from Vitale. impairment visual have permanent will of patients percent to fifty “Forty-five conditions. serious other for asymptom be may and serious be may of body. uveitis form Any ciliary and W only the is He surgery. vitreoretinal well as as disease inflammatory and immunology ocular in training dual with country the in of people of ahandful one also is He of eye. the diseases inflammatory and infections other and of uveitis treatment and diagnosis the in West specializing in the Intermountain ophthalmologists only 2012 in Dr.published Foster. co-author C. with Stephen Dr. of the one is Vitale organization,” was “encyclopedic its for noted book, The Treatment of Uveitis. and T. of Dr. edition Albert Vitale’s second the Diagnosis welcoming definitivetextbook, in community medical worldwide the answer. the and may be Moran join Please physician Moran of one philosophy conscious and commitment extraordinary The yet another tome…and the second edition at that? and references, how does one become excited about theAs ophthalmic community is rife with uveitis texts O Treatment and Diagnosis of Uveitis EditionSecond UR provider of such expertise in the Intermountain W Intermountain the in expertise of such provider key,” states Dr. Vitale. Uveitis is inflammation of the uvea, the middle layer of the eye, consisting of the iris, choroid, choroid, iris, of the eye, of the layer consisting key,” middle the uvea, of the inflammation is Dr. states Uveitis Vitale. “That’s uveitis. treated of inadequately 10-15 that aresult is know not US do the in people blindness of all percent many blindness, cause can pigmentosa retinitis and degeneration, macular glaucoma, that known well is it hile M ISSION IS REMISSI est. ON

much. It is humbling. It is a real privilege to aphysician.” be privilege areal is It humbling. is It much. so me teach just do. They of my patients…I really care to taking in it,”day attentive awake and every that Dr. says see “I Vitale. are you if us separates than together us binds that more other. much is each to help There planet the on we are that believe “I ducing untoward side effects,” he stresses. pro- without inflammation of the control to gain different something try isn’t working, something If to treatment. your response patient’s the rethink and evaluate, reassess, always adiagnosis, with up “You come don’t you if atfirst have tohunt: the in stay Dr. chapters,” in explains Vitale. specifics, for available…you here categories…you’ve look information can this all got broad in Ithink user-friendly—very readable. very is this but textbooks, great are which books, other are 1,200 “There pages. over and chapters, 83 sections, six offering scope, in comprehensive is philosophy, its it about clear book the is only Not burden thattheymanageisalmost and thetrustthattheyputinme.The patients handletremendousadversity by thewayinwhichmanyofmy VITALE unthinkable sometimes.” “I’m totallyawed A lows at the M the at lows Clinic at S the Fourth works with the indigent and underserved in S in underserved and indigent the with works A world the of through Division O International developing the in care retinal sustainable and comprehensive of delivery the in involved is he addition, In degeneration. macular andage-related disease inflammatory ocular between uveitis,ric andthe interface in of the management uveitis, pediat surgery vitreoretinal anddiagnostic andtherapeutic degeneration, macular age-related disease, inflammatory ocular of treatment the for systems delivery and drugs novel merican lbert lbert T . V A itale itale cademy of of cademy oran oran M —Albert T. Vitale D, has incorporated his research interests research his incorporated D, has E ye Center, but andinternationally, nationally editor contributing as for several serving

treet Clinic. Dr. V Clinic. treet and humbled O phthalmology publications. phthalmology itale is committed to education, not only among residents and fel and residents among only not to education, committed is itale phthalmology at thephthalmology M alt alt L ake City, serving as M as serving City, ake

into clinical practice and is focused on on focused is and practice clinical into oran oran edical Director for the M the for Director edical E ye Center and O and ye Center RBI S . He also also . He oran oran E ye ye - - 32 F      process—and needs just asmuch attention. negative results have been harder to publish. However, corrective science part of is the ere huge is pressure Moran Researchers UpendPrevailing Theoriesabout A commitmenttoongoing, S. Bernstein, MD,PhD;and theirwillingnesstoquestionassumptionsbehind acceptedtheories. S. Bernstein, Ching-Kang Cheng,PhD; ZongzhongTong, PhD; CarlB.Watt, PhD;BryanW. Jones,PhD;Paul like DavidKrizaj,PhD(pronounced KREE-zhai);PeterBarabas,PhD;AihuaLiu, PhD;Wei Xing; lives setstheMoranEyeCenterapart.Keeping attheforefront are creative researchers

for scientists to report positive ndings, and historically, R ARE

—Bryan W.—Bryan Jones, PhD intensivevisionresearch withthepotentialtochange millionsof C HILD HOOD Bryan W. Jones, PhD, and Peter Barabas, PhD Barabas, Peter and PhD, W.Bryan Jones, PhD, Krizaj, David PhD, MD, Bernstein, S. Paul DISEASE Photo credit: Bryan William Jones, PhD Jones, William Bryan credit: Photo of the disease. mechanisms the of some study Center Eye Moran the at scientists let to designed green, and red in model amouse of retina the of top on projected is scan retinal is blindness. and loss vision progressive causes that degeneration macular of form inherited an avimaculatus, fundus or Disease, Stargardt with retina apatient’s of A scan manifesting.” from it prevent maybe then and delay to first treatments find possibly we can causes, its understand be,” we can “If might explains. he disease devastating this underlying mechanism the to as what theory definitive amore atproviding ashot we physiology—we had their thought cells—mainly photoreceptor on is lab our in focus the “While motivating. as well as fascinating academically was To challenge the team, his Dr. and Krizaj survive.” not did ELOVL4 out which in knocked was disease—mice of the model animal an to generate unable were scientists thing, one for because, dispute for up been always has acids fatty long-chain about theory prevailing to Dr. “The According Krizaj, contentious. somewhat been 3have actually type Stargardt regarding results and family.) However, aUtah in studies it ELOV4 of the ongoing characterized discoverers having mutation, original of the one was sciences, visual and of ophthalmology professor and specialist Dr.(Moran’s retinal Bernstein, Paul ELOVL4. gene the in by defects caused is disease, of the form dominant autosomal and 3, rare the type that thought ELOV4. and ABCA4, CNGB3, have long mutations: Scientists gene different by three caused are of Stargardt types Three blind. legally children rendering worse, slightly or to 20/200 decline can acuity visual but remain, may vision peripheral Some retina. of the center the in macula, the in intense most is loss vision widely, but varies disease of the progression and severity The twenty. and of six ages the between children ten-thousand in one about strikes that degeneration of macular aform is eye disease, incurable an Stargardt, degeneration. 3retinal type Stargardt with children in blindness caused cells photoreceptor in (VLC-PUFAs) acids fatty long-chain of very alack that believed scientists vision years, For point: in Case best way to first delay and then prevent Stargardt type 3?” type Stargardt prevent then and way delay to first best the is what question: grand the to pursue of Health Institutes National to go the eventually will and Blindness Fighting to Foundation the Dr. with agrant Bernstein We have submitted disease. Stargardt human of the replicas closer are models mouse Our of cones. percentage asmall have just they so nocturnal, basically are Dr. “Mice Krizaj. photoreceptors much more than rods during the daytime,” explains cone on rely “Humans have asolution. researchers 3. Moran type Stargardt of human replications perfect by means no are models While the published study constituted a breakthrough moment, mouse Forward Going notes. drains,” cells’ the Krizaj clogging and traffic lular intracel by blocking death cell photoreceptor like causing almost is This proteins. normal and of mutated deposits large in resulting and cell, the in substance ajelly-like cytoplasm, the in aggregating are reticulum mic - endoplas the from escaping proteins mutated that is One possibilities. of new thinking start we can and aside, set be can strategies treatment moment—which, according to Dr. Krizaj, “means that a set of proposed As a result, the research experienced a community “one-step-back” study. the on author first Dr. in fellow PhD, Krizaj’s apostdoctoral group, the Peter is Barabas, 11, March online, PNAS in findings its 2013. published group The cells. photoreceptor in acids fatty long-chain very in reduction dramatic the despite affected not was sight that showed mice the in vision night and Stargardt disease. Electrophysiological and behavioral testing of day with children in loss vision replicates acids fatty long-chain of very loss whether to directly test them allowed This percent. to up 90 reduced cells those in acids fatty the with but to survive, mice the allowing cells, photoreceptor ELOVL4 their lacked in only models Our theory. prevailing the disproved researchers the mouse, abetter breeding actually By Engineering Change

- 33 F      34 F      December 27, December of Medicine, 2012. Journal England New the in published University, Vanderbilt of PhD, Penn, John co-author and by Dr. Hartnett Report Progress of aMedical subject the is and infants premature in only occurs prematurity of Retinopathy scars. form and bleed gel wherethey vitreous the into to grow start vessels blood the retina, the into growing of instead whereby vessels, blood retinal the of development abnormal vision-threatening caused disease by a is prematurity of Retinopathy under term birth. ese infants were experiencing retinal detachments from retinopathy of prematurity (ROP). of prematurity retinopathy from detachments retinal were experiencing infants ese birth. term under was combined age chronologic and gestational whose Eye infants on Center, preterm Moran to operate had at the has surgery and diseases retinal adult and pediatric in specializes who Dr. Hartnett, which in cases have been there yet, And high.” incredibly are stakes “Obviously, the shesays. detachment,” retinal to inoperable lead could which retina, the or lens injure tiny the damage you could of that, Outside wide. amillimeter than less is baby of eye apremature to enter the area safe “ e it. to nd determined If there any is way Prematurity on Retinopathyof New Light SHEDDING R: P M Mary Elizabeth Hartnett, MD Mary Elizabeth Hartnett, to avoid the need for vitreoretinal surgery on a preterm baby, Dr. Mary Elizabeth Hartnett is is Hartnett baby, Elizabeth on apreterm Dr. surgery Mary for need vitreoretinal to avoid the

US, older and larger preterm infants infants preterm larger older and US, outside the countries developing However, this. in with changed has of ROP appearance younger, the and ROP to develop become has survive who infants of preterm age gestational e for over years. 20 surgery and laser with them treating and babies worldwide. “I’ve been examining blindness childhood and infant of cause aleading ROP become has world, the throughout developed has babies preterm younger and smaller to save ever technology But because term. full until developed not fully is retina the for ROPat risk because 2-3/4 been havethan always pounds less weighing born babies Premature

dierent form of ROP than we see now we see of form ROPdierent than may havea represented descriptions initial changed: since has perspective our infants, to preterm oxygen regulate to ability the But with cells. endothelial developing newly babies’ the injured some cases—which 100 percent in babies— to preterm given being was that of oxygen amount of the because to manifest thought it was US, the in recognized ROP rst “When was she says. 1950s,” the US in the in occurred to what ROP developing similar are infants of these Many lacking. are oxygen to regulate resources the because ROP part developing in are

one of the main translational eye study sections that reviews grants for the National Eye Institute. Pathophysiology of the Visual System at Study the Section Center for Scientific Review, 2013. chair, As she will leading be for aprestigious with the National post Eye Institute at the National Institutes of Health as Chairperson and to the Diseases a role model and mentor for pursuing people in careers vision and ophthalmology research. She was also recently selected was awarded the Honor of Silver Fellow, 2013, by for the Research Association in Vision and Ophthalmology for her work as Mary Mary surgery infant an experiences Whether PEDIATRIC models,” Dr. mouse Hartnett using ROP weConsequently, study by avoided. muchis too blood taking don’t have so alotinfants of blood, preterm course, of And blindness. to lead can and risky extremely is eye the from uid any one, taking apremature especially infant, the In ROP. to research dicult “It really is of vision. loss in results this cases, severe In eye’s surface. the inner from loose retina the pull and develop may tissue scar aconsequence, As eye. the into bleeding causing leak, can and fragile are vessels ese eye. the of back the lls gel that clear normally the into retina the from abnormally grow vessels instead, and slowed down, is development vessel retinal normal that we see vessels, retinal developed already injuring than “Rather explains. Dr. Hartnett regulated,” is oxygen that doctors nationwide. nationwide. doctors what can done, be including vetting websites, the best providing reliable information and images, and consulting with retina specialists by bridging the gap what between and doctors patients know about pediatric retinal conditions and The Pediatric Retina Center at Moran can also of be particular help in small rural or that areas may not have pediatric region. mountain it to the clinic with or their The doctors. center has the potential to ahub become and in of resources services the inter children can’t achart), read consultations, and visual rehabilitation. The team also consults with people who can’t make and diagnostic offers testing, such electroretinography as (which the measures function of the retina since young very rare situations specific to children. Moran’s highly specialized team has the capacity vitreoretinal to perform surgery The Pediatric Retina Center at Moran is equipped to diagnose and and treat these myriad other conditions, including points out, and “Doctors parents must constant be advocates for kids. these It is important.” so eye), and glaucoma. In eye many these problems cases, can treated be controlled, or but Dr. as Elizabeth Mary Hartnett problems later in life, such retinal as detachment, myopia (nearsightedness), strabismus amblyopia eyes), (crossed (lazy that eventually on its own, resolves infants with ROP are considered to at higher be risk for developing certain eye E lizabeth Hartnett, M Hartnett, lizabeth R ETINA ETINA D, Professor, of Ophthalmology Department and Visual Sciences at the Moran Eye Center, C ENTER AT MORAN Some treatments, such as anti-vascular anti-vascular as such treatments, Some of dilemmas. anumber with ux, in aeld is this out, points article the As for ROP.”to treatments may lead Pennthat by John developed model arat using important to be appear that pathways various described we part, second the “In she says. article,” of our part rst the was at disease. the able to study to be models animal relevant to use need we really infant, human the do in we what can as far as limited wherewe are adisease in but of babies, levels oxygen monitor the and regulate we can that so occurred have advances of technical number US today. ROPthe Aof in the we see most doesn’t reect really model mouse ROP. in changes of pathologic But the progression the drive that mechanisms molecular and cellular the examine to oxygen high using retinopathy of oxygen-induced model amouse was there 1940s–60s, “From the explains. for the most progressive stages of ROP for develops theor stages progressive most amilder form need forneed surgery.” avoidthe hopefully, and development, improve visual disease, the treat better ROP, able to be with babies we will more of preterm what’s on in going we understand As infant. preterm the development of the in important also ROP of are features pathologic cause VEGF, as that such factors, “Sometimes shenotes. disease,” the as well as development of issues with dealing We babies. preterm are on with going things many so are there that is it hard lab). makes Dr. “What from Hartnett’s papers published recently in explored topic (this is eects have adverse to help may also seem that injections (VEGF) factor growth endothelial - 35 F      36 F o c u s 2 0 1 3 ophthalmologists startseeingpatientsondayone,underthesupervisionofaboard certifiedophthalmologist. 2012 ushered inaninnovativeeducationmodelatMoran—a“ResidentContinuityClinic”whichfuture Ophthalmology trainingatthehighestlevels Jim Bell, MD Zachary Joos,MD RussellSwan, MD MD BrianStagg, Adam Jorgensen, MD moran eye center eye moran Residenc SEC Dan Bettis, MD MD BrianZaugg, Trent Richards, MD THIRD Y FIRST P o r ND o y y gr y EAR EAR am 2013-2014 EAR Leah Owen, MD, PhD RESIDENTS Joseph Chen,MD Nikhil Batra, MD Valli Muthappan,MD G RETINA C ORN L

au AND Fellowship P COM ea

FELL a Meng Lu,MD Ronald Hobbs, MD Luis Santiago-Caban, MD 2013-2014 o WS r o gr am 2013-2014 Benjamin Thomas, MD Krista Kinard, MD F I M oPHTHALM N NTERNATI ELL EUR OR o a o- WSHIP N o o NAL L o G y Inte Scott Cole,MD Rene Choi,MD, PhD JuliaByrd, MD Eileen Hwang,MD, PhD moran eye center eye moran r o ns &Ocula CULAR PATH ohaFr,M Justin Kohl, MD Joshua Ford, MD r Patholo I NTERNS o L o G gy y/R Fellows2013-2014 ESEARCH I NTERNS the John contributing to makingthepostgraduate positions available at be ranked among thetop citiesinwhich to live—all factors a population known for friendliness,SaltLake continues to in Utah. gorgeous Withworld-class skiing, desertcountry, and University ofUtah istheflagshipinstitution ofhighereducation Located at thebaseofspectacular Wasatch Mountains, the Center Children’s andPrimary Hospital. provide training at the131-bedVeterans Administration Medical among physicians staffing fourUniversity hospitals. Consistently ranked satellite clinics.Thisincludesmore than1,200board-certified are key components ofthe400-bedUniversity Hospital andits t specialist whowe train. mesh perfectly andto enhancetheeducation ofeachindividual The Moran residency andfellowship programs are crafted to of clinical and surgical experiences for both residents and fellows. sufficient patient visits(120,000/year) toensure afullspectrum 8,000 surgeries peryear. TheMoran Eye Center benefits from suites, over 40ophthalmology specialists carry outmore than With 12locations and four state-of-the-art ophthalmic surgery Fantastic program, hospital, university, andlocation he Department of

AND US News &World Report’s a . . m oran

PATH e o ye ye phthalmology andthe c enter asuperboverall experience. G o L o 2013-2014 “Best Hospitals,” y F m ELL oran we also e o ye ye WS c enter

38 F      2012 ushered in innovative an Zaugg Brian Bettis, Dan Owen, Leah Holt, Derick Trent Richards, Bell, Jim Kinard, Krista Joos, Zachary Swan, Russell Drs. Clinic Continuity Resident Moran’s New complicated patient who had been to emergency two times then then times two to emergency been had who patient complicated areally had “We example, For plan. own his with it compares Dr. and plan, Pettey then atreatment with up come and diagnose to able are residents Senior process. the throughout residents the teaching patients, same the Dr.sis. examines Pettey also adiagno- propose and patients examine residents as begins It training.” their personalize to really residents for opportunity an is one,” day Dr. says beginning Pettey. of responsibility, levels “This provider to how become to learn residents for opportunity an and ment ophthalmologist. clinic “The provides a unique teaching environ- certified of aboard supervision the under training their during which provides for opportunities residents to follow patients Clinic,” “Continuity model aresident-staffed established he result, provider. eye care a As primary their as adoctor identifies patient a when occur that of training aspects important some on out miss may residents that found He teaching. and training in innovations cutting-edge on focusing worldwide, and States United the in evaluated current academic ophthalmology practices and models Sciences, Visual and of Ophthalmology Director Program sociate As- and Dr. Pettey, Professor program, Jeff Assistant resident forward-thinking progressive, most the to provide to continue striving and director program residency new as Taking helm the Your Meet Patient One: Day of ophthalmologist. a board certified supervision the under one, day on patients seeing start mologists Moran—a “Resident Continuity Clinic” in which future ophthal- for the patient in a well-supervised setting with graduated graduated with setting awell-supervised in patient the for Aabid Faruukhi, U of U medical student with a Fourth Street patient Street aFourth with student Umedical Uof Faruukhi, Aabid education model at model education the the Dr. Je Pettey examines Fourth Street patient Street Fourth examines Pettey Dr. Je Day O Day ne: Meet Your Meet ne: Patient way teacher-student relationship. I learn from them every day.” every them from Ilearn relationship. way teacher-student aone- than rewarding more much is vision—I’m process the but see and teaching, still success—to to connect them get to residents’ the Dr. success,” says attached every in Pettey. personally get challenge, “I every joyin the finding in believe “I fellowships—again,subspecialty always of ophthalmologist. underthea board supervision certified to year, third apply they their when surgeon to primary transition and years two first the for surgery in assist Residents year. each advance they as time patient increasing week, each day one-half for patients see Interns of experience. a range get to stroke, to residents so diabetes of vision loss from range may Issues efforts. of Moran’s outreach local part as Clinic Street Fourth atthe seen are Others stable. medically are they if to Moran come may and problems medical have complex who in-patients Hospital University clinic’s of the are Some patients personalized. highly is care and patients, with time more day—Dr. to of patients—an of ten per six volume alow average get sees to time to residents teach, more take able Pettey is Clinic Continuity the patient’s of Because the treatment. course entire the for patient own their see residents clinics, During mine,” Dr. Pettey notes. to surpasses or equal attimes is of knowledge level residents’ the that humbled I’m life. his saving frequently tests, literally for to emergency back be—and him we sent should clot together—he the where clues the exactly put knew Aresident agnosed. di- properly not if him have killed would that brain his in clot ablood had He infection. of aviral signs with to clinic the came resident Dr. Tom Oberg, year,is competition the more was intense ever.” than submittedand our matches; it’s exciting,” very Dr. said Je Pettey. applicants 28 interviewing out nished top-tier of 400 candidates number the in of resident applications received to date. “We just resulted program has arecord-high in graduate training increase Moran’s continually rising reputation and state-of-the-art state-of-the-art and reputation —Dr. Je Pettey, January 2013 39 F      40 F o c u s 2 0 1 3 practice—I want to all.”practice—I want it do a having quo. Teaching, status the research, with staying not solutions, with up like “I coming examinations. for lane another add and place in equipment better ways find put toto help plans also efficiently.” more He eye clinic the run and difference abig make we can Ithink because them for of time blocks special up setting notes. “I’m on challenge,” he working aspecial are ill chronically “The patients. Now, examining team of the he’s amember also to work. straight go could they so ready and up set was everything that sure made Stagg to diabetes, cataracts from issues with patients to help clinic the visited doctors Moran When needed. if surgery, to after stay place a had and to it Moran made actually treatment further needed who patients sure to making appointments scheduling from thing every- doing clinic, the managed and volunteers coordinated He population. to city’s the homeless healthcare comprehensive provides that Clinic—aclinic Lake’s Street free atSalt Fourth reach out- Moran’s monthly with involved ongoing, deeply was Stagg program, residency the entered he before Even relationships. ing by motivated build- is he byeye as the Dr. fascinated as is Stagg relationships.” patient building includes that experience special avery we get Clinic Continuity Moran’s with but ophthalmology, in of alot experience with year intern don’t you an faculty,” get places, most “In says. he average—as above the is far really is atMoran get residents of experience amount the that found and possibilities several into looked “I of Utah. University the from degree amedical and Young University Brigham from honors with Portuguese in minor a and Neuroscience in of Science aBachelor includes resume his to credit, his publications and research, teaching, projects, of service adecade to having addition In program. a residency on deciding was he when of choices C. MD, plenty Stagg, had Brian resident Moran twenty-nine-year-old that It’s surprise no is Already Making aDifference Moran Resident C. Brian Stagg, MD, A Clear Vision of Service ARCS Foundation ScholarAwards. eligibletoreceive are top 100inthecountry rankedinthe ties whosedepartmentsare OnlyUSuniversi- and medicalresearch.” inscience,engineering, complete degrees cally outstandingUScitizensstudyingto by providingfinancialawardstoacademi- “advance scienceandtechnologyintheUS Inc. (ARCS).Thefoundation’s mission isto Rewards forCollegeScientistsFoundation Scholar AwardfromtheAchievement Brian C.Stagg,MD,receivedthe2013 Dr. Grant Morshedi, Kevin Kirk, U of U fourth- Uof Kirk, Kevin Morshedi, Dr. Grant year medical student at Fourth Street Clinic Street Fourth at student medical year Stagg C. Dr. Brian Monjaras, Hector Dr.Pettey, Jeff practice—I want to do it all.” Teaching, research, a having quo. status the with staying “I like coming“I up like with solutions,with —Brian C. Stagg, MD Stagg, —Brian C. not not

Moran e a full range of world-class medical services. medical range of world-class a full provides which Clinic, Health ofCare Utah aUniversity with located are typically Clinics Front. Community Moran eyewear, all to We lenses meet of your eye needs. the along care haveWasatch and the contact latest locations 13 moran eye center eye moran ye Center in your Community

o C The Moran Eye Moran comprehensiveeyeThe Center provides exams, MMUNIT y CLINICS Bryan Vincent, OD Vincent, Bryan Smith, OD Craig Colleen Schubach, OD Clair Palmer, OD OD Olafsson, Harald OD Morgan, Alan McKay,Mark OD OD Gibbons, Timothy OD Corry, Robert Optometry of Doctors Eye Center Moran 2013 fashion fashion

41 F o c u s 2 0 1 3 David KelbyJohnson Game-changer forMoran’s Outreach Program A Grandson’s Legacy anda HOPE FUND dreams, shedreams big. When ElizabethHopeJohnsonofSaltLakeCity christened itthe“DavidKelbyJohnsonHopeFund.” donation ofonemilliondollars,andMrs.Johnsonhappily The center’s namesake,JohnA.Moran,matchedher ongoing outreach programs—locally andaround theworld. true withanextraordinary, heart-feltdonationtoMoran’s David KelbyJohnson.In2013shemadethatwishcome been tohonorandshare the memoryofherlategrandson, six continents. establish, eventually covering twenty-two countries on on y it.banner the will at ey eacheyecamp that they and ahuge unfurl banner with David’s faceand name mission to Nepal inOctober, Moran teams carry will Nation, just blows my mind!” Starting with next their overall world the and right here inUtah, Navajo inthe her words, sight-saving “ e work that Moran is doing providing hope, understanding, and treatment to In all. thatfact David’s name live will on inMoran’s mission of ecstatic” about matching the her gi, donation, and the City Ski and Mountain from Resort bankruptcy,” says nancial world, saving Alpine both Meadows and Park construction the “Butclosed rm. he stayed active inthe andCalifornia nearby Tahoe. Lake Aer 20years, he own construction largest rm—the inMarin County, schemes. Aer he resigned from FBI, the he his started to uncoverhis expertise anumber nancial of illegal by FBI the where he worked agent, as aspecial using exam at age 22,Raymond was immediately snapped up businessmen. e youngest person everto pass CPA the a man would who become one of Utah’s most successful aperson’sto discern nature, she inlove had fallen with outstanding head-of-his-class “Pi Kap.” True to her ability and four years later Raymond Johnson, married Irvin an As ayoung “Tri Delt” at University the of Utah, she met of integrity and abilitynature true the to see of people.” with some“born kindof spunk inside—and dose agood happiestthe she says childhood, she to seems have been to live with relatives City. inSalt Lake While it wasn’t years old her when mother away passed and she was sent inNorthBorn Carolina was just in1917,Elizabeth two Elizabeth’s Story a-half-year-old, Elizabeth “spunky”A self-described ninety-ve-and

says she is “simply

One ofherwisheshasalways and traveling world. the her lush gardens, creating warm and welcoming homes, immense pleasure and pride inplanting and nurturing roughoutElizabeth. marriage, their took Elizabeth part ofpart that.” delightedwould so be to know that forever he will a be sight and give hope them for abrighter future. David help manywill so desperate young people to restore their fond of saying. “And inMoran. Ireally believe is gi “I’ve always up stood for what in,” Ibelieve is Elizabeth springboard for more long-term, sustainable programs.” regionsunderserved of world, the and give it us will a more blind patients insome of and most the neglected bringit will more sight-saving surgeries many to so expand our programs into areas new of desperate need— e David Kelby Johnson Hope Fund allow us to will “Elizabeth’s incredibly generous game-changer. is atrue gi International Division Manager Michael Yei notes, Game-changer to remember it,” she says. “Please, donot and drink drive.” want people to know about what happened to David, and relentless against driving crusader eversince. drunk “I forever changed and shea aected has Elizabeth; been street corner of Main Street City. inSalt Lake at tragedy standingby driver while on adrunk on the sidewalk the When he was just eight years old, David was hit and killed andsad senseless loss of her grandson over 30years ago. stop and breath adeep take she when contemplates the much gets past her. But to day, this has to still Elizabeth and eliciting laughs with pointed comments—and not eyes,constantlykling gesturing with her delicate hands She punctuates her conversation and with smiles twin- David’s Legacy 

David Kelby Johnson Kelby David

43 F      44 F      mirrored in the livesmirrored of their children.” saved and hard their money to world createthrough philanthropy. abetter Weprinciples same these see father. and hewas husband adedicated businessman, wiferemarkable his worked dear Aline and Sam throughouttheir lives. friends cial With Sam’s we passing, we’ve all feel only was Not afriend. lost hea Eye Moran Center,John A. have Mr. this Moran spe- about John said and Skaggs been “Sam Skaggs: Dr. Skaggs. ofbenefactor in theSam passing CEO and of Chair of JOlson, Ophthalmology the Randall year faculty,This generous Eye and Moran friend adear of Center lost the A. John friends staff, and L. Sam Skaggs Sam L. speeding up research that is bringing us closer to treatments and cures for vision loss. loss. vision for cures and to treatments closer us bringing is that research up speeding literally is Sam’s to Moran. top scientists generosity new to recruit helping are laboratories research state-of-the-art These possible. as quickly as care to patient discoveries research to bring desire our symbolizing facilities, clinical to our by bridges connected also is It Campus. of Utah University the around scattered once were who researchers vision PhD 60 than more unites Eye Center Moran atthe Pavilion W. Research Aline L.S. Skaggs six-story and The 2006.” in eye center new beautiful our to construct possible it making gift, major second that with up stepped Foundation ALSAM The and Skaggs Sam construction. to begin gift major another Eye Center, 210,000-square-foot new needed the Moran Moran toward gift lead gave his Moran John after “Two-and-a-half years family: Skaggs the from gift acritical Dr. recalls Olson friends.” of my dearest one him Iconsider support. longtime his Sam’s and me in belief forgotten Ihave never navy,” the my in confidence. boosted to alot and duty fondly. me active Mr. meant “It recalls Moran from I’d released after been Ijoined firm investment the with transaction financing my first complete me helped “Sam John A. Moran met Sam Skaggs in 1962 in Skaggs Sam met Moran A. John The Expanding, Enduring Legacy of Legacy Enduring Expanding, The Moran Eye Center construction 2005 construction Center Eye Moran biologist and geneticist Dr. Margaret DeAngelis and her team as they carry out research research out carry they as team her and Dr. DeAngelis geneticist Margaret and biologist molecular Moran funding is donation This tribes. America’s underserved to help a desire of Mr. felt who passion Skaggs alifelong Utah, in populations American Native to with work researchers Moran for donation agenerous provided Foundation ALSAM recently, The Most S the mouths ofthe mouths men.”—Quintus Ennius through fro to and mourning; Ipass for Istill live,as with my celebrate funeral or for me, weep one “Let no when Mr. Moran was a young investment banker just getting started. started. getting just banker Mr. investment ayoung was when Moran am S am kaggs John A. Moran A. John L.S. Skaggs Pharmacy building. to We’re akey the was donor years. 60 over Moran to John that say proud to education commitment father/son the demonstrates school great into one 1950s the in Sam’s to buildings honor of two constructed father. joining The building pharmacy to older the connects which Institute, Research Pharmacy L.S. new Skaggs the is of Utah University atthe research and care, health to education, commitment Skaggs’ Sam representing jewel crown The future.” key the to successful as our research and of education friend of business, world competitive and intricate the in leader needs, care health and of pharmaceuticals distribution the in administrator capable and personality, West, ofJr., the dynamic son native distinguished “To Mr. of giving: spirit his L.S. Skaggs, captures that of Utah University the 1970, as from early As acitation education. received on he had has Skaggs Many universities and have colleges recognized the Sam effect important Institute. Research Scripps atThe Biology Chemical for Center Skaggs of The creation the for research to medical made ever gifts Mr. largest of the gave one funding. Skaggs generous to due their Aline and Sam after school pharmacy their housing Six major universities have named either their pharmacy school or a building Dr. Margaret DeAngelis and Luttrell Skaggs Claudia

elementary and secondary complex, located in Salt Lake City. Lake Salt in located complex, secondary and elementary parochial nation’s the single and centers, largest research and university many of funding or establishment the by way of scholarships, research and care, health to education, of dollars of millions hundreds have given They years. 65 past the over founded they entities other and Foundation ALSAM The through and personally of giving alegacy have bestowed Skaggs Aline and Sam to come for generations Making place the worldabetter Skaggs Aline and Sam of Philanthropy The men.” of mouths the through fro to and Ipass live, as Istill for mourning; with funeral my celebrate me, for or weep one no “Let say: and Ennius of Quintus wish the echo might to he today, if us speak wonders could one Skaggs Sam If to program. time this to her donate continues and service and philanthropy to quiet committed is father’s her Claudia in footsteps, Following population. this in disease retinal to Dr. ameliorate DeAngelis alongside working was Claudia daughter his that to learn proud and Mr. delighted was Skaggs passing, his Before children. his in instilled Skaggs Sam that of giving legacy the firsthand to witness privileged we have been of research, program this out carry researchers Moran As Americans. Native among diseases into retinal John A. Moran Eye Center Eye Moran A. John L.S. Skaggs Pharmacy Research Institute Research Pharmacy Skaggs L.S. 45 F      46 F o c u s 2 0 1 3 Drs. Sanduk Ruit, Randall J Olson, Geoffrey Tabin Geoffrey JOlson, Randall Ruit, Sanduk Drs. Africa. Sub-Saharan and Himalayas the in those including nations, impoverished and isolated most world’s the of some in individuals million 1 than more to sight restoring for responsible indirectly or directly are Ruit Tabin and To Drs. date, process. surgical this in doctors international and local other train then who doctors local training and nations emerging in hospitals self-sustaining building includes system Their dollars. twenty about costs that surgery minute ten- revolutionary a developing by world the in blindness preventable eliminating to efforts and time their dedicated have Ruit Tabin and Drs. globe. the across countries developing in blindness preventable cure help to and delivery eye-care improve of both and the story doctors’book tells work to develop Relin’s Nepal. captivating Kathmandu, in Centre Eye Tilganga the of Director Medical and Center Eye Moran the at Ophthalmology of Professor Adjunct Dr.Ruit is care. refractive and cataract, corneal, in specializing of Moran’s Co-director and Division, ences International Sci- Visual and Ophthalmology of Dr. Tabin Professor is Relin. Oliver David author YorkNew bestselling Times by book released recently a Suns, Second in chronicled is Ruit, Sanduk and Tabin Geoffrey Drs. members faculty Moran of work sight-restoring dedicated The featured inNewBook moR interest inhumanitarian philanthropy…” —Outside Magazine Second Suns:“Required reading for anybody with an an’s DR s. GeoFFReyta to feel a little better about the world.” the about better alittle to feel matter, for a desire that philanthropy—or, humanitarian in interest an with Magazine media. electronic, and print, broadcast, international and national June 18, 2013, release its Since place.” in is system our wherever year each down go diseases eye blinding with individuals of number the witnessing are history, we in time Tabin. “I’m said first third,” for proud the that to say by one- expectancy life the lower actually can affliction acurable such where countries developing in occurs blindness cataract of percent “Ninety skills. sight-restoring same the physicians local to teach and surgeries these to perform countries hometheir to then back go They sight. for restoring techniques advanced learn they where specialists ophthalmology Moran with train and observe to Center Eye Moran the to brought are world the around from Doctors in featured some of those year, including every missions medical sight-restoring international on multiple surgeons ophthalmic sends Center Eye Moran The Moran’s RoleinaSustainableEye Care Model states that “ that states Second Suns. Suns. Second D s BIn anD Second Suns Second Second Suns Second should be required reading for anybody for anybody reading required be should anD has been featured in hundreds of hundreds in featured been has uk RuIt

Outside International Presentations International n Research Grants and Contracts Research Published Grand and Intellectual Property/Patents t Trials Clinical LeadershipIndustry and Service Appointments and Honors Awards Report Donor content echnology echnology ational and and ational r ounds c

ommercialization

S

72 64 56 54 48 79 68 66 62 APPENDICES 47 F o c u s 2 0 1 3 48 F o c u s 2 0 1 3 Brindle Foundation John I.and Toni F. Bloomberg Richard D. Bass ARCS Foundation Inc., Utah Chapter Allergan, Inc. and above gifts of Noel and Florence Rothman Family A.JohnsonElizabeth IVEENA LLC Wattis Foundation Dumke Bausch &Lomb Bamberger-Allen Health & Avis Badami and above gifts of B. andBen Iris M.Margolis Alan J. Hirschfield Willard L.Eccles Charitable Frank E.Delvie* and above gifts of John A.and Carole Moran and above gifts of Moran Eye Center from January 1, 2012 through December 31, 2012 31, December through 2012 1, January from MoranCenter Eye the to contributed organizations and individuals following The Education Foundation Foundation Foundation $10,000 $25,000 $50,000 $1,000,000 JoHN

o M A.

RAN E y E Balamurali K.Ambati, MD, PhD Alcon Laboratories and above gifts of James W. and Jeanne J. Welch Utah Lions Foundation Susan O. Taylor Jack C.Taylor Hank and Tauber Sally Strazza Family Trust Sobel R. Denise Snowbird Ski &Summer Resort Richard A.and Rogers Carmen Rayner Intraocular LTD Lenses Gordon M.and Marcia* Olch A.and JoanRobert Judelson Stephen C.and Lynda M.Jacobsen Stephen A.andM.Huish Elizabeth Hoya Medical Singapore PTELTD Good The Works Institute Inc. Fred W. and A.Fairclough Christine Kathleen Digre, MDand Edmund W. and Carol B. Dumke The ALSAM Foundation and above gifts of Humanitarian Services Michael Varner, MD CENTER

$5,000 $500,000

R o N Do

Donors R EP o Sylvia Prahl-Brodbeck Helen K.and Val A.and D. Edith Green John B. and and above gifts of Rafati Foundation Powervision, Inc. Margaret D. Ordway Kirk and Nobis Linda P.Ralph and Marge L.Neilson Herbert I.and Vicki B. Merchant James M.and Luckman Alison R. Paul Joos, MD G. Frank and Pamela M.Joklik Johnson Foundation The Jarstad Family T.Chase Hibbard and William K.and Fern H.England Errol P. and Sonja Eernisse Chesley LawrenceThe T. and Janet Dee T. William H.and Patricia W. Child A.andDale Janeel O. Burningham Kurt Bestor Barry Bonnie OpticsAnew R o F RT Arthur E.Johnson Foundation Foundation W.*Geraldine Goddard Elsa B.Elsa Michael Foundation Emily L.Stonington Foundation $100,000 2012 2012 Larry A.Donoso, MD,Larry PhD Cameron Brady Diehl Barbara S.*and George L.Denton, Jr. Tim and Candace Dee de Conde’s CycleSmith W.Robert and Carol N.Culver F. Anthony and Joyce G.Crandall Julie Crandalland Kenneth D. Collins Whitney O. and Frances Cluff R. Cionni,Robert MD Irene G.Casper Foundation, S.Carter Robert Inc. A.and Ann JanetteRobert L.Carlson Laura D. Byrne Timothy L.Byers, MD, PhD Eveline Bruenger H.and Rodney Bonar Bob BMW of Murray Ann and Paul MD Bernstein, JewelersBennion William F. and Victoria F. Bennion Joseph C.and Gainor L.Bennett Raymond E.and Janette H.Beckham Dan Bass N.L. and Anderson, David R. MD G. W. and Ida Anderson Lee George M.Ahn Aaren Scientific, Inc. and above gifts of Wolcott Lewis Linda and J. M.Steele West Jordan Lions Club Lincoln Shurtz and Harrison Lisa Khosrow B. and Ghazaleh Semnani Hazel M.Robertson Alan S.Crandall, MD Carolyn H.(Mitzi) Brady $1,000 JoHN

o M A. RAN Outdoor Research Ruth L. Olson andJ Olson, Randall MD Marilyn Olson George G.and Pauline Mulligan John J. Moy Mimi B. Mortensen Michael V. and Paula F. Morris G. Mitchell* and June M.Morris Ruth A.Morey Corey A.and Nancy J. Miller Valerie A.and Mark D. Mifflin, MD Peter and Kathy R. Metcalf R. Ambrose P. McLaughlin, III,MD A.and EdwardBeth M.McGill, MD Marmot Mountain LLC James JDand Carol C.Lewis, L.Jent andMihail S.Lari Scott E.Murray Ace Kvale Brad, Tracey, Sam, Jonah, Katz and Zev Frank J. and Sarah G.Johnson Alan E.and B. Drue Huish Howard Horinbein Rodney Ann Hollowell Carolyn S.and C. Charles and Hetzel Elise HatziathanasiouLeah and family Adrienne Graves Jason A.Goldsmith, MD Nicholas Gibbs and Courtney Angela and Michael T. Furlong, MD Friberg Inc. Fine Art, H. Foxley,Cecelia PhD Joan B. and John H.Firmage II Carol W. and John H.Firmage III Michael A.and Muffy M. Ferro Eye System Inc. Jane Durcan, MDand and (Zeke) KatherineE. R. W. Dumke E y E Robert O.Robert Hoffman, MD John Hoffmann, MD CENTER R o N Do R EP Jess and Olivia Agraz Jean W. Adamson Joel Adams Photography Curtis E.Ackerlind, Jr. Ann Acaya and Greg Balch G. Howard Abplanalp Abel Automatics, Inc. and above gifts of C.and PatienceRobert Ziebarth andLouise Norm A.Zabriskie, MD Terry L.Wright James Wilson and R. Linda R. Thacher W. White and Luree C.Welch, and Robert MD Weis Eye Center, PA Anna M.and JeffreyR. Weis, MD WanSutter Insurance M. Walker and SueWallace R. James H.and Rolande K.Vaughn Yvette S.Ungricht Tueng T. Shen, MDand Jan H.Thijssen O. C.Tanner Company Brad D. Strong Blake E.and Cindy Ann Strong Strong Audi Tom and Kristin Stockham Howard S.Spurrier, DDS andClough Kay Shelton Michael and Rothman Bonnie Rockwell Collins Edward N.and Carol S.Robinson TheRegence Group Ron and Carolyn Reaveley Raymond James Charitable Richard F.* and Jan Rasmussen PhD Rankin, Linda Porcupine Pub &Grill o Doris Blazek-White Endowment Fund R o F RT

$100 2012

49 F o c u s 2 0 1 3 50 F o c u s 2 0 1 3 J. Steven and Susan J. Brown Hugh and Constance Brennan Carolyn O. Braza Stephen K.Bradley, MD T.Betsy Bradley Dave D. and Cate H.Boulden Steven J. Borst Blum, Inc. B.Elizabeth and D.Elmen and Monika Bloedel Emmy S.Blechmann Black Diamond Equipment, Ltd. Carl M.Biehn Brian Besch Patricia Ann Berg Bonds Bail Beehive Jon C.and Carol L.Beck Lloyd and Nancy Beacom Bastakoti andSurya and Laurel R. Robert Barrett Jean S.Barker A.Baker Leah Pamela J. Atkinson Alan C.and Karen Ashton AsArt John W. and Diane V. Armour Aristo’s Mark and Archibald Christine Joey Archer J.Catherine and Barry Angstman Milton M.and Dianne K.Anderson Gaby Anderson Amoogum Anil Ray W. and Lou Alvord Bonnie Raymond H.and Jane Ila Aldrich Richard A.Aldous, MD TrainingAlcohol Servers of Utah LLC Hans G.and Martha S.Ahrens H. Allen Bloomer,H. Allen MD L.FournierCarmen JoHN o M A. RAN E y E Gwila C.DespainGwila Denver Eye Surgeons Edward and Terri R. Dejulis Ranch Deerfield Winery Craig W. Dayhuff Alan S.and Joan E.Cruickshank Paul B. Crookston Yue and Donnell J. Creel, PhD Rufus L.Crawford Z.andLisa David A.Crandall, MD Vicki Cram William and Barbara B. Cowan andEd A.Cooper Deborah Michael* and Diane Cooper W.Drury Cooper, III D. D.Robert and Cheryl Cook Joseph V. &Nancy C.Cook Sports Cole Richard and Susan Coe Willa Cocorinis Dean Glenn D. and Kara E.Clapp, PhD ChurchThe of JesusChrist Thayer S. and Sue ChristensenD. T.Mary and Don V. and Anne E.Christensen Qing Chong George A.and Pauline O. Childs Todd Chikaraishi, DDS Michelle and Craig J. Chaya, MD Rameshwor Chapagain S.and KimberlyRobert Ann Carson Canyons Resort Robin C.Campbell and William L.and Sheral L.Calvin John K.Bushnell Shirley E.and N.Burke Billie Dolores Z.Buchanan of Latter-day Saints Foundation Andrew B. Christensen, PhD Marion Rogers Riley CENTER R o N Do R EP o Deanna R. Gerber Deanna R. Gastronomy, Inc. Paul E.Garland, MD David P. and Sheila S.Gardner David Ganansky and Cindy Nordling Jay and Lynda Gamble Heidi L.and Roger C.Furlong, MD Peter Q. Freed Arthur E.and Victoria E.Franks O.Bonnie and Joseph B. Fowler, Jr. Stanley and Janice T. Foutz Frankie Ford Foothill Oriental Rugs Flowrider Keith A.and Cindy Hadden Fleming Carole Fishburn, E.and R. Bruce MD Fish Tech Outfitters Spencer P. and Barbara S.Felt Michael S.and Eugene Feldman Richard A.and Carol M.Fay Fat Cats James Farmer Falcon’s Ledge Rolf Engen Sarah Ehrlich and Bob John S.and Evelyn B. Edwards M. David Eckersley and Anne Milne Joshua D. Echols Steven George and Ingunn HoffEarl George H.and Joan D. Earl Gaye Michael N.and R. MD Duffin, Draper Lions Club Restaurant Dodo The Vera Caren Dixon Dash The Dirty Raymon E.Diehl Chantryce Elana Diehl T. Jerald and Carol D. Diana Steven and Susan Dewey R o F RT 2012 Edward M.and Nita Jenkins* Intermountain Harley Davidson James F. Ingold H. andGilbert Thelma P. Iker Edward L.Hughes and H. Earland Barbara C.Hoover Einar and Madora I.Hoff Ross and Kathy S.Hinman, DVM Himalayan Kitchen Restaurant David C.and Grevey Eileen Hillson Hidden Valley Club Country Margaret D. and Hillard D. Hicks Ruth A.Hensel J.Gary and I.Hennings Elvia John B. and Jean M.Henkels Jack Hegardt Masonry William G.Hayward, Jr. Rick F. and Jane Hays R. Jim and Jennifer Hathorne Barbara Ann Hathaway Joy T. Hashimoto Sylvia and Roger P. Harrie, MD andJoGerald Betty Hanson K.HanoverBarry and John and Andrea R. M.Hampshire David G.and Donna Ann Hall Doug and Kristy Gunnell Thomas L. and Victoria E.* Guinney The GroupEstate, Real LLC andDonald Susan R. Greenberg Neil J. and Stephanie D. Gray Grant Farms M.and JoyceRobert S.*Graham Shari Gowers Roxanne Googin Lawrence K.and Suzanne Goldsmith Stephen L. and Goddard Leslie Roberta L.Anner-HughesRoberta Brunvand R. Allison JoHN o M A. RAN Michael and Andrea Manship Brent V. and C.Manning Chris Tad and Mancini Mary Mammco, LLC Mercina and Nick Mamalis, MD James L.and Carol C.Macfarlane MiradoresLos Unit Richard M.and Susan N.Lockwood Laura P. P. and Robert Liss, MD Research to LLC Clinical Links M.andRalph Susan M.Lewis G.and Claire O.Larry Leonard G.and DixieD.Larry Lehman Polly I.Lambson Peter and S.Kypreos Geraldine JamesRodney Korst and William M.and andCarl Gillean R. M.Kjeldsberg Jean L.Kendall KellerDennis KEEN Kearns Lions Club Charles and Laurel D. Kay Alan and Pam Kantrowitz Michael J. and Dianne Jean Kane Wally Joyner Carol A.Jost Joos, MD Zachary L.andLeon Judith Anne Jones Ryan C.and Jaime Lynn Jones Patty S.and Randolph L.Johnston, MD Thomas P. and Wendy A. Johnson Johnie’s Lars and Kendeyl D. Johansen Norman S.and Jensen Gail R. J.Jerry and Roslyn Jensen JenningsMartha Lewis E y E Owners AssociationOwners Lynn Price, MD Julia J. Kleinschmidt, PhD CENTER R o N Do R EP Gene MuirGene Mountain View Animal Hospital Mountain Trails Foundation Mountain inTelluride Film Anna C.and Grant Morshedi, MD John and Morris Cherie Anthony W. and Ann Mary Morgan Judith S.Moreton John A.Moran Eye Center D.Amedee and CammieMoran Montgomery Fur Co. Montebello Truck Terminals Aditya V. Mishra, MD Nathan Miller Patricia G.Millington Sports H.Miller Larry Lloyd and Marjorie R. Merrill R. andMarvin Melville Renee Don and Mealing Mary John and Emily McVey Philip M.and Susan L.McLaughlin Ms. Jeanne L.McJoynt Scott E.McIntosh Daniel J. McInerney Molly L.McFadden Sandra and Duncan K.McDonald, MD David and Laura McArthur MayfieldLions Club E.andLes Therese M. Mayes Willard Z.and Maughan Rona Lee Charles and Florence I.Masters William A.Marshall George and Marshall Connie Steven and Karen Marsden Julie Marple Franklin Marold o Family Foundation ShopOptical & Entertainment Group R o F RT 2012 51 F o c u s 2 0 1 3 52 F o c u s 2 0 1 3 James W. Rail and Brunhilda Susan J. PhD Quaal, The Pub Group Blanche B. Prisbrey W.Ralph and Maurine* Pixton Paul Z.and Dang Lisa Pilzer Marlynn Pike Piaget Designs PETZL America Raymond and Judith R. C. Peterson Peter W. and Anne P. Peterson PetersonGary Elaine Peterson N.andChase Grethe B. Peterson Gregory G.Pavich Patagonia Karen and Matthew Parsons, R. MD Park City Lions Club Joseph J. and Richard D. Paisner and Weiner Christie Paisley Pomegranate Eugene and Jean Overfelt Outdoor Utah Osprey Packs The Olive Garden James and Sandra O’Hearn Charles W. and Joan Odd David and E.Oberly Karen Ehresman Clay W. and Northrop Dianne R. Michael A.Norseth Jennifer Norris, MD Samdup Norgyal and Thupten Wangmo Roland C.Nickerson Hanh T. Ngo Newpark and Resort Hotel William H.and M. Nelson Christine Native Eye Wear Bobby Nassir Ron and Kris Murri Dorothy Ann Moyle Palmer JoHN o M A. RAN E y E Mark E.and Vicki L.Southwick Otto F. Smith, MD Clark T. Smith Smelzer,Quentin R. Jr. H.Small Albert William Simkins Pamela B. Sheeler Roger Shane Chevrolet Employees Seiner Jerry Fund and Art Sego Frame Michael Scott and R. Susan B. Schulman John F. Schroll Peter and Jutta Scholla Tasha Savage Paul F. and Janice W. Sargent MarriottSalt Lake Downtown CountySalt Lake Government Center Club Country Salt Lake David E.and Lois P. Salisbury John M.and Melanie A.Sacco Saari RevocableTrust Melodie Rydalch Susan L.Ruebush Ron Rubin Manda E.Robinson, and Robert JD Phil and Glenda Riesen Alvin and Helene Richer Gladys Richardson Rezai andSaeed Research to Prevent Blindness Donald G.Reid E.andRalph Rita G.Reese M.ReardonColleen Debra S.and J. Scott Raymond, MD L. Richard and Jean C.Raybould J.Mervin and Verna B. Rasmussen D.Elizabeth and V. Ramama Rao Loretta G.Falvo-Scott M.Turner-RezaiChristine CENTER R o N Do R EP o Albert T.Albert Vitale, MD and Vinto Restaurant Maynard H.and Carol B. Victor V Chocolates Utah Mountain Adventures Paul and Kristi Ann Urry Stephen C.and Kathy Ure Kirk A.Umphrey, CPA Jim and Candy Turnbull Kris Tribe and Scott S.Hale S.TinsleyLilian Craig Tinkham E.ThompsonMary David B. Theobald Thanksgiving Point BurkeR. Teichert C.and JacqueRobert Taylor Mark Taylor Carolyn W. and Kim Y. Taylor, MD William Tanner &Susan Heath J.Lary and Judy W. Talbot Geoffrey Tabin, MD Edward Harris Sweet Super CarWash Sonic Sundance Institute Carlton T. Sumison Raju Subedi Charles and Kathleen Feid Sturgis Preston and M.Catherine Strazza William E.and Stratton Dena John and Helen R. B. Stone Thomas G.* and G. Martha Stockham Shirley N.Stevenson Starr and Rosemary Robert Marland L.and Stanley Rachel Squatter’s Pub Brewery Heather and Spencer 2010Vision PC R o F RT Patricia A.Vitale, MD Terrence Scott Spencer, MD 2012 Alan E.Huish Susan W. Hodgins Jason Goldsmith, MD Laverne and David Diehl Julie and Alan Crandall, MD andKim Corbin-Lewis Paul MD, S.Bernstein, PhD Captain Daniel M.Anderson, MD 2012 through December 31,2012 to the Moran Eye Center from January 1, Those in whose honorgifts were made Zy Restaurant Michael H.Yei and Jill A.Miller Richard and Nancy S.Wolthius and Jean R. Bruce P. Wisan Wisan, Smith, &Prescott Racker Pamela W. and Robert Wing, MD David B. and Jeralynn T. Winder Ted L.Wilson and Holly J. Mullen Jennifer Wilson and Trell Rohovit Gordon and A.Wilson Georgia R.* John W. Williams Don M.*and Joleen Willey Pauline Wiessner, PhD L.andBart Marlene G.Wheelwright Marilyn F. Westegaard WellsFargo George P. and Adele W. Weiler Marta Sutton Weeks-Wulf Judith E.A.Warner, MD Jeffrey S. Ware Matthew and Lynn W. Ward Jana C.and Ward, Curtis R. JD W. Jeffrey and Mona Walters WallaceGerald and Ruth Y. Cooke D. Jesse and Ann T. Wagstaff William L.and Nancy Y. Wagner I N N I David R. Lewis David R. HONOR JoHN

OF o M A. RAN Mark Hanna Ted Hallstrom Mildred Gawlicki Jack Forgie Susan Fallentine Flatberg Edith A.Fallentine Donald “Don” Eyre Duke Robert CliffordBenjamin Digre V.Robert Despain Helen Crawford Bell Eloise and Kirkham V. Crabb Dan Collings Dan Changar Callahan Thomas Buchmiller Robert Eugene (Jim) Smith Bezzant Charles W. Bezyack Maxine Bernhisel Beier R. Elizabeth Louis B. Baker 2012 through December 31,2012 to the Moran Eye Center from January 1, Those in whosegifts memory were made John Waldrip Vitale,Albert MD Michael P. Teske, MD Thomas Starkovich Tami Porter Matthew Porter Matthew Parsons, R. MD Terry and Tiffany Parkin Majid Moshirfar, MD John A.and Carole Moran and MesserlyBonnie Ernie Katz,Bradley MD, PhD Brandon Jensen and Rebecca G.JensenCollin and I N N I E y E Heidi J. Hunsaker R MEMo CENTER y o F R o N Do R EP contact at us 801-585-9700. change your listing, please feel free to Should you find an errorwish or to Donor asaccurate Report is aspossible. effort to ensureevery that this 2012 our mission and goals. We have made for the contributions made to support The Moran EyeCenter grateful is very *Deceased William Meeks Wirthlin Don Willey WansgaardLeslie and Pearl Kirk Elton Varner Effie Torrey Thomas Isabel James H.Swonson C.Sloan Robert Edward G.Shearer Lynn Seely Ramona Rochford Maurine Pixton A.Pirtle Robert Anna K.Picco and Patricia Politano Neuman C.Petty Don Percival Donna Olson Elaine Nielson Steven Nichols Fern Whicker Mortensen Kevin Craig McKenna Thomas J. McJoynt Tim Lynch Lois Johnson E.Bleak Clara Jaques Richins Jensen Jennie Janzen Margaret Hutchings Martha Ann Healy Dumke o R o F RT 2012 53 F o c u s 2 0 1 3 54 F o c u s 2 0 1 3 Liliana Werner, MD, PhD Randall J Nick Mamalis,MD Wayne Imbrescia, MPH,MHSA James Gilman, CRA, F James Gilman,CRA, y Kathleen BDigre, MD Wolfgang BBaehr, PhD ElizabethMary Hartnett, MD PhD, MBA Balamurali KAmbati, MD, R MichaelDuffin,MD Gregory SHageman, PhD ingbin Fu,PhD Appointments, Honors, and Awards o lson, MD o PS Board member, Institutional Review Board, University of Utah President until March 2014 April 1,2012–March 31,2013;continuing to serve inthe capacity of Past President oftheAssociation ofUniversity Professors ofOphthalmology Governing Board, American Society ofCataract andRefractive Surgery President ofUniversity Administrators ofOphthalmology Academic Senate Teleophthalmology Board University ofUtah Committee for Academic Promotions, Retention, and Tenure Credentials Committee, MaculaSociety National Research Policy Committee, American Diabetes Association Women inOphthalmology AuditCommittee Study Section for Diseasesand Pathology oftheVisual System Honors and Awards “expand thefrontiers ofvisionsciencesthroughout the world” a $100,000prize from theALCON Research Institute for research that islikely to Association for Research inVisionandOphthalmology’s highest research honor, Chair Elect,ARVO Ethics andRegulations inHuman Research Committee Program Committee for Retinal CellBiology International Association for Research inVisionandOphthalmology (ARVO) Official Utah Utes TeamOphthalmologist Symposium, Bad Gögging, Bavaria,Symposium, BadGögging, Germany National Eye Institute Travel Award, XVth International Retinal Degeneration at their20thAnniversary Celebration, SanSalvador organizationservice dedicated to providing eye care to theneedy, inElSalvador Appointments Recognition for Humanitarian from Service FUDEM,a woman’s humanitarian Prix delaRecherche, MaculaofParis advance inthefieldwith work ofanenduring nature that hasinspired others” Lighthouse International MadameGeorgette PisartVision Award forthe“mostextraordinary Commission onAlliedHealthPersonnel inOphthalmology Outstanding Contribution Award for five years of teaching from theJoint at theAmerican Academy ofOphthalmology Annual meeting “Iris Tumor” at theOphthalmic Photographers’ Society (OPS)Scientific Exhibit Honorable Mention for “Ravenous Retinopathy” andSecond Place foran of Utah, Utah Department ofHealth Martha HughesCannonAward for contributions to women’s healthinthe state Rosenblatt Prize for Excellence, theUniversity ofUtah’s highest faculty honor JoHN o M A. RAN E y E

CENTER

2012-2013

Paul Zimmerman,MD Robert EMarc, PhD Nick Mamalis,MD Julia Kleinschmidt,PhD, LCSW Bryan WJones,PhD Richard ANormann,PhD Mark DMifflin,MD Robert ElizabethMary Hartnett, MD Liliana Werner, MD, PhD Monica Vetter, PhD Randall J Roger PHarrie,MD o Hoffman,MD o lson, MD were honored at anevent heldat Moran Eye Center, 18 September, 2012 Dr. Zimmerman, theUtah LionsEye Bank,and otherdonors who helpedpurchase the simulator of astate-of-the-art eye surgery simulator (EYESi) to enhance education and training programs. Center, alongwiththeUtah LionsEye Bankandmany other donors, madepossiblethepurchase The family ofthelate Dr. Zimmerman,former ophthalmologist andeducator at theMoran Eye UV-Vis spectrophotometer (Perkin-Elmer Inc) for theseanalyses: ananterior segment analyzer (EAS-1000 Scheimpflug camera, Nidek) anda ary Intervention:ary 2011Update. American Academy ofOphthalmologyChicago annualmeeting, ,Il Best Poster Award –ASCRS/ESCRS, 2012:Survey on Foldable IOLsRequiring Explanation orSecond Awarded EmeritusProfessorship, theUniversity ofUtah, 2012 sponsored by thejournal First Place,International ScienceandEngineeringVisualization Challenge Investigator-eROP, Utah StudyCenter lenses. Alcon alsoprovided two piecesofequipment inthevalue of$30,000,whichare essential dollars to supportanalyses oflight scattering andlight transmission of explanted intraocular The Mamalis/Werner Labreceived adonation from Alcon Laboratories inthe value of$50,000 São Paulo, Brazil Afonso Fatorelli Medaland Lecture, XIIInternational Congress ofCataract and Refractive Surgery, and Refractive Surgery Video Festival, São Paulo, Brazil Miyake-Apple Perspective, First Prize, EDUCATIONAL category for Residents’ Outstanding Faculty MemberAward, 2012 University ofUtah Distinguished Professorship Lewis Peterson Award at Children’s Primary Medical Center, Principle Representative nominated by Retina Society for Practicing Ophthalmologist Curriculum which hechecks theeyes ofyouth indetention anddonates glasses to thosewhoneedthem Refractive Surgery, Chicago, Illinois Hydrophobic IOLs,” Acrylic theAnnualMeeting oftheAmerican Society ofCataract and “Pathological Assessment ofComplications withAsymmetric orSulcusFixation ofSquare-edged Best-Paper-of-Session Award, Session3-NILIntraocular Surgery Complications: 2010 VisualSystem Development Chair, 1R13EY020680VisualSystem Development GordonResearch Conference, Innovative Ophthalmic Research Award for Research to Prevent Blindness; Binkhorst Award for American Society ofCataract andRefractive Surgery, 2012 ophthalmologists,” American Society ofCataract andRefractive Surgery and practice ofophthalmology andestablishes that person amongthe world’s most prominent Binkhorst MedalofHonorfor “an individual asmakingsignificant contributions tothescience February 8,2013 asatributeserving ormemorialespeciallyto ascholar,” honoringhis 70thbirthday, Presented withaFestchrift, “a volume oflearnedarticlesoressays by colleaguesandadmirers, AwardAnnual Service from theSaltLake Valley Youth Detention Center for aglassesproject in Age-related MacularDegeneration Week Congressional Briefing Featured Speaker, AEVRSponsored of Nebraska Medical Center, Omaha,Nebraska Harold Gifford Jr, MD, Lecture, Stanley M Truhlsen Eye Institute, University Senior Scientific Investigator Award, Research to Prevent Blindness JoHN o M A. RAN Science at thevideofestival oftheXIIInternational Congress of Cataract andtheNational Science Foundation E y E The ArtofthePre-chopping:Analysesfrom 2012,20September, Washington DC CENTER International 55 F o c u s 2 0 1 3 56 F o c u s 2 0 1 3 Industry Leadership and Service Margaret DeAngelis, PhD Paul SBernstein, MD, PhD Wolfgang B Baehr, PhD Alessandra Angelucci, MD, PhD Balamurali KAmbati, MD, PhD, MBA

2005-Present 2006-Present 2012-Present 2008-2011 2008-Present 2011-Present 2012-Present 2004-Present 2012 1990-Present 1994-Present 1997-Present 2002-Present 2007-Present 2007-Present 2008-Present c 2008-Present

Member, Scientific Board, Advisory International Symposiumon Ophthalmic Pharmacology U and Therapeutics Medical Advisor, Elected Member, America’s Best Doctors and Editor, Retinal Neuroscience, Berlin, Germany Organizer, the five-day XXBiennialMeeting ofthe International Society for Eye Research, preceded ARVO, Ft.Lauderdale Member, Age-related MacularDegeneration Gene Consortium Myopia and forError Refractive Member,Consortium International Member, Editorial Board, International Scholarly Research Network Genetics Error andMyopia, sponsored by NEI/NIH Member, Executive Committee, International Consortium for Refractive Committee Member, Biochemistry Program, Association for Research inVision Boesche EndowedMary Professor ofOphthalmology andVisualSciences Organizer, the 17thInternational Symposium onCarotenoids, Park City, Utah Member, Board ofTrustees, Association for Research inVisionandOphthalmology Senior Editor, Research Conference on“Retina Ciliopathies: From Genes to Mechanisms and Treatment” a two-day meeting on Retinal Ciliopathies: From Genes to Mechanisms and Treatment, Organizer, the 14thAnnualVisionResearch Conference, Board ofVisionResearch; Member, Italian Medical Doctors Association, Italy Member, Society for Neuroscience, USA Member, British Neuroscience Association, UK Seminar Series, Department ofOphthalmology, University ofUtah Committee Member, Departmental Distinguished Speaker Member, American Physiological Society, USA Review Editor, Member, Editorial Board for Review Editor, Ad HocMember, National Eye Institute, SpecialEmphasis Panel Section Editor, American Academy ofOphthalmology, Basic&Clinical Science This is a partial list of Moran Industry Leadership and Service for 2012 for Service and Leadership Moran of Industry list partial a is This ourse in a ward o phthalmology Vision Research, JoHN o phthalmology Vision Research, Frontiers in Systems Neuroscience Frontiers in Neuroanatomy Journal ofOphthalmic Photography, o M A. volume 53, (2012).Special Edition ofthe14thBiannualVision Visual Neuroscience Elsevier Science, SanDiego, CA RAN E y E CENTER University ofUtah World 2012 c lass Sabine Fuhrmann,PhD R MichaelDuffin, MD Kathleen B Digre, MD 2008-Present

2010-Present 2004-Present 2012 2008-Present

2011-Present

2012 2012 2011-Present 2012 1995-Present 1998-Present 1999-Present 2001-Present 2002-Present 2003-Present 2004-Present 2007-Present 2010-Present 2012

Member, Guide Dogsfor the Blind, Research Peer Review Panel, United Kingdom Member, Australia MacularDegeneration Foundation, Research Peer Review Panel United Kingdom Society for Developmental Biology, Research to Prevent Blindness Member, National Institutes of Health, Research Peer Review Panel, Edinburgh, Scotland, Degeneration Gene Consortium, sponsored bythe NEI/NIH Member, Society for Neuroscience, Association for Research andVisioninOphthalmology, Member, Editorial Board, Developmental Dynamics Member, FundingIncentive Seed Grant Program Member, Interview Sub-committee oftheAdmissionsCommittee ofthe University of Utah humanitarian vision care projects for the needy inLatin America School of Member, Senior Executive Committee/Steering Committee, Age-related Macular and Vascular Science andRoyal Hospitals, Queens University, Belfast, Ireland and Judge, Post-doctoral Fellows Poster Sessions: 9thAlumni&Research Day, Centre for Vision Vascular ScienceandRoyal Hospitals, Queens University, Belfast, Ireland Chairperson, RapidFire Presentations: 9thAlumni& Research Day, Centre for Visionand Meeting oftheInternational Society for Eye Research, Berlin, Germany Church ofJesus Christ ofLatter-day Saints, with responsibilities toassist in developing Internal Reviewer, Graduate CouncilReview for the Department ofPharmacology Member, Molecular BiologyGraduate Program AdmissionCommittee Academic Senate CommitteeMember ofthe Vision Advisory of the Humanitarian Department ofThe Member, Editorial Board, Board ofDirectors, Member, North American Neuro-Ophthalmology Society Member, Association for Research inVisionandOphthalmology Member, American Headache Society Grant andAwards Committee Fellow, American HeartAssociation Stroke Council (aka American Brain Coalition) Representative, American Neurological Association, toOne-Voice Member, American Headache Society Review Board Member, International Genetic Epidemiology Society Member, American Neurological Association Membership Committee Chair, American Headache Society Publications Committee Chairman, Board ofDirectors, North American Neuro-Ophthalmologic Society Differential Diagnosisof Headache and Eye Pain Visiting Professor, American Academy ofOphthalmology, Neuro-Ophthalmology/Orbit, Member, Achievement Rewards for College Scientists Session Co-chair, “Nuclear Receptors andtheir Role intheRetina andin AMD,” Biennial Peer Review Panel Member, MacularDegeneration Foundation, Australia Research Grants Program, Development, andBioengineering StudySection Member, National Institute ofHealth ZRG1 F05-R Fellowship: CellBiology, t oxicology JoHN m edicine o M A. Journal ofNeuro-Ophthalmology RAN E y E CENTER 57 F o c u s 2 0 1 3 58 F      Mary ElizabethMary Hartnett, MD Gregory SHageman, PhD 2009-Present 2009-Present 2011-Present 2012-Present

2012 2009-Present 2010-Present 2011-Present 2012-Present 2012 Member, Editorial Board, Clinical Ophthalmology Member, Honorary Editorial Board, Eye and Brain Member, Honorary Editorial Board, Patient Related Outcome Measures (Dove Press) Editor, MolecularVisionScientific Review Editor, American Academy ofPediatric Ophthalmology andStrabismus Park City, Utah Organizer andHost, International Association for Pediatric Retinal Surgeons Meeting, Teleophthalmology Board, University ofUtah Member, Committee for Academic Promotions, Retention, and Tenure; Academic Senate Member, Credentials Committee, theMaculaSociety Member, National Research Policy Committee, theAmerican Diabetes Association Member Elect, Board ofDirectors, Women inOphthalmology Visual System Member, National Eye Institute Study Section forDiseases and Pathologyof the Chair Elect, ARVO Ethics Committee Committee Member Elect, ARVO Program for Retinal CellBiology Advisor, Allergan Pharmaceuticals, California Irvine, Member, Alcon Research Institute Member, Edward N &Della LThome Memorial Foundation Scientific Review Committee Member, Executive Committee, ArnoldandMabel BeckmanInitiative forMacular Research Member, AMDAllianceInternational Board ofDirectors Member, Society for Neuroscience Member, SigmaXiScientific Research Society Member, Schepens International Society Member, PhiBeta Kappa Member, MaculaSociety Member, International Society for OcularCellBiology Member, International Society for Matrix Biology Member, International Society for Eye Research Member, International Complement Society Member, Electron Microscopy Society ofAmerica Member, Central States Microscopy &Microanalysis Society Member, Association for Research inVisionandOphthalmology Member, American Society for Matrix Biology Member, American Society for CellBiology Advisor, Apeliotus Technologies Inc. Member, Board, Advisory ViroPharma Incorporated Member, Macular Degeneration Foundation Australia Scientific Committee Member, Foundation Fighting BlindnessScientific Advisory Board Advisor, Gerson LehrmanGroup Member, Sequenom, Inc.,Ophthalmology Clinical Board Advisory Member, National Eye Institute Age-related Macular Degeneration GeneConsortium Member, NIH ZEY1VSN StudySection Member, National Eye Institute, Age-related Eye Disease Study2Advisory Group Scientific Founder, Voyant Biotherapeutics LLC, Salt Lake City, UT JoHN o M A. RAN E y E

CENTER

Nick Mamalis,MD Edward MLevine, PhD David Krizaj, PhD Bradley JKatz, MD, PhD Bryan WJones,PhD

2009-Present

1988-Present 1989-Present 1997-Present 1998-Present 2007-Present 2012 2004-Present 1992-Present 1996-Present 2004-Present 2006-Present 2007-Present 2009-Present 2010-Present 2011-Present 2012-Present 2012 2011-Present 2004-Present 1999-Present 1992-Present 2002-Present

Acute Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) (Stratum II), QUARK Member, Committee American Academy onAging, ofOphthalmology Pharmaceuticals, Fremont, California by aSingleIntravitreal Injection to PatientsNerve with Optic Atrophy (Stratum I) and Primary SitePrimary Investigator, PhaseIOpen Label,DoseEscalating TrialofQPI-1007Delivered Commercialization Office Thin Filmsto Treat Photophobia andMigraine,” University ofUtah Technology Investigator,Primary Technology Commercialization Project Grant, “Development of of Volunteer, Research to Prevent Blindness Ophthalmological Associate Member, Board ofDirectors, National Society to Prevent Blindness: Utah Affiliate Member, American Society ofCataract andRefractive Surgery Cataract Clinical Committee Editorial Board, Review ofOphthalmology Member, Executive Committee, American Society of Cataract and Refractive Surgery Editor, JournalofCataract andRefractive Surgery Chicago, Illinois Moderator, Cataract Symposium, American Society ofCataract andRefractive Surgery, Member, Editorial Board, Developmental Dynamics Member, Society for Neuroscience Member, Association for Research inVisionandOphthalmology Member, Sinapsa (Slovenian Association for Neuroscience) Member, International Society for Eye Research Member, American Association for theAdvancement ofScience under auspices ofTanner HumanitiesCenter Member, Scientific Inquires inQualia Interdisciplinary Faculty Research Interest Group Member, American Physiological Society Animal Physiology Member, Editorial Board, Society for Neuroscience Intermountain Chapter, OpenAccess Pharmacology Member, Editorial Board, International JournalofPhysiology, Pathophysiology and Member, Editorial Board, Center for Translational Medicine, University ofUtah Research Conference, Berlin Session Co-moderator, Channels inEye Research,” “TRP International Society for Eye Co-organizer andModerator, RGC Death inOptic Neuropathies and Retinal Ischemia Member, SpecialInterest Group, Association for Research inVisionandOphthalmology and SignalTransduction Poster Session Moderator, Association for Research inVisionandOphthalmology, Membrane Physiology, Member, Self-assessment Committee, Item Review Subcommittee, American Academy Member, Medical SchoolAdmissionsCommittee Member, Association for Research inVisionandOphthalmology Member, American Association for theAdvancement ofScience Editor/Webmaster, Webvision http://webvision.med.utah.edu O phthalmology JoHN o M A. RAN E y E CENTER

59 F      60 F      Albert TVitale, MD Monica Vetter, PhD Geoffrey Tabin, MD Bhupendra CKPatel, MD, FRCS, FRC Randall J Richard ANormann,PhD Majid Moshirfar, MD Robert EMarc, PhD 2005-Present

2006-Present 2009-Present 1991-Present 1996-Present 1999-Present 2000-Present 2002-Present 2003-Present 2005-Present 2009-Present 2006-Present 2011-Present 2011-present 2006-Present 2007-Present 2012 2009-Present 2011-Present 2012-Present 2012 o lson, MD

Section Editor, Uveitis andIntraocular Tumors, Focal Points, Uveitis, BCSC9,BasicScience Course,” American Academy Ophthalmology Contributing Editor and Writing Committee Member, “Intraocular Inflammation and Editor, Intraocular Inflammation, Uveitis, and Tumors, Focal Points Editor, American Academy ofOphthalmology BasicScience Course Committee, American Academy ofOphthalmology of Member, Editorial Board, Editorial andWriting Committee for Practicing Ophthalmologists Member, American Uveitis Society Executive Committee, Secretary for Internal Affairs (SUN) Working Group Reconstructive Surgery Member, Editorial Board, Abstracts fromtheLiterature for Ophthalmic, Plastic, and Member, Medical Board, Advisory American Society ofOcularists Member, Editorial Board, JournalofCranio-Maxillofacial Trauma Member, Editorial Board, Aesthetique Editor, USA ORBIT Member, Editorial Board, Evidence BasedEye Care Chief Co-editor, ORBIT Member, American Uveitis Society, Standardization of Uveitis Nomenclature International Workshop onUveitis inChildren, Jules Stein Eye Institute Chief Section Editor, Plastic Surgery, EYE Member, University ofCalifornia, LosAngeles, UCLACenter for the Health Sciences, Member, Scientific Board, Advisory “Catalyst foraCure 2,” Glaucoma Research Foundation Editor, Stedman’s Medical Dictionary Chief Section Editor, Plastic Surgery, Editorial Board, Ophthalmologica Executive Editor, American JournalofOphthalmology Host, 40thNeural Interfaces Conference, SaltLake City, Utah of Ophthalmology Member, Editorial Board, International Board, Advisory Middle East African Journal Member, Editorial Board, Scientific WorldJournal Member, Editorial Board, JournalofCataract andRefractive SurgeonsConsultation Section Member, Editorial Board, OmanJournalofOphthalmology Member, Optical Society ofAmerica Member, American Association for theAdvancement ofScience Member, Association for Research inVisionandOphthalmology Member, Editorial Board, JournalofComparative Neurology, Society for N O phthalmology JoHN o M A. RAN BritishJournalofOphthalmology E y E

CENTER A merican A cademy euroscience

Jun Barbara MWirostko, MD Liliana Werner, MD, PhD Judith EAWarner, MD 2007-Present 2009-Present 2010-Present 2011

2011-Present 2012 2012 2011-present 2012-present 2012 2004-Present 2009-present 2009-present 2010-present 2003-present 2004-Present 2004-Present y ang, PhD ang,

Associate Editor andPeer Reviewer, Acta Ophthalmologica America Top Ophthalmologist, JournalofConsumer Research Grants Review Working Group, Editorial Board, Acta Ophthalmologica Member, California Institute for Regenerative Medicine Scientific andMedical Research Conference, Boston, Massachusetts BoardAdvisory Member, Chairperson, Moderator, 3rd OcularDiseases &DrugDiscovery Francisco, California Member, Scientific Committee Advisory forGlaucoma Research Foundation, San Clinical Research, University ofUtah Member/Advisor, Entrepreneurial Faculty Scholars, Entrepreneurial Opportunities and Investigating Novel Delivery Methods forOphthalmic Diseases: AMD&Glaucoma Chief Medical OfficerandStrategic Board Advisory Member, SKS Biotech Incubator Research Protocols andStrategy Wokingham, United Kingdom; expert Advisor, Ophthalmology DrugDevelopment Clinical Ophthalmology Consultant andMember, Medical Board, Advisory Premier Research LTD., Rho Kinase Inhibitor, Currently inPhase 2 Executive Team Member, Lead Clinical Development Program &Glaucoma Strategy, Novel Chief Medical Officer Retained Consultant, Altheos, Inc. Discovery Conference, LasVegas, Nevada Member, Scientific Review Committee, Fight forSight, New York, New York Member, Board Advisory andChairperson/ Moderator, 4thOcularDiseases andDrug Board Member, Institutional Review Board, University of Utah 2012 Member, Scientific Board, Advisory Powervision Inc. Surgery Chief Judge, AnnualVideo Festival, American Society ofCataract and Refractive Member, Editorial Board, Neuro-Ophthalmology Member oftheScientific Board Advisory of Powervision Inc., USA Chair, Sequenom, Inc., Clinical Board Advisory and Refractive Surgery 2010-Present Chair, Continuing Medical Education Committee, Advisory American Society of Cataract of Cataract andRefractive Surgery Member, Continuing Medical Education Committee, Advisory American Society Member, Editorial Board, EyeWorld Magazine Member, Editorial Board, JournalofCataract &Refractive Surgery Member, American Academy ofOphthalmology Ophthalmic News &Education Network JoHN o M A. RAN E y E CENTER

61 F      62 F      T Title: Principal Investigator: Sponsor: Sponsor: N Title: Principal Investigator: Sponsor: Degeneration Macular [EPA]) Acid Age-related in Eicosapentaenoic and [DHA] Acid (Docosahexaenoic Acids Fatty Polyunsaturated Long-Chain Omega-3 and Zeaxanthin, Trial Lutein, of Randomized Title: Principal Investigator: Sponsor: Degeneration Macular Atrophic for (CNTF) Factor Neurotrophic Ciliary Releasing Cells NTC-201 Human Encapsulated of Implants Title: RETINA Sponsor: Title: Principal Investigator: Sponsor: Retina Human Title: Principal Investigator: Sponsor: Degeneration Macular Age-related Neovascular with Subjects in LUCENTIS® with Combination in Given Aptamer) Pegylated (Anti-PDGF E10030 of Injections Intravitreous of Efficacy and Safety the Establish Title: Principal Investigator: of Treatment and Pathogenesis the in Carotenoids Pigment Macular Title: Principal Investigator: Sponsor: Sponsor: Diseases (eyeGENE) Ophthalmic Inherited for Repository DNA of 1—Creation Stage Title: Principal Investigator: Sponsor: Pigmentosa Retinitis for Acid Valproic Oral Title: Principal Investigator: Principal Investigator: Sponsor: Degeneration Macular Age-related to Secondary Atrophy Geographic with Patients Adult in GSK933776 of Pharmacodynamics and Pharmacokinetics, Efficacy, Tolerability, Safety, the Title: Principal Investigator: he he eovascular eovascular M M ac Genetics Protocol of Macular Telangiectasia 2: Type Macular of Telangiectasia Protocol Genetics Home-vision Monitoring in AREDS2 for Progression to to Progression for AREDS2 in Monitoring Home-vision 2(AREDS2): AMulti-center, Study Eye Disease Age-related of Study Prior a from Participants of Evaluation Follow-up Macular Pigment Imaging in Infants Using the RetCam® the Using Infants in Imaging Pigment Macular the in Pigments Carotenoid Macular of Measurement Raman Trial to Controlled Double-masked, 2, Randomized, APhase the of Role the of Study Collaborative the for Center Utah National Ophthalmic Genotyping and Phenotyping Network, Network, Phenotyping and Genotyping Ophthalmic National of Trial Placebo-controlled Randomized, Site, Multiple II APhase Phase 2 Multicenter, Randomized Study to Investigate Investigate to Study Randomized 2 Multicenter, Phase ac T el T

NIH/NEI Institute Research Lowy NIH/NEI Inc. Ophthotech, NIH/NEI Institute Research Neurovision National GlaxoSmithKline Notal Vision, Ltd. Vision, Notal Lowy Research Foundation Research Lowy Abbott Laboratories, Inc. Laboratories, Abbott Lowy Research Institute Research Lowy el Study el AM D Using the ForeseeHome Device ForeseeHome the D Using Currently, more than 50 clinical research trials are being carried outMoran atthe Eye Center carried are being Currently, trials research more50 clinical than Paul S Bernstein, MD, PhD SBernstein, Paul Paul S Bernstein, MD, PhD SBernstein, Paul MD, PhD SBernstein, Paul Paul S Bernstein, MD, PhD SBernstein, Paul MD, PhD SBernstein, Paul MD, PhD SBernstein, Paul MD, PhD SBernstein, Paul Paul S Bernstein, MD, PhD SBernstein, Paul Paul S Bernstein, MD, PhD SBernstein, Paul MD, PhD SBernstein, Paul Paul S Bernstein, MD, PhD MD, PhD SBernstein, Paul

CLINICAL

Principal Investigator: Sponsor: NAION Acute for Factor Trigger Title: NEUR Principal Investigator: Sponsor: (CPTS) Study Success Title: Principal Investigator: Sponsor: Title: CORN Principal Investigator: Sponsor: Title: Principal Investigator: Sponsor: (CELR) Replacement Lens with Extraction Cataract Unilateral Undergoing Subjects in Inflammation and Pain Relieve and Mydriasis Maintain to Combination, in and Alone Ability, Title: Principal Investigator: Sponsor: Extraction Cataract Undergoing Patients in Lens Intraocular Optic Dual Synchrony® the of Effectiveness and Title: GLAUC AND CATARACT Sponsor: Macular Degeneration Age-related End-stage with Associated Impairment Vision Central Profound to Severe with Patients in Telescope Miniature Implantable Title: Sponsor: Pan-uveitis or Posterior-, Intermediate-, tious Non-infec Active for Corticosteroids High-dose Requiring Subjects in Therapy Maintenance as Adalimumab Antibody Monoclonal Anti-TNF Title: Principal Investigator: Sponsor: Pan-uveitis or Posterior-, Intermediate-, Non-infectious Inactive with Subjects in Adalimumab Antibody Monoclonal Anti-TNF Title: Principal Investigator: Sponsor: IncorporatingAmendment 1 Pan-uveitis or Posterior-, Intermediate-, Non-infectious with Subjects in Adalimumab Antibody Monoclonal Anti-TNF Human the of Efficacy Title: Principal Investigator: Sponsor: Trial (MUST) Steroid Treatment Uveitis Title: Principal Investigator: Principal Investigator:

TRIALS Case-crossover Study of PDE5 Inhibitor Exposure as a Potential aPotential as Exposure Inhibitor PDE5 of Study Case-crossover Graft Long-term on Time Preservation Graft Corneal of Effect C Outcomes Patient and Glaucoma about Communication Tromethamine’s Ketorolac and HCl’s Phenylephrine of AStudy Saftey the Evaluate to Study Clinical Multicenter AProspcetive VisionCare’s of Study Post-approval Multicenter Prospective A Multicenter Study of the Efficacy and Safety of the Human Human the of Safety and Efficacy the of Study AMulticenter A Multicenter Study of the Efficacy and Safety of the Human Human the of Safety and Efficacy the of Study AMulticenter A Multicenter Open-label Study of the Long-term Safety and and Safety Long-term the of Study Open-label AMulticenter Long-term Followup of Patients Participating in the Multicenter Multicenter the in Participating Patients of Followup Long-term o-o EA ornea Donor Study Pfizer, Inc. Pfizer,Inc. NIH/NEI Research/NEI Health for Center JAEB NIH Omeros Corporation Inc. Visiogen, Vision Abbott Laboratories, Inc. Laboratories, Abbott Abbott Laboratories, Inc. Laboratories, Abbott Abbott Laboratories, Inc. Laboratories, Abbott NIH/NEI

PHTHALM C are are

Ophthalmic T Ophthalmic Kathleen B Digre, MD BDigre, Kathleen MD D Mifflin, Mark MD Goldsmith, Jason MD SCrandall, Alan Majid Moshirfar, MD Moshirfar, Majid Albert T Vitale, MD TVitale, Albert Albert T Vitale, MD TVitale, Albert Albert T Vitale, MD TVitale, Albert Albert T Vitale, MD TVitale, Albert oLoGy Mark D Mifflin, MD DMifflin, Mark MD SCrandall, Alan o MA

echnologies

- Principal Investigator: of Prematurity Title: Principal Investigator: Title: Principal Investigator: Title: Principal Investigator: Title: Principal Investigator: Status Carotenoid Infant on tion Title: Principal Investigator: STGD3 with Patients in Supplementation DHA Dystrophy: Sponsor: (G-ROP) Study Development Sponsor: Study) e-ROP (The Principal Investigator: Sponsor: Title: Principal Investigator: Sponsor: for Title: Principal Investigator: Title: INVESTIGAT Title: Principal Investigator: Title: Principal Investigator: Title: PEDIATRIC Sponsor: Loss Visual Mild with Hypertension Intracranial Idiopathic with Subjects in Placebo Plus Diet vs amide Acetazol Plus Diet Low-sodium and/or Weight-reduction of Study Title: Principal Investigator: Sponsor: Migraine with Patients in Headaches Title: Principal Investigator: Sponsor: Outcomes MS for Two-year Neuritis Optic Title: Principal Investigator: Sponsor: Neuropathy Optic Ischemic Anterior Non-arteritic Acute and Atrophy Nerve Optic with Patients to Injection Intravitreal by Title: Principal Investigator: A mbylopia Genetic Associations in Preterm Infants at Risk of Retinopathy Retinopathy of Risk at Infants Preterm in Associations Genetic Patients Eye Center Moran in Photophobia of Assessment Imaging with Neuropathies Optic of Evaluation Exists Papilledema Without IIH Restric Growth Intrauterine and Nutrition Maternal of Effects Pediatric Cataract Surgery Outcomes Registry Outcomes Surgery Cataract Pediatric Topical Clinical Interventions Against Stargardt Macular Macular Stargardt Against Interventions Clinical Topical Keratoplasty Lamellar Anterior Deep Assisted Collagenase Patching (ATS)15: Treatment Study Increasing Ambylopia Model Prematurity of Retinopathy and Growth Postnatal ROP Acute-phase Evaluating to Approaches Telemedicine Placebo-controlled Randomized, Double-blind, AMulitcenter, Thin-film Spectacle Coatings to Reduce Light Sensitivity and Sensitivity Light Reduce to Coatings Spectacle Thin-film of Onset at Measurements MRI Nerve Optic of Value Predictive Delivered QPI-1007 of Trial Dose-escalating IOpen-label, Phase

JAEB Center for Health Research/NIH Health for Center JAEB NIH/NEI Axon Optics Axon Cummings Foundation Inc. Pharmaceuticals, Quark NIH/NEI Jaeb Center for Health Research/NIH Health for Center Jaeb NIH/NEI o o PHTHALM R-SP

o Robert O Hoffman, MD OHoffman, Robert NS

Kathleen B Digre, MD BDigre, Kathleen MD BDigre, Kathleen MD BDigre, Kathleen MD, PhD SBernstein, Paul MD, PhD SBernstein, Paul Marielle Young, MD Young, Marielle MD Young, Marielle Balamurali K Ambati, MD, PhD, MBA K Ambati, Balamurali Bradley J Katz, MD, PhD JKatz, Bradley MD, PhD JKatz, Bradley MD, PhD JKatz, Bradley MD BDigre, Kathleen Mary Elizabeth Hartnett, MD Hartnett, Elizabeth Mary Robert O Hoffman, MD OHoffman, Robert o oLoGy RED CLINICAL RESEARCH PR RESEARCH CLINICAL RED

o JECTS

- -

Principal Investigator: their Relationship to Glaucoma and Parameters Diagnostic and Vascular Novel Various Assessing Title: Principal Investigator: Hemorrhage Sub-macular Treatment of the for Inhibitor Plasminogen Title: Principal Investigator: Title: Principal Investigator: C Title: Principal Investigator: Title: Principal Investigator: Title: Principal Investigator: (PRK) Keratectomy Photorefractive and (LASIK) Keratomileusis situ Title: Principal Investigator: (LASIK) Keratomileusis Situ Title: Principal Investigator: (PRK) Keratectomy Genetic Mapping Title: Principal Investigator: Outcomes Endothelial Keratoplasty Title: Principal Investigator: Title: Principal Investigator: Title: Principal Investigator: Title: Principal Investigator: Neuropathy Optic Title: Principal Investigator: Title: Principal Investigator: Title: Principal Investigator: after Treatment Outcome Glioma Optic Title: Principal Investigator: Title: Principal Investigator: Title: ataract Surgery Impact of AcrySof Glistenings on Visual Quality Quality Visual on Glistenings AcrySof of Impact in Assisted Laser after Cornea the in Changes Biomechanical in Assisted Laser in Tetracaine vs Proparacaine Topical Topical Proparacaine vs Tetracaine in Photorefractive Photorefractive in Tetracaine vs Proparacaine Topical Automated Stripping Descement’s of Study Retrospective Nerve Optic the of Diseases for Device Screening Antibiotics with Arteritis Cell Giant Treatment of Ischemic Anterior Non-arteritic of Analysis Genomic Arteritis Cell Giant of Genomics and Proteomics Frequency Fusion Flicker Critical of Measurement 1-associated Type Neurofibromatosis of Analysis Retrospective Prematurity of Retinopathy and Preeclampsia Disorders Retinal of Pediatric Genetics Optic Nerve Drusen: Clinical Characterization and and Characterization Clinical Drusen: Nerve Optic Non-interventional Cross-sectional Observational Study Tissue Sub-retinal and Vitrectomy Plana Pars of Efficacy Patients Homeless for Clinic Ophthalmology an in Experience Following Population Indigent an in Assessment Life of Quality Dysphotopsia Pseudophakic and Index Refractive Barbara M Wirostko, MD MWirostko, Barbara P Teske, MD Michael MD Stagg, Brian Pettey, MD Jeff MD JOlson, Randall MD JOlson, Randall MD Moshirfar, Majid MD Moshirfar, Majid MD Moshirfar, Majid Mark D Mifflin, MD DMifflin, Mark MD, PhD JKatz, Bradley MD, PhD JKatz, Bradley MD, PhD JKatz, Bradley MD, PhD JKatz, Bradley MD OHoffman, Robert MD Hartnett, Elizabeth Mary MD Hartnett, Elizabeth Mary Bradley J Katz, MD, PhD JKatz, Bradley MD, PhD JKatz, Bradley

63 F      64 F o c u s 2 0 1 3 and Vascular Demarcations,” U-5512. U-5400. and Symptoms Thereof.” Treating Vascular Associated Maculopathy Age-related MacularDegeneration,” US8232056. Washington, DC.Patent andTrademark Office. AMD (ParAllele).” “Genes andPolymorphisms Associated with Washington, DC.Patent and Trademark Office. Disruptive Disorders(AMD to AAA).” “Diagnostics andTherapeutics forArterial Wall Washington, DC.Patent andTrademark Office. lar Degeneration(DIGE&MALDIBiomarkers).” “Biomarkers Associated WithAge-related Macu- Washington, DC.Patent andTrademark Office. Protein (CFH-CRPBinding).” “Binding ofComplement Factor Hto C-Reactive Washington, DC.Patent andTrademark Office. Patents Pending: University ofUtah Research Foundation, WO 2012/125872. Patent: 9/2012 Gregory SHageman, PhD;y No. 13/115,912. of age-related maculardegeneration. US Patent Application the DeAngelis laboratory that linked genetic variants to risk Patent filedasa result ofassociation studiesperformed in Patent: 7/31/2012 Margaret DeAngelis, PhD Patent Pending: 12/05/2012 Released to Inventor: 11/29/2012 Patent Pending: 06/13/2012 Balamurali KAmbati, MD, PhD, MBA Vascular Disorders(ParAllele).” Patents, Patents Pending, Industry &Technology, Technological, andOtherScientific Innovations Property/Patents Intellectual and Commercialization Technology “Methods and ofDiagnosing “Methods for Detecting Neovascular “Raver2asController ofsFlt-1 “NitinolRing-Capsulotome,” “Assessing Susceptibility to “The Poodle-Cat,”“The U-5510. ingbin Fu,PhD JoHN o M A. RAN Modulating Circadian Cycles.” Severity ofPhotophobic Responses orfor Apparatus for Reducing theFrequency and/or Asha Vision,LLC, Founder andCEO 2012 Salcantay VisionSolutions,LLC CEO 2012 David Krizaj, PhD proprietary property. headaches. TheUniversity ofUtah hasregistered theexisting ated andexacerbating withtriggering debilitating migraine cause ofphotophobic symptoms, particularlythoseassoci- specific wavelengths oflight that have beenimplicated asthe process for plastic spectacle lenses.Theprocess blocks the develop aground-breaking optical interference filter coating Dr. Bradley JKatz, MD, PhD, joinedwithTecport Optics to Founder andCEO ofAxon Optics,www.axonoptics.com Patent Pending: 2012 Bradley JKatz, MD, PhD Patent Pending: 2012 Bryan WJones,PhD;Robert EMarc, PhD DC. Patent andTrademark Office. HagemanAllikmets RL, GS,DeanMC, GoldAM.Washington, (CFB/C2 Diagnostics).” Predict Age-related MacularDegeneration “Variants InComplement Regulatory Genes Washington, DC.Patent andTrademark Office. AMD andMPGNII.” “RCA LocusAnalysisto AssessSusceptibility to Washington, DC.Patent andTrademark Office. LOC387715 (ParAllele).” C2, Factor B, PLEKHA1,HTRA1,PRELP, or “Predicting AMDwithSNPsWithinorNear Washington, DC.Patent andTrademark Office. Macular Degeneration(CFHR1/R3Deletion).” Diagnosis ofVascular DisordersandAge-related “Methods andReagents for Treatment and Computational Molecular Phenotyping.” E y E CENTER “Methods, Systems, and “Oncological Application of 2012-2013

D 00846-US01. Antagonists inGlaucomatous Neuroprotection,” in OcularDisease.” Legeais JM,Legeay G, intraoculaire.” produits ainsiobtenus. Téflon AFpourimplant “Procédé derevêtement dematériaux et 1996-present Liliana Werner MD, PhD patent 5087 Patents Pending: Patent Submitted: 2012 Randall Jo human volunteers. Projects Agency). Theproject sets thestage for work inblind amputee (project supported by Defense Advanced Research of Utah Richard ANormann,PhD, performed thefirst humanimplant 2012 Richard ANormann,PhD Krizaj, DA Ryskamp, PBarabas. Patent Pending: 10/16/2012 ganglion neurons in glaucoma. ments that regulate intraocular pressure andprotect retinal wide impactonclinical care, asthere are currently notreat- been validated inanimalmodelsandhasthepotential for a mechanical environment withintheeye. coma andotheroculardiseasesassociated withabnormal Barabas. Inventor ofanovel method for treatment ofglau- Docket No.00846-U5301.PROV. DKrizaj, DA Ryskamp, P Patent Pending: 5/10/2012 University ofUtah, member. Center for Translational Medicine(CTM), 2012 the State ofUtah. Commercialization andInnovation Program (TCIP) grant from Dr. David Krizaj, PhD, andAshaVisionreceived aTechnology “Saving Sight by CuringGlaucoma.” Minimize Intraocular LensRotation.” Reduce Infection.” Hypodermic NeedleSystem andMethod to number FR9604267,registered onApril4th,1996,Paris.

e lectrode

lson, MD a rrays insevered nerves ofanupperlimb “Mechanosensory Channel “Mechanosensory “Role ofTRPV4 Antagonists “A VisionCorrection System,” WernerL, patent 4826 “A Vision Correction System to r enard G.French patent JoHN t he method has o M A.

RAN Application #3Provisional US Patent No.3246-005 “DermalWound Healing.” Application #2US Patent No.61/58,1845(Filed2012) “Corneal Wound Healing.” Application #1US Patent No.61/62,4730(Filed2011) Patents Pending filed by Jade Therapeutics,Inc.: 2011-2012 been awarded in2013. SBIR-Phase ISolicitation FY-2013; 12-605(BM3).Grant has Barbara MWirostko, MD, through Jade, has submitted anNSF 2012 preclinical work. NO:120336. CRADA inplacebetween JadeandUSAIRS for this Title/#/ Solicitation Date: Internal Core FundsAIBS 5 percent effort. Institute ofSurgical Research; CO-I: Barbara MWirostko, MD, PI: Col.Anthony Johnson,MD, Task Area Manager ofUSArmy the neededdrugloadeddelivery materials. models NOT includedintheBAA proposal. Jadewillsupply concept preclinical work to occurat USAISR usingnovel burn without compensation. CRADA inplace for non-GLPproof of Dr. Wirostko isproviding strategic andtechnical oversight Growth Hormone.” A Novel Sustained ofHuman DrugDelivery “Treatment ofCornealEpithelial Wound Using Fort Detrick, MD21702.Submitted 2012; awarded 2013. Directorate 5.ATTN: MCMR-RTR, 504Scott Street BLDG722, and Rehabilitative Medicine Research Program Research Area US 2012 percent effort. and universities to market. PI:Barbara MWirostko, MD, 10 taking cutting-edge technologies developed at Utah’s colleges Utah Legislature in1986to helpaccelerate theprocess of grant andmentoring program originallydeveloped by the The TCIP (formerly “Centers ofExcellence”) isastate-funded 8/2012–2/2013 Program” (TCIP) grants through USTAR, $40,000each. neurial grants: “Technology Commercialization andInnovation Jade Therapeutics isthe recipient oftwo prestigious entrepre- 4/2012; 9/2012 crosslinked hyaluronic acidbiodegradable polymer. ucts inophthalmic areas ofhighunmet needutilizinganovel focusing ondeveloping sustained delivery drugsandprod Officer ofJadeTherapeutics, LLCDrug Development Company Barbara MWirostko, MD, isco-founder andChief Scientific 2011-present Barbara MWirostko, MD (Filed 2012) E y E a rmy m CENTER edical

“Corneal Re Innervation.”

r esearch and m ateriel c ommand c linical -

65 F o c u s 2 0 1 3 66 F o c u s 2 0 1 3 29 February 22 February February 15 February 8 February 1 February 25 January 18 January 11 January D 14 March 7 March June 6 June 23 May 9 May 25 April 18 April 11 April 28 March 21 March

May 30 May June 20 June 13 June 18 July

ATE

Grand Rounds P Joyce Mitchell, Biomedical, Biomedical, Mitchell, Joyce MD MWirostko, Barbara MD Goldsmith, Jason Genetech at Tony Adamis, VP & Global Head of Ophthalmology Ophthalmology of Head &Global VP Tony Adamis, MD, Resident Zaugg, Brian MD, PhD, MBA K Ambati, Balamurali MD SCrandall, Alan of Alabama, Birmingham Cornea, of &Director Ophthalmology of Professor Clinical MD, Associate Michelson, Mark MD, Resident Kinard, Krista Williams, MD Lloyd Marielle Young, MD Institute & Lead Partner of Moran’s International International Moran’s of Partner Lead & Institute Eye Tilganga the of Founder Ruit, Dr. Sanduk MD SHageman, Gregory Resident MD, Neurology Peters, Angela MD, Resident Bell, Jim Gene Kim, MD Kim, Gene o MD, Resident Owen, Leah Fuhrmann,Sabine PhD Briana Sawyer, Genetic Counselor, Counselor, Genetic Sawyer, Briana Intern MD Joos, Zachary Student, Medical Todd Cahoon, MD Bettis, Dan Library MD, Moran/Eccles BDigre, Kathleen OBGYN Varner, MD, Professor, Michael of Division Tom Oberg, MD, Resident Tom Oberg, MD Hsu, Maylon Rachel Simpson, MSIV, Simpson, Rachel SOM Washington of University MSIV, Butikofer, Scott of Utah University MSIV, Behunin, Nick University of Arizona COM Arizona of University phthalmology Services RESENTER o phthalmology

University of Utah University University of Utah University University of Utah University University To c Moran the at Opportunities Research Making Decision Medical in Errors Cognitive Next Steps in AMD in Steps Next Lymphoma Ocular Anti-Angiogenics for Springboard to FLT-1: Avascularity of Soluble Wellspring From &Ultrachopper Femtosecond Another Perspective Pseudophakic Accommodation: Restrictionvs Dysinnervation Sudan South Torsion Ocular of &Management Diagnosis The Ataxia & Retinitis Pigmentosa &Retinitis Ataxia Weakness, Muscle Neurogenic NARP: Stiffness with Loss Vision Unilateral Acute Developing World the in Blindness Cataract Overcoming Age-related of Understanding Our in Era A New Confocal Microscopy of the Cornea: Cornea: the of Microscopy Confocal Family— the in Run Ears &Bad Eyes Bad e Signals Regulating Extracellular Retinopathy Type 1Diabetic Murine Introduction to Genetic Counseling Genetic to Introduction Insulin Forgotten and Fatigue, Floaters, in Function and Structure Visual Enhances COMP.Ang1-induced Vascular Normalization Loss Vision Unexplained Career your Enhance to Resources Library Using Care Health Personalized Macular Degeneration Clinical Applications & Standardizing Data Data Standardizing & Applications Clinical Loss Hearing and Vision Onset Early Cryoprin Associated Periodic Syndromes & the &the Syndromes Periodic Associated Cryoprin Spot Blind +ABig Cases Challenging of Outcomes & Complication & Grafts Thin Ultra DSAEK Neuritis Optic vs. Neuroretinitis + Acquisition Ocular Complications of Diabetes of Complications Ocular Endophthalmitis Enterobacter Cloacae Post-surgical Treatments Keratoconus Future and Spectrum Arteritis: Cell Eye +Gial ye Development linical linical PIC c ohort Finding with the FU the with Finding ohort o 2012 R T ITLE rt He r System

15 August 8 August 25 July D August 22 August

August 29 August

September 5 September 12

September 26 September 19 October 10 October

October 24 October 17 October November 7 November 31 October December December 12 5 December 28 November 14 November ATE

Grand Rounds John Bennion, John SOM Columbia Missouri of University MSIV, Lenci, Lucas P Gavin Roddy, MSIV, Roddy, Gavin MSIV, Christensen, Steve MD SCrandall, Alan Resident MD, Neurology Nelson, Gary Sciences Health University West Virginia Andrew Rodenburg, MSIV, Rodenburg, Andrew COM Texas Sciences A&M Health Bryce Radmall, MSIV, Radmall, Bryce Zach Oakey, MSIV, Zach MSIV, Smith, Chris SOM Dakota North of University University of Texas Medical Branch Texas of Medical University Paul S Bernstein, MD, PhD, & Brianna Sawyer, Sawyer, MD, PhD, &Brianna SBernstein, Paul Ronnie Bhola, MD MD Bhola, Ronnie Services Ophthalmology Counselor, Genetic Visiting Physician, Trinidad/Tobago Physician, Visiting Zachary Joos, MD Joos, Zachary Dallas at Center Medical MSIV, U Ririe, Peter SOM Washington of University MSIV, Hooten, Jason MSIV, Jackson, Chad Brian Stagg, MD, Intern Stagg, Brian Allison Jarstad, MSIV, Jarstad, Allison Trent Richards, MD Trent Richards, FRC MD, FRCS, CKPatel, Bhupendra Sciences Health of University Randall J Olson, MD JOlson, Randall MD, Resident Zaugg, Brian Peter Barabas, PostDoc in Krizaj Lab Krizaj in PostDoc Barabas, Peter MD Bettis, Dan Pettey, MD Jeff Werner, MD, PhD Liliana Nick Mamalis, MD Resident MD, Neurology Lee, Chung MD Bell, Jim RESENTER University of Utah University niversity of Texas of SW niversity

University of Kentucky COM Kentucky of University University of Utah University Pacific Northwest University of Utah University To Orbital Cellulitis Cellulitis Orbital Ocular Manifestations of Inflammatory of Inflammatory Ocular Manifestations Keratometric Changes after Refractive Surgery Refractive after Changes Keratometric Surgery Glaucoma Invasive Minimally on Update Palsy Nerve Third Disease Bowel Adult Stem/Progenitor Cells & Their Secreted Secreted &Their Cells Stem/Progenitor Adult Proteins for the Treatment of Ocular Disease Ocular Treatment of the for Proteins Ophthalmology: The Digital Age Digital The Ophthalmology: Vision of the Homeless: The Moran Eye Center at at Eye Center Moran The Homeless: the of Vision Case Presentation Keratoconus, Anatomy, Pathology, and and Pathology, Anatomy, Keratoconus, Endothelial Keratoplasty Automated Stripping Descemet’s after Microscopy Confoval &Contact Noncontact of Comparison Genetic Counseling in Ophthalmology in Counseling Genetic Street Fourth the Trocar Assisted Sutureless Scleral Fixation Fixation Scleral Sutureless Assisted Trocar of Posterior Chamber IOL Viscodissection Viscodissection IOL Chamber Posterior of e with Atwenty-year-old Case: Clinical Matricies Fibrin through Migration a Discussion & Presentation Case Degeneration Terrien’s Marginal Retinachoroidopathy Not? or Birdshot Birdshot DiabeticDelamination Pre-operative Medical Assessment of Patients of Assessment Medical Pre-operative Undergoing Child with Rapidly Progressive Proptosis Progressive Rapidly with Child a Patient with Multiple Branch Retinal Retinal Branch Multiple with Patient Tips with Presentation Video 1. Part Ophthalmologists: for Procedures What Does Optical Quality Mean and and Mean Quality Optical Does What Syndrome Iris Floppy Intraoperative Wait…Can you Fake That? you Wait…Can Sleep Deprivation Subluxation/Dislocation IOL/CTR PX of Pathology Word Blindness Curiosity AUveitic &Intubated: Eyes Red Tell It Us Can What Mouse Models of STGD3 of Models Mouse ncephalopathy &Scotoma ncephalopathy rtery n ovel ovel PIC o m cclusions cclusions odel for Studying Fibroblast Studying for odel o e 2012 ye ye Surgery R T c linic ITLE 67 F o c u s 2 0 1 3 68 F      J Hum Genet 2012; 201;158, 475-81 475-81 201;158, 2012; Genet J Hum loss. vision and cytopenias, splenomegaly, BJ. W, Katz Gellerman JE, Warner M, Sharifzadeh PS, Bernstein KB, Digre S, Llop JE, Frandsen Ophthalmology of Archives 32-37 proteins. binding their and carotenoids of interactions the on studies (SPR) resonance plasmon PS. Bernstein P, K, Vachali Nelson B, Li Biophysics and of Biochemistry Archives expression. erythropoietin local down-regulating by vascularization retinal inhibits STAT3 activation VE ME. Hartnett M, McCloskey GW, Jiang Smith G, Y, Byfield H, Wang ofPathology Journal American R GS, Hageman LD, Robman PN, Baird DS, J, Chauhan Xie SS, Wickremasinghe JH, Lim Ophthalmology of Journal American AT, Vitale FC, Clayton M, DeAngelis KJ, Smock DJ, Creel KB, Digre LB, Williams SK, Tantravahi Genetics of Human Journal American subunits. alpha1 Cav1.4 requires photoreceptors mouse in complexes signaling PMCA presynaptic of D. Trafficking Krizaj A, W,Xing Akopian Biology & Medicine Experimental in Advances Kopplin LJ, Przepyszny K, Schmotzer B, Rudo K, K, Rudo B, Schmotzer K, Przepyszny LJ, Kopplin Infants. preterm very in angiogensis retinal normal for gain weight postnatal early of Importance WINROP ME, Consortium. Hartnett A, Hellstrom DK, VanderVeen L, Smith C, Lofqvist Wu C, 645-7 130(5), 2012; Ophthalmol of visual impairment and blindness. Global burden Group. Expert Loss Vision GBD ME, Hartnett G, Stevens H, Price R, Bourne 259-60 blepharospasm. essential benign and migraine photosensitive with patients in imaging autofluorescence Werner S, L. Goyal DJ, Spalton A, Dhital 678-86 degeneration. macular age-related for factor growth endothelial anti-vascular with treated patients Am J Ophthalmol 2012 Jun; 153(6):1154-60.e1 Jun; 2012 JOphthalmol Am gas. intraocular of injection with associated lenses intraocular hydrophilic in Calcification H. H.

Quantification of macular carotenoids using using carotenoids macular of Quantification ogers G Rogers Delay to treatment and visual outcomes in in outcomes visual and treatment to Delay Arch Ophthalmol 2012; 1-8 1-8 2012; Ophthalmol Arch Arch Biochem Biophys 2012; 519(1), 2012; Biophys Biochem Arch Adv Exp Med Biol 2012; 723:739-744 2012; Biol Med Exp Adv Am J Pathol 2012; 180(3), 1243-53 180(3), 2012; JPathol Am M

. Am J Ophthalmol 2012; 153(4), 2012; JOphthalmol Am A Arch Ophthalmol 2012; 130(2), 130(2), 2012; Ophthalmol Arch n inheritedwith disorder A sample of more than 200 published and presented materials by Moran faculty members members Moran by faculty materials presented and published of more200 than A sample GF-mediated

Guymer Guymer Arch Arch Surface Surface

Am Am

between January 1 and December 31, December 1and January 2012between P J Ophthalmol 2012; 47(2),131-9 2012; J Ophthalmol Can States. United the and Canada in practices 344:e554 extension. label open 2year and trial placebo-controlled double-masked, randomised, 3, aphase from pulmonary arterial hypertension: results for chronically administered when citrate o AM. Laties G, Burgess LJ, Hwang C, Tressler BM, Wirostko Journal Medical British ophthalmology. BM. P,K, Wirostko Garff Egan A, Amireskandari J, Behzadi I, Januleviciene B, Siesky Tobe LA, A, Harris M, Zore macular telangiectasia. 2 type in accumulation debris subretinal of MC GS, T, AP, Hunyor Hageman SH, Young Nolan M, Zhu MC, Killingsworth S, Cherepanoff of Ophthalmology Journal British thickness. corneal central to severity dystrophy corneal MD). (Mifflin Group Study Multi-center Genetics Dystrophy Corneal Endothelial Fuchs JH, Lass SK, Iyengar U, DD, SV, Jurkunas Patel Verdier DC, Babineau J. Gilman B, Katz J, Warner K, Digre (6),2012; 213-8 in bioengineered cornea. hyaluronic scaffold:acid-derived a new horizon Moshirfar M. C, GY, Wang B, McBride Bunnell L, Espandar 433-439 fiber layer. fiber nerve retinal myelinated of characteristics doi:10.1093 fieldbordering dorsalV2. visual the of representation acomplete reveals connections in marm A. Angelucciand JM, Ichida Federer J, F, Jeffs Cortex Cerebral 149(4),847-59 2012; Cell MyD88. and inflammasome NLRP3 the via degeneration macular age-related induced RNA Alu and loss J. DICER1 Ambati ME, Kleinman JZ, Baffi G, P, Nunez DR, Hinton AmbatiBK, MP, JL, Murphy G, Dunaief Chaudhuri SL, Ponicsan JA, JF, Kugel VA, Goodrich WW, Chiodo Hauswirth RJ, Albuquerque S, Bogdanovich BJ, Fowler H, Y, Kaneko WG, Kim N, Cho Kerur S, BD, Dridi Y, V,Tarallo Gelfand Hirano Cell o R, Braga-Mele M, Bradley T, CC, Chan Sorensen of Ophthalmology Journal Canadian

UBLISHED High-resolution mappingHigh-resolution of anatomical . RJ. lson Ultrastructural and clinical evidence evidence clinical and Ultrastructural British Medical Journal 2012 Feb 21; Feb 2012 Journal Medical British Arch Ophthalmol 2012; 130(4), 130(4), 2012; Ophthalmol Arch Arch Ophthalmol 2012 Ophthalmol Arch Ogura Y, Yoo JW, Lee DK, Provost Y, Provost Yoo Ogura JW,DK, Lee A comparison of cataract surgical surgical cataract of A comparison

Relationship of Fuchs endothelial Adipose-derived stem cells on on cells stem Adipose-derived cular safety of sildenafil sildenafil of safety cular Br J Ophthalmol 2012 Nov 9 Nov 2012 JOphthalmol Br oset extrastri Br J Ophthalmol 2012 2012 JOphthalmol Br Generic medications in A Cerebral Cortex 2012; 2012; Cortex Cerebral R rch rch O ESEARCH phthalmol phthalmol ate cortex cortex ate Imaging Gillies

degeneration. endothelial associated keratotomy Radial RT, M. Hau Semnani A, Ollerton M, Moshirfar (6), 2012; 425-432 Ophthalmol S, Hus M, Moshirfar M, M. Hus S, Sikder SM, Christianse LL, MD, Leishman Mifflin literature. the of review a mellitus: diabetes with patients in keratomileusis in-situ Laser SM. Christiansen JN, Edmonds M, Moshirfar RG, Simpson (10), 2012; 2147 Ophthalmol automated endothelial automated keratoplasty. endothelial stripping Descemet’s in preparation graft ultra-thin for technique microkeratome pass Moshirfar M. WL, Hereth M, Huse keratectomy. photorefractive after prophylaxis routine for Clin Clin literature. the of areview disease: vascular collagen with patients in keratomileusis situ in N. Laser Behunin SM, Christiansen JN, Edmonds M, Moshirfar RG, Simpson (6), 2012; 1719-22 Ophthalmol 40(7):697-705 Sep; 2012 Ophthalmol presenting as bilateral Mooren-like ulcers. Mooren-like bilateral as presenting keratopathy Anesthetic NL. Behunin JN, Edmonds SM, Christiansen AH, Vejdani H, Garaee RG, Simpson M, Moshirfar H, Khakshoor 6,2109-17 2012; Ophthalmol D.Clin <1.00 astigmatism with myopia in LASIK and PRK after ablation spherical conventional by induced Moshirfar RG, M. Simpson JN, MD, Edmonds Mifflin SM, Christiansen Ophthalmology Clinical glaucoma and diabetes. angle open with patients in regulation B, Wirostko A, T, Cantor Ciulla S, Primus R, Y, Ehrlich Arieli MM, Shoja A, Y, Harris Shoshani Ophthalmology &Experimental Clinical (Mifflin MD). Study Group (Mifflin Multi-center Genetics FECD SK, Iyengar JH, GO, Lass MO,Rosenwasser Price CR, Croasdale AJ, D, Aldave Bardenstein A, Tagliaferri JR, Igo LJ, Fondran RP, Kopplin MD, Louttit 533-537 donor cap histopathology. and series case a keratectomy: photorefractive or keratomileusis situ in laser previous with endothelial keratoplasty using donor corneas MD. Mifflin N, Mamalis JC, Change L, Espandar CR, D, Fenzl Davis YM, Khalifa M, Moshirfar 2012 Cornea model. suture and keratoplasty BK. Ambati B, Archer JR, Young H, Uehara YK, Cho Cornea Impaired ocular blood flow flow blood ocular Impaired BA. Siesky

Pretreatment in a murine penetrating penetrating amurine in Pretreatment Descement stripping automated automated stripping Descement Clin Ophthalmol 2012; (6), 2012; 1665-74 Ophthalmol Clin Clin Ophthalmol 2012; (6), 2012; 653-9 Ophthalmol Clin Clin Ophthalmol 2012; (6), 2012; 213-8 Ophthalmol Clin

U C se of lotoprednol lin lin

A multicenter study study A multicenter Cornea 2012; 31(5), 2012; Cornea Astigmatism Astigmatism E xperiment xperiment

Double- Clin Clin

Clin Clin EyeNet 2012; (2),48-9. 2012; EyeNet 835-44 rat model of diabetes. a in function endothelial retinal in changes cal pathophysiologi inhibits (SHPS)-1 substrate-1 tyrosine phosphatase non-receptor type with (IAP) protein integrin-associated of tion 22:568-574 April; 2012 Neurobiol Crandall Crandall EyeNet Magazine ME, G, Hartnett Byfield Wai C, K, Gollahon LA, Maile Diabetologia 241:941-952 2012; Dynamics, mental Develop- retina. mouse postnatal the in esis histogen alters and proliferation extends tion Levine AM, Clark G, Das Dynamics Developmental 23(1), 2012; 62-7 Ophthalmol C stand? we do where lens: intraocular glued or lens, intraocular chamber posterior sutured lens, intraocular chamber Anterior B, J, Stagg Young DG, Holt Ophthalmology in Opinion Current Building retinalconnectomes. BW,CB. Watt Jones JR, Anderson RE, Marc Neurobiology in Opinion Current Jan;37(1):1-112012 glaucoma. of treatment possible and pathogenesis the in role suspected its and B. Y, Wirostko and Arieli B, Siesky D, Rusia MM, Shoja A, Harris YZ, Shoshani Eye Research Current membrance endothelial transfer. descemet in proliferation cell endothelial host of role The G. Kim M, Moshirfar lens. intraocular chamber anterior and aphakia, exchange, lens intraocular with stripping automated endothelial keratoplasy MD. Mifflin M, Moshirfar AJ, Jorgensen M, Hsu 31(10),1141-1147 factors on corneal graftrejection. MD). (Mifflin Group Investigator Study Donor Cornea W, FJr, DD, Verdier Stark Price MJ, Mannis C, Kollman EJ, Holland RL, Gal RS, Feder M, Dontchev M, Belin R, Beck A, RD,Sugar Stulting 1503. entity revisited. clinical distinct a keratitis: interstitial Linear MD. Mifflin N, Mamalis S, Sikder CM, Calvo 1445 from older donors. cornea donor study on acceptance of corneas ( Group Investigator Study Donor Cornea Tennant BA, MJ, Mannis J, Malling C, Kollman RL, Gal M, Dontchev JW, Cowden R, Beck MM, Montoya A, Sugar heritability. and characteristics baseline dystrophy: cornea endothelial Fuchs for genes map to C Management and outcomes of descemet descemet of outcomes and Management Disruption of the associa the of D. Disruption lemmons A S. Cornea 2012; 31(1), 2012; Cornea 26-35

Case 4: fun with zonules (not). zonules with 4: fun Case Effect of donor and recipient recipient and donor of Effect Cornea 2012; 31(12), 2012; 1500- Cornea Cornea 2012; 31(12), 2012; 1441- Cornea Mifflin MD). Mifflin Diabetologia 2012; 55(3), 2012; Diabetologia E M. M. AmbatiBK. Cyclin D1 inactiva Cyclin C urr urr Impact of the the of Impact C Cornea 2012 Cornea E Cornea 2012; 2012; Cornea urr urr ndothelin ndothelin Cornea 2012 Cornea Opin Opin

E urr urr ye ye

Res Res Opin Opin

-

- - - Mol Genet 2012; 21(3), 2012; 692-710 Genet Mol Hum II. type syndrome Usher of mechanism the into insight an function: actin-regulatory its modulates and espin with interacts Ophthalmol Vis Sci 2012; 53(4), 2012; 2328-36 Sci Vis Ophthalmol when combined with triamcinolone. effects anti-angiogenic and survival graft in 26(1),J 2012; 81-92 neuritogenesis in retinal degenerations. RE. MV,Shaw Marc y CB, Watt PS, W, Bernstein Baehr L, Tucker JF, Luo BW,A, K, Y, Liu Rapp Lin Jones J2012 FASEB 2(KDR). receptor factor growth morpholinos targetingvascular endothelial splice-shifting by lymphangiogenesis and BK. Ambati B, Archer N, Sigh L, Luo X, Zhang UB, Tyagi P, JR, Young H, Uehara Kompella YK, Cho 53(6),2012; 2837-44 neovascularization. shRNA.VEGF-aplasmids regresses corneal delivery of Nanoparticle-mediated BK. Ambati UB, J, Komeplla Simonis L, Luo X, Zhang S, Singh N, Singh B, Y,Qazi Stagg Sciences Visual and Ophthalmology Investigative 52(4), 2012; 243-256 Clinic, choroidopathy. inner punctate and choroiditis multifocal of management and AT. Imaging Vitale in the diagnosis A, Shakoor Clinics Ophthalmology International analysis. sequence image for fields random markov Fisher. Steven E, Robert W, Marc Bryan Jones R, James Anderson, BS Manjunath, BS Jagadeesh, Vignesh Processing Image IEEE E, y Song Z, J, Shen Zou L, Wang Genetics Molecular Human 4(2), 2012; 16 Medicine Genome functional networks. phenotype-specific and biomarkers global reveals degeneration macular age-related of analysis Systems-level LV, MJ. Johnson Radeke DH, Anderson GS, Hageman JB, Cooper MA, Maloney CM, Radeke NJ, Miller LS, Hancox NB, Gallo AM, Newman Medicine Genome BK. J,Ambati Ambati N, Singh SK, Das L, Luo B, J,Archer J,Cahoon Y, Cho H, Simonis Uehara Experimental Biology Journal for Societies ofAmerican Federation 35(11),June; 1692-1704 with retinaldegeneration. rats to transplants sheet retinal of phenotyping C RE. Marc HS, rstead Kei YangPB, RB, BW, Aramant Jones MJ, Seiler of Neuroscience Journal European 555-60 preschool children. in intake vegetable and fruit of abiomarker as spectroscopy Raman resonance by measured PS, W, Bernstein IV, Ermakov Gellermann H, Lin B, Cartmel H, Peracchio K, Henebery S, Scarmo Nutrition of Clinical Journal European Skin carotenoid status status ST. carotenoid Skin Mayne VB, Duffy

Flt23k nanoparticles offer additive benefit benefit additive offer nanoparticles Flt23k of Dual hemangiogenesis suppression Parameter estimation in dynamic dynamic in estimation Parameter IEEE Image Processing 2012; Online Online 2012; Processing Image IEEE Eur J Clin Nutr 2012; 66(5), 66(5), 2012; Nutr JClin Eur Retinoidreceptors trigger Invest Ophthalmol Vis Sci Sci Vis Ophthalmol Invest omputational molecular Eur J Neurosci 2012 2012 JNeurosci Eur J. ang Inter Ophth Ophth Inter ang JH, ang Invest Invest Whirlin FASEB FASEB

- Jensen M, Kavoussi SC, Hill M, Hill SC, Kavoussi M, Jensen SR, Fuller N, Mamalis T, L, Werner Goecks 38,1902-10 common causes. most the on update syndrome: segment S, Clouser Z, Bodnar 155-62 1; 38, Jan 2012 Surg Refract Cataract eyes. cadaver pseudophakic in fixation MM, P, De SM, E, Van Hummelen Adams Palescandolo LE, MacConaill JE, Lee AB, Daniels 53(10), 2012; 6178-86 Sci Vis Ophthalmol Invest Center. Eye Moran the at enrolled subjects AREDS2 of study ancillary an participants: Baehr W, T, Zhang Baehr 9; 53(11):6991-6 Oct 2012 Sci Vis uvealprimary melanoma. mutationprofiling spectrometry-based of High throughput mass IK. Kim LA, Garraway hydrophilic acrylic I acrylic hydrophilic M, Hill McIntyre JS, 1316-2 38, 2012; Surg Refract J Cataract lens. intraocular of fixation scleral externo Ab RJ Cionni MA, Hater DS, Slade 38(10), 2012; 1876-7 Surg Refract Cataract implants. iris cosmetic of explanation the to G. Kim M, Moshirfar Surgery Refractive & of Cataract Journal J AAPOS 2012; 16(6), 2012; 554-7 J AAPOS cataracts. infantile bilateral with patients in nystagmus of develpment and surgery cataract of timing the between Relationship y 16(3),2012; 234-7 JAAPOS children. in nonperfusion retinal peripheral normal estimate to anaiography ME. MP, Hartnett MJ, Blair Shapiro of AAOPS Journal 56(4),2012; 289-306 RE. Marc BW, Jones Ophthalmology of Journal Japanese January; 53(1), 501-507 January; pigmentosa. retinitis of model pig miniature inbred an of Generation HJ. Kaplan RS, PJ, Prather DeMarco MA, McCall JM, Noel W, L, Wang Zhou RE, Marc P, BW, Bray-Ward C, Jones E, Rios Walters M, JP, J, Samuel Castro Zhao de JW, Fernandez Ross 3356 3349- 53(7), 2012; Sci Vis Ophthalmol Invest amaurosis. congenital Leber of model mouse a in photoreceptors cone preserves TUDCA W. Gellermann I, Ermakov M, Sharifzadeh X, AmbatiBK. X, Zhang B, Archer JR, Young H, Uehara YK, Cho Bernstein Bernstein PS, 53(2), 2012; 685-92 Sci Vis Ophthalmol Invest model. suture corneal amurine in receptor 1 morpholino decreases angiogenesis Heidary G, VanderVeen DK. DK. VanderVeen G, MP,oung Heidary

Macular pigment imaging in AREDS2 AREDS2 in imaging pigment Macular Hahn WC, Gragoudas ES, Harbour JW, Harbour ES, Gragoudas WC, Hahn Assesment of a single-piece asingle-piece of Assesment N. Mamalis Retinalremodeling. Kondo M, Terasaki H, Lin Y, McCall M, M, Y, McCall Lin H, Terasaki M, Kondo

Vascular endothelial growth factor factor growth endothelial Vascular Fuller SR. Kavouissi AC, AC, Kavouissi SR. Fuller L, Werner Invest Ophthalmol Vis Sci 2012 2012 Sci Vis Ophthalmol Invest Ahmed F, Liu A, Allman S, Sheng Sheng S, F, Allman A, Ahmed Liu Cataract Refract Surg 2012; 2012; Surg Refract JCataract Fu y. Mamalis N. Toxic N. anterior Mamalis o Complicationsrelated L for piggyback sulcus sulcus piggyback L for

Chemical chaperone Chemical chaperone Invest Ophthalmol Ophthalmol Invest , Crandall AS. AS. , Crandall o Jpn JO Jpn lson RJ. RJ. lson Angelis Angelis Fluorescein- phthalmol phthalmol J Toxicity

J

69 F      70 F      38(2):227-33 Canada and States United the in survey contracture o R, Braga-Mele M, Bradley T, CC, Chan Sorensen 1476-85 38(8), Aug; 2012 Surg Refract because of optic opacification. explanted lenses intraocular in transmittance light and scattering Light Z. Bodnar L, J, Werner L, Michelson 38(4), 720-1 Apr; 2012 Surg gas. of injection intracameral with association in lenses intraocular acrylic J Michelson A, Ollerton G, Wilbanks L, Werner 38(3), 507-12 Mar; 2012 tensile model. strength amechanized using dye blue trypan without and with tearing to resistance capsulorhexis of Comparison N. Mamalis M, Burrow S, McIntyre SC, Kavoussi S, Fuller L, Werner R, Jaber 1077-85 38(6), Jun; 2012 Surg Refract Cataract J changes. optic lens intraocular postoperative of assessment the in tomography coherence Anterior Z. segment optical Bodnar L, Leishman A, J, Ollerton Michelson L, Werner 1664-70 38(9), Sep; lens. intraocular disk-shaped acrylic hydrophilic a modified with opacification bag capsular of Prevention M, J, Schmutz Michelson A, Leishman L, 38(10):1827-32 Oct; 2012 Surg Refract Cataract J model. rabbit the in lens intraocular acrylic hydrophobic content water 4% single-piece McIntyre JS, A, Ollerton J variables affecting intraoperative aberrometry. J, Stringham 1065-1071 38(6), 2012; Surg Refract Cataract chatter. and efficiency regarding modalities comparison of 4 nonlongitudinal ultrasound G, Wong GJ, Jardine JD, Jensen JH, Pettey BE, Zaugg DL, DeMill (6), 2012; 459-64 Surg Refract J Cataract G. Kim M, Moshirfar 38(2), 2012; 357-61 Surg Refract JC postoperatively. years 14 ingrowth epithelial and macrostriae with dislocation flap LASIK traumatic of management MD. Surgical Mifflin S, Sikder DG, Holt (3), 38 2012; 384-6 Surg Refract with intraocular lens implantation. lens intraocular with surgery cataract phacoemulsification and stripping automated endothelial keratoplasty Descemet- for agents mydriatic preoperative Topical-intracameral anesthesia without o 137-145 rabbit eyes. and without a bioadhesive system in delivery with azithromycin intraocular of comparison . Cataract Refract Surg 2012 Mar; 38(3), 470-4 Mar; 2012 Surg Refract Cataract RJ. lson Sikder S, Jorgensen AJ, Jorgensen S, TJ, Sikder berg Localized calcification of hydrophilic hydrophilic of calcification Localized J Cataract Refract Surg. 2012 Feb; Feb; 2012 Surg. Refract JCataract Ultrasound-induced Ultrasound-induced corneal incision Fuller SR, Kavoussi SC, SC, Kavoussi SR, Fuller L, Werner Bodnar Z, Ollerton Ollerton Z, Bodnar L, Werner

Pettey JH, o JH, Pettey Evaluation of a new new of a Evaluation N. Mamalis J Cataract Refract Surg 2012; 38(1), 2012; Surg Refract J Cataract

J Cataract Refract Surg 2012 2012 Surg Refract J Cataract o May consultation #2. lson RJ. o RJ. lson Ollerton A, Leishman Leishman A, Ollerton JC lson RJ. Evaluation RJ. of lson ataract Mamalis N. J JC C bjective Mifflin MD. Mifflin ataract ataract R

efract Surg J C ataract ataract Refract Refract

J

24 September Online 24 September migraine patient. visual cortex. primary primate the in modulation surround networks compute the orientation-tuning of Strong recurrent A. Angelucci L, Schwabe PC, P, JM, Mangapathy Ichida Shushruth, of Neuroscience Journal 371,2012; 57-65 Biol Dev zebrafish. in evagination vesicle optic during fate retinal dorsal triggers ectoderm Chien RI, CB. Dorsky S, Fuhrmann ES, Veien TS, J,Quist Rosenthal R, Kruse-Bend Biology ofDevelopmental Journal 8 Oct 2012 Neurol J retina. rabbit the of layer plexiform o the in synapses axonal cell bipolar RE. JV, Marc Hoang S, Mohammed BW, CB, Watt Jones JR, Anderson JS, Lauritzen Neurology of Comparative Journal Digre KB. SM, FJ, Hamilton J, Durcan Thostenson I, Irak-Dersu 19(1), 2012; 174-6 Neurosci J Clin reversible cerebral syndrome. vasoconstriction of treatment the in verapamil intra-arterial of use Repetitive 3rd. DV Barge La KB, Digre AG, Smith M, J, Wilder Allred RE, KF,French Hoesch Neuroscience of Clinical Journal photophobia. KC. Brennan KB, Digre Journal of Neuro-Ophthalmology J nerves. limb hind in arrays electrode slanted Utah by produced stance feline GA Clark DA, NM,Warren Ledbetter SD, Hiatt AM, Wilder MA, Frankel BR, Dowden Normann, RA Engineering of Neural Journal 20 Jan 2012 JGlaucoma hypertension. ocular and glaucoma open-angle primary evaluating trials clinical in pressure intraocular on diagnosis pigment dispersion and exfoliation glaucoma of influence the of Review JA. Stewart LA, Wirostko BM, DL, DeMill WC, Stewart conjunctival dissection. mini-glaucoma shunt implantation without Minimally invasive external AC. Sims M, Packer IH, Fine DA, Crandall AS, Crandall RS, Hoffman of Glaucoma Journal 367:91-99 2012; Biol Dev transition. in acomplex organogenesis: ML. Vetter I, Diri Al migraine. with associated defects field visual altitudinal Reversible prolonged bilateral inferior JB, Shelton 2012 artery. carotid internal fibrillation and completeocclusion ofright atrial with patient in stroke Chiasmal JB, Shelton 68-81 Eng 2012 Apr; 9(2):026019 Apr; 2012 Eng . Coordinated, multi-joint, fatigue-resistant Coordinated, fatigue-resistant multi-joint,

J Neuro-ophthalmol 2012 J Neuro-ophthalmol Digre KB, Katz BJ, Warner JE. JE. Warner BJ, Katz KB, Digre JE. Warner BJ, Katz KB, Digre

J. Neurosci 2012; 32:308-321 2012; Neurosci J. o J Neuro-ophthalmol 2012; 32(1), 2012; J Neuro-ophthalmol ptic disc and visual findings in findings visual and disc ptic J Clinical Neuroscience. 2012; 2012; Neuroscience. JClinical PRC2 during vertebrate vertebrate during PRC2 Shedding lightShedding on J Neuro-ophthalmol J Neuro-ophthalmol J Glaucoma 2012 2012 JGlaucoma

Extraocular Extraocular o N cone N cone Bressloff FF inner Nelson Nelson Comp Comp N eural eural

Ophthalmol 2012; 19(4),376-81 2012; Ophthalmol 10;7:7. 10.1186/1750-1326-7-7 doi: degeneration. retinal during 2trafficking receptor glutamate WD, Ferrell JS, Lauritzen FR, Vazquéz-Chona BW,A, Y, Liu Lin Jones Neurodegeneration Molecular photorefractive keratectomy. or keratomileusis situ in laser-assisted prior without or with keratoplasty conductive after MD. Mifflin JM, Armenia M, E, Hsu Anderson M, Moshirfar Ophthalmology of Journal African Eastern Middle ablation. myopic by induced change refractive to change keratometric of ratio the of Comparison G. Kim SM, Christiansen M, Moshirfar 28(2), 2012; 127-32 Surg J Refract function. visual postoperative of comparison eye contralateral randomized, prospective, Moshirfar M. CJ, Kurz S, Sikder BB, MD, Hatch Mifflin Surgery of Refractive Journal 537-53 telangiectasia. macular disease retinal the to iTRAQ of MC. Pilot application Gillies M, Fruttiger X, Song GS, Hageman L, Zhu MB, Powner AC, Len Research of Proteome Journal rods. regulate calcium intracellular in mammalian D. Krizaj Vand Kefalov C, Punzo L, P, T, Birnbaumer Barabas Molnar of Physiology Journal 2012 Nutr Gastroenterol JPediatr status. carotenoid infant preterm the and spectroscopy raman Resonance P, P, R Bhosale M, Bernstein Ermakova Gellermann MM, W, Chan GM, Chan Gastroenterology of Pediatric Journal 32(2),189 2012; JO artery. carotid internal right atrial fibrillation and completeocclusion of with patient in EP.stroke Quigley Chiasmal JE, Warner BJ, Katz KB, Digre JB, Shelton 27-32 2012; Ophthalmol J keratomileusis. situ in laser and keratectomy serous chorioretinopathy after photorefractive ME. Hartnett S, Sikder J, J,Armenia Schulman M, Hsu M, Moshirfar Ophthalmology of Journal M RE, Marc W, BW, Tam FV, Ferrell Jones D, B, Chona Lee 2128 degeneration. retinal reverse to regenerating of capable and active metabolically are pigmentosa retinitis of model rhodopsin mutant aP23H in Journal of Physiology 2012; 590: 3465 3465 590: 2012; Physiology of Journal J Refract Surg 2012; 28(10), 675-82 28(10), 2012; 675-82 Surg JRefract oritz Comparing the rate of regression

Custom vs conventional PRK: a PRK: conventional vs Custom

Mol Neurodegener. 2012 Feb; Feb; 2012 Neurodegener. Mol J Neurosci 2012 Feb; 32(6), Feb; 2012 2121- J Neurosci J Proteome Res 2012; 11(2), 2012; Res JProteome O.

Dysmorphic photoreceptors The incidence of central central of incidence The Store-operated channels channels Store-operated Marc RE. Rapid RE. Marc M phthalmol phthalmol iddle Ermakov I, I, Ermakov au au E

ast ast

C. C. A fr J J fr

Open Ophthalmol J 2012; (6),6-7 J 2012; Ophthalmol Open patient. myopic apregnant in lens intraocular phakic iris-supposed verisyse of implantation Choroidal neovascularization following 657-74 18, 2012; age-related macular degeneration. SLC2A1 single nucleotidepolymorphisms and 10-6 Nepal. in center care eye tertiary at a service vitreo-retinal the attending patients diabetic among retinopathy Betts BS, o BS, Betts Journal Ophthalmology Open expression. inhibition ofchemokine receptor C ofmediated C6 suppression gliomas involves J, Ambati B, J, Ge Zhang YangY, S, X, Pan Tian Z, Chen Yu K, Rep Oncol 5(2),109-11 2012; JOphthalmol Oman primary presentation of foodbornebotulism. Moshirfar M. BK, Armstrong AH, Vejdani AA, Moghaddam H, Khakshoor of Ophthalmology Journal Oman literature. the of review and cases two of report illness: following systemic moxifloxacin for respiratory AT. DI, Bettis RG, Morshedi In ammation and Immunology Ocular 367(26), 2012; 15-26 JMed Engl N prematurity. of retinopathy of management Mechanisms and JS. Penn ME, Hartnett of Medicine Journal New England (2), 2012; 1-8 Oncol multicenter retrospective analysis. a chemotherapy: following glioma pathway with neurofibromatosistype 1-associated optic children in outcomes GT. Visual Liu LJ, Balcer LT,Bilaniuk J, Charrow E, Bouffet DR, Hargrave R Hoffman U, Tabori RJ, Pakcer NJ, Ullrich RE, Ferner R, Listernick DH, Gutmann M, Loguidice MJ, Fisher Neuro-Oncology visual synesthesia. auditory- acquired idiopathic of investigation Neurophysiological JE. T, Warner F, Constantino Matsuo M, Johnson M, J, Funke P,Afra Anderson Neurocase PS. Bernstein N, Maharjan G, Poudyal R, Thapa of Ophthalmology Journal Nepal AA Bergen GS, Hageman R, Allikmets BH, Weber M, Dean CC, Klaver JR, Vingerling JB, TenA, Brink PT, Hofman Jong de AG, Uitterlinden CM, Duijn BP, van TG, Koeleman R, Gorgels Slot Het van JE, Merriam LG, Tanck MW, L, Ho Fritsche DC, Baas Vision Molecular .

Bilateral acute iris transillumination Demographics and awareness of diabetic diabetic of awareness and Demographics Multicenter cohort association study of study association cohort Multicenter

o, Ocul Immunol Inflamm 2012 2012 Inflamm Immunol Ocul Hsu M, Moshirfar M, TJ, M. Hsu berg Oncol Rep 2012; 28(3), 2012; 955-60 Rep Oncol Zhuang J. Tetramethylpyrazine- J. Zhuang Ardern-Holmes SL, Hummel TR, TR, Hummel SL, Ardern-Holmes Nepal J Ophthalmol 2012; 4(7), 4(7), 2012; JOphthalmol Nepal Neurocase 2012;Neurocase 18(4),323-9 Moshirfar M, Vitale Vitale M, Moshirfar

Diplopia as the Neuro- xCR4 xCR4 M ol Vis Vis ol

T M, T, Burrow Neuhann B, Zaugg L, Werner 119,907-913 intraocular lenses. acrylic hydrophobic square-edged of fixation sulcus or asymmetric with complications Mamalis N. L, L, Werner KR, Kirk 119(6),1151-8 2012; Ophthalmology head. nerve optic and layer fiber nerve with comparison thickness: layer plexiform cell-inner ganglion of accuracy 119(2):266-71 Feb; 2012 Ophthalmology cases. 23 of series a dislocation: or subluxation lens intraocular Ophthalmology Ophthalmology 7(10),e46742 endothelial corneal dystrophy. Co and TCF4 for roles Differing MD). (Mifflin Group Study Multi-center Genetics FECD SK, Iyengar JH, Lass M, MO,Rosenwasser Price CR, Croasdale AJ, D, Aldave J, Bardenstein P, Joseph Fondran B, Truitt LJ, Jr, RP Igo Kopplin 7(4):e35295 ocular ocular melanoma families. cutaneous- and melanoma ocular metastatic with associated preferentially is inactivation Tsao Germline H. BAP1 LM, E, Duncan Gragoudas MM, DeAngelis AM, Lane M, Taylor M, Gabree A, Piris I, Kim CN, Njauw e24268 7(8), 2012; ONE PLoS 2. type telangiectasia macular for locus susceptibility a potential I R. JD, Allikmets Terwilliger K, Kiryluk PS, Bernstein MC, T, Peto AC, Gillies Bird M, Figueroa C, Schubert NL, Parmalee 7(3),2012; e33576 ocular and tumor neovascularization. decreased in results Flt-1 expression soluble in J, o One PLoS Levine C, Zou PLoS Genetics 2012 Pharmaceutics drug delivery for glaucoma management. o BM. Wirostko BK, Ambati B, Archer RM, Burr R, Condie SA, Molokhia N, Gooch Pharmaceutics 43(1):45-9 Jan-Feb; 2012 Imaging Lasers hydrophilic intraocular lenses. N. Mamalis L, J, Werner S,Enin Agarwal N, Saffra &Imaging Lasers Surgery, Ophthalmic clinical trials. glaucoma in analyses pressure intraocular A WC. Stewart JA, Stewart LA, Nelson BM, Wirostko DL, DeMill OphthalmicResearch Crandall R, Carter DG, Godfrey A, RT, Neelakantan Change FE, Sayyad DL, Budenz MK, Durbin JC, Mwanza binding. DNA high-affinity for required residues via homeodomain and non-homeodomain identity progenitor retinal and organogenesis etz etz Morpholino-mediated increase Morpholino-mediated BK. Ambati wen LA, LA, wen

In vitro analysis of Nd: of analysis vitro In L8A2 in central corneal thickness and fuchs fuchs and thickness corneal central in L8A2 M . In-the-bag capsular tension ring and and ring tension capsular In-the-bag PLoS ONE 2012; 7(3), 2012; ONE e33576 PLoS Uehara H, Cahoon J, Huang W, J, Huang Simonis Cahoon H, Uehara Ophthalmic Res 2012; 49:49-51 2012; Res Ophthalmic

E Pathologic assessment of of assessment Pathologic M. M. verage eye versus highest highest versus eye verage Jaber R, Strenk S, Strenk Strenk S, Strenk R, Jaber A Vsx2 controls eye eye controls Vsx2 Ophthalmology 2012; 2012; Ophthalmology S.

Glaucoma diagnostic y AG laser damage to to damage AG laser

PLoS One 2012; 2012; One PLoS dentification of O

PLoS ONE 2012; 2012; ONE PLoS phthalmic Surg Surg phthalmic cular

PLoS ONE ONE PLoS

in photoreceptors. independent mutually is Ca(v)1.3alpha(1) and Incorporated, New Jersey. 2012 Jersey. New Incorporated, Slack 48). (Chapter Questions Clinical Uveitis:49 EM (ed.), Curbside Consultationin Opremcak from Endophthalmitis? Uveitis AT,Vitale YangP. IDifferentiate Do How 2012 Jaypee-Highlights. 137-145). pp. India: 38, Dehli, New Edition, (Eds.), Phacoemulsification Jacob Soosan Syndrome. Mamalis N 2012 Slovenia. Ljubljana, Publishers, New Delhi, India. 2012 India. Delhi, New Publishers, Medical Brothers Jaypee Edition. Second Uveitis, JM, Baehr W. Baehr JM, CD, Frederick Gerstner H, Zhang R, Constantine 88-97 75, 2012. Res Vision dystrophy associated with nephronophthisis. retinal of form Asyndromic Syndrome: Løken W. Baehr PS, Bernstein CC, Ronquillo 19-25 75, 2012; Res Vision chaperone involved in intracellular trafficking. Zou J, Lee A, y A, J,Lee Zou 1 75, 2012; Res Vision treatment. and mechanisms to genes W. Baehr H, Khanna proteins. myristoylated of trafficking the coordinating System. Visual the in Integration D. Krizaj DA and Ryskamp 22453974. PMID: 740: 873-889 Biol Med Exp Adv review. Invited Berlin. Verlag, Springer Islam, Shahidul Experimental Medicine and Biology Function. D. Krizaj Published Chapters Book Vitale CS, Foster Published Books W. Baehr JM, R, Frederick Constantine H, Zhang Research Vision Physician, 2012; 9(2):18-22 2012; Physician, Retinal uveitis. treating in go to way right the is PPV if tell to soon too It’s uveitis: in remission drug-free of induction the for vitrectomy AT, Vitale Smet M, M Colucciello Physician Retinal Acad Sci U S A 2012; 109(34),13781-6 USA2012; Sci Acad age-related macular degeneration. J. Ambati BD, Gelfand JZ, Baffi ME, Kleinman DR, Hinton SL, Ponicsan JA, JF,WW, Kugel Goodrich AmbatiBK, Y, V, Tarallo Hirano BJ, Y, S, Kim Fowler Dridi of Sciences of the United States States United of the of Sciences Academy National of the Proceedings ERK1/2 activation is a therapeutic target in target therapeutic isa activation ERK1/2

The prenyl-binding protein PrBP/δ: a protein prenyl-binding The Calcium Stores and Photoreceptor Photoreceptor and Stores Calcium Vision Res 2012; 75, 26-32 75, 2012; Res Vision In: Calcium Signaling, Advances in in Advances Signaling, In: Calcium , Fuller S. Toxic S. , Fuller Anterior Segment In Amar Agarwal, Athlyn Agarwal, Agarwal, Athlyn Agarwal, Amar In Bogdanovich, Chiodo VA, Hauswirth Hauswirth VA, Chiodo Bogdanovich, J. ang Uncoordinated(UNC)119: A. Vision Res 2012; 75,53 -5 75,53 2012; Res Vision

Diagnosis and Treatment of Treatment of and Diagnosis The expression of whirlin whirlin of expression The Retina ciliopathies: from from ciliopathies: Retina

In Foster CS, Hinkle D& D& Hinkle CS, Foster In Polymodal Sensory Pars Plana Plana Pars de. Proc. IJS, Proc.

Proc Natl Natl Proc vol. 740, Ed. 740, Ed. vol. Senior- (4th (4th

71 F      72 F o c u s 2 0 1 3 Intraceptor 1/1/09–12/31/12 Duration: Inc. Blindness, Prevent to Research Award Physician-scientist 10/01/09–9/13/13 Duration: (US Veteran’s Administration) City Lake Center/Salt VA Medical Award Merit VEGF. of VA Interference Pre-mRNA 5/1/12–5/31/13 Duration: e of Office Governor’s Utah Easier and Safer Surgery Cataract Making Endoshield: 6/1/12–5/31/13 Duration: Foundation Research Utah of University Surgery Cataract in Protection Corneal for Lens Endo-contact 12/1/12–8/31/13 Duration: Reeves Foundation Duration: 8/1/09–7/31/12 Duration: Health of Institutes National V1 Pathways V2 to MD, PhD Angelucci, Alessandra 4/1/07–3/31/12 Duration: Institute Eye National Corneal Angiogenesis. 5R01EY017182-02 in VEGF of Interference Intraceptor 5/1/08–4/30/12 Duration: EyeInstitute National NIH c AMD for Diagnostics Early and Therapy Novel for Analyzer Health Retinal 12/1/11–11/30/12 Duration: Foundation Research Utah of University Gel Glaucoma Subconjunctival 2/1/08–4/30/12 Duration: Institute Eye National Pathways VEGF of Interference Intraceptor 5/1/08–4/30/13 Duration: Institute Eye National Avascularity SFLT of Role Corneal in The MD, PhD,MBA KAmbati, Balamurali R Research Grants and Contracts conomic Development Development conomic arl arl ESEARCH m arshall & arshall G m RANTS ildred ildred a lmen lmen JoHN

$60,000 $650,000 $40,000 $35,000 $372,488 $250,000 $1,498,040 $20,000 $35,000 $278,187 $338,625 o M A. RAN Duration: 12/1/12–8/31/13 Duration: Reeves Foundation c AMD for Supplement AREDS Generation Next the of Support in Studies Biochemical 11/1/10–10/31/12 Duration: Institute Research Medical Lowy Carotenoids Macular Mactel 12/16/09–12/15/12 Duration: Foundation Research Vision Macula Disorders Macular 7/1/07–4/30/12 Duration: Health of Institutes National Macular Cartenoids of &Pharmacology Biochemistry MD, PhD SBernstein, Paul 10/7/11–11/7/12 Duration: Foundation Research Retinal International of ANKMY2 Function The 8/1/10–7/31/13 Duration: Foundation Fighting Blindness Degeneration Retinal of Study 8/1/12–7/31/14 Duration: Health of Institutes National Degeneration Retinal in Nephrocystin-5 of Role The 5/1/12–4/30/16 Duration: Health of Institutes National NPHP5 and KIF17, RP2, Ciliopathies: Photoreceptor 12/1/08–11/30/13 Duration: Health of Institutes National Membrane Protein Trafficking 7/1/10–6/30/15 Duration: Health of Institutes National (Baehr & Bernstein) Grant Research Vision Core BBaehr, PhD Wolfgang 5/1/12–7/31/14 Duration: Health of Institutes National Cortex Cerebral the in Connections Long-range Single-cell Mapping for Approach A Novel 1/1/12–12/31/12 Duration: Foundation Research Utah of University Circuits Connectomics-feedback 3/1/09–2/29/12 Duration: NationalScience Foundation in V1 Effects Contextual E y E arl arl m arshall & arshall CENTER m ildred ildred

a lmen lmen 2012-2013 $171,493 $298,916 $28,000 $120,000 $20,000 $147,600 $80,000 $372,488 $90,500 $57,000 $33,695 $373,750 $335,239 Duration: 1/1/11–12/31/14 Duration: Transcend Medical, Inc. Implant Glaucoma Cypass 9/1/11–12/31/12 Duration: Omeros Corporation Oms302-Ilr-003 4/12/12–6/30/13 Duration: Omeros Corporation Oms302-Ilr-004 MD SCrandall, Alan 1/1/06–12/31/12 Duration: Emmes Corporation 2 AREDS 5/1/89–12/31/12 Duration: Ltd. Institute, Research Medical Lowy MacTelStudy Genetics 10/1/11–9/30/12 Duration: Emmes Corporation Opera 5/1/11–12/31/14 Duration: Glaxosmithkline Bam114341 12/1/10–11/30/12 Duration: Institute Research Medical Lowy Carotenoids Pigment Macular 06/1/10–1/31/13 Duration: Institute Research Neurovision National Vpa Protocol 06/1/10–12/31/12 Duration: Emmes Corporation Device Foreseehome 8/1/09–12/15/12 Duration: Foundation Research Vision Macular Disorders Macular 3/1/09–2/28/12 Duration: Foundation Fighting Blindness Research Vision For NEER-CTEC 9/28/07–Present Duration: Inc. USA, Neurotech Outcome Primary the as Acuity Visual Using Pigmentosa Retinitis with Participants (CNTF) for Factor Neurotropic Ciliary Releasing Implants NTC-201 Cell Human Encapsulated of Study II/III A Phase 7/1/07–6/30/12 Duration: Health of Institutes National 11600 EY R01 Cartenoids Macular the of Pharmacology and Biochemistry 06/01/06–Present Duration: Institute Eye Corporation/National EMMES II (AREDS) Study Eye Disease Age-related 05/01/11–12/31/14 Duration: Glaxosmithkline Bam114341 MD, PhD SBernstein, Paul

$110,289 $110,289 $21,467 $48,270 $149,081 $66,506 $3,109 $234,887 $179,500 $628,276 $66,568 $240,000 $302,582 $114,820 $1,250,000 $168,000 $234,887 Duration: 9/1/11–08/31/16 Duration: Institute Cancer National Community Healthier Coalition 9/1/11–8/31/16 Duration: Services Human and Health of Department onWomen’s Health, Office Gender-based Research Present 1/1/08– Duration: Services Human and Health of Department Centers Health Local with Libraries Local Pairing 9/1/07–Present Duration: Health of Department Utah Network Information Women’sUtah Health MD BDigre, Kathleen 1/1/09–12/31/12 Duration: Health of Institutes National R01EY-014458 Degeneration Macular Age-related of Study Sibling 9/1/10–8/31/12 Duration: Women’s and Brigham Hospital Of AMD Epidemiology Genetic 5/1/11–5/31/12 Duration: Council Development Resource Educational Degeneration Macular Age-related for Cohorts Iowa and Utah the of Study Genetic 12/1/12–8/31/13 Duration: Foundation, Inc. c Elizabeth Hartnett Mary DeAngelis, Margaret Investigators: Principal Laboratories Hartnett and DeAngelis by the Studies Functional and Assays Expression Gene of Purpose the for Degeneration Macular Age-related of Studies for Cells Endothelial Choroidal Human of Isolation the Including Tissue for Eye Bank Lions Utah the Eyes from Human of Repository a Build to To Continue 3/16/12–12/31/13 Duration: Foundation ALSAM Recognized NativeAmericans Federally Eye among Posterior the of Diseases Blinding of Epidemiology Genetic the Understand to Research 12/15/09–12/14/12 Duration: Foundation Memorial LThome N&Della Edward and Interventions Therapeutic Preventive Appropriate of Development the for Degeneration Macular Age-related of Mechanisms Underlying Identifying 7/1/10–12/14/12 Duration: Memorial LThome N&Della Edward Degeneration Macular Age-related of Mechanisms Underlying Identifying PhD DeAngelis, Margaret arl arl m arshall arshall r eeves & eeves m ildred ildred

a lmen lmen

r

eeves eeves $465,701 na $25,000 $500,000 $1,000,000 $94,310 $7,000 $20,000 $963,100 $681,816 $250,000

73 F o c u s 2 0 1 3 74 F      Duration: 9/1/10–8/31/13 9/1/10–8/31/13 Duration: C Degeneration Macular Age-related to Susceptibility Genetic 9/1/09–7/31/12 Duration: Health of Institutes National Therapy MOD Complement DEC PhD SHageman, Gregory 2/1/11–Present Duration: Health of Institutes National Outcomes Patient and Glaucoma about Communication 3/1/11–4/30/13 Duration: Hill Chapel at Carolina North of University Glaucoma about Communication MD Goldsmith, Jason 1/1/10–12/31/13 Duration: Health of Institutes National Development RPE Controlling Mechanisms Fuhrmann,Sabine PhD 12/1/2012– 8/31/2013 Duration: Foundation M Carl Degeneration Macular Age-related for TreatmentStrategy A New 7/1/12–6/30/13 Duration: Templar Knights Eye Foundation for Leber Congenital Amaurosis Therapies Effective of Development 7/1/11–6/30/12 Duration: Templar Knights Eye Foundation Leber Congenital Amaurosis 7/1/11–6/30/14 Duration: Foundation Ziegler E Matilda Congenital Strategies-Leber Amaurosis 7/1/08–6/30/12 Duration: Blindness Prevent to Research Award Development Career RPB Duration: 9/30/12–8/31/17 Health of Institutes National Cone Opsins in Photoreceptor Degeneration Fu, PhD yingbin Duration: 10/1/09–1/31/12 Center Hospital Lukes-Roosevelt St. Iihtt Nordic $2,500 1/1/12–6/30/12 Duration: onWomen’s Health Office DHHS 2012 Week Women’sHealth National 12/12/11–9/14/12 Duration: onWomen’s Health Office DHHS Women for Campaign Heart 12/2/11–9/14/12 Duration: onWomen’s Health Office DHHS Women’s Health Conference PhD BDigre, Kathleen olumbia University University olumbia arshall & M arshall

Almen Reeves Reeves ildred Almen

$55,963 $2,986,452 $91,426 $54,551 $376,250 $200,000 $373,541 $147,365 $10,000 $1,811 $20,000 $60,000 $40,000 $240,000 Age-related Macular Degeneration Macular Age-related and Normal the of Imaging Hyperspectral Duration: 2012– Duration: Chapter Utah Dimes of March TreatmentSafe a Seeking of Prematurity: Retinopathy in Erythroprotein Regarding Saftey and Mechanisms Angiogenic on Studies 1/1/07– Duration: EyeInstitute National EY01 3R01 Degeneration Macular Age-related Endothelial Transmigration inNeovascular 1/1/09–11/1/12 Duration: Health of Institutes National Supplement Instrument Degeneration, Macular Age-related Transmigration inNeovascular EY0170113R01 03S1- Endothelial 1/1/11–Present Duration: Health of Institutes National Network Research Clinical Retinopathy Diabetic 4/1/12–3/31/17 Duration: Health of Institutes National Degeneration Macular Age-related Neovascular in Endothelial Transmigration 7/1/10–6/30/14 Duration: Health of Institutes National ROP in Angiogenesis of Mechanisms MD Hartnett, Elizabeth Mary 8/1/06–7/31/12Duration: Health of Institutes National Degeneration: 1-R24-EY017404 Macular Age-related for Therapeutics Modulating Complement of Development 1/1/10–12/31/12 Duration: Inc. Laboratories, Alcon Award Recognition Alcon Duration: 7/28/11–07/28/12 Foundation Degeneration Macular American Africa in AMD of Investigations 10/4/11–10/4/14Duration: Australia of Foundation Degeneration Macular Modalities Functional and Imaging Novel Employing AMD, Early in Phenotypes High-risk of Characterization Improved 1/1/12–12/31/12 Duration: Inc. Blindness, Prevent to Research Award Investigator Scientific Senior Blindness Prevent to Research 4/1/11–3/31/13 Duration: YorkNew University

2015 2/29/17

$90,000 $373,750 $500,000 NA $373,7505 $438,909 $12,837,275 $200,000 $25,000 $400,000 $150,000 $37,243 Duration: 9/1/07– Duration: EyeInstitute National Retina the in Neurotransmission of Regulation PhD Krizaj, David 9/1/12–8/31/16 Duration: Inc. Pharmaceuticals, Quark 007 Quark 9/1/12– Duration: Activity Acquisition Research Medical Army LMonson Kenneth JKatz Bradley AGoldsmith, Fu, Jason Yingbin Coats, Brittany Investigators: Principal Injury Ocular Blast MD, PhD JKatz, Bradley 12/1/03–3/31/16 Duration: Health of Institutes National EMarc Robert WJones, Bryan Investigators: Principal Remodeling Retinal 12/1/11–11/30/16 Duration: Health of Institutes National EMarc Robert WJones, Bryan Investigators: Principal Retinal Circuits 12/15/09–9/14/13 Duration: Memorial LThome N&Della Edward AMD Phenotypes Stage Late vs. Aging Normal PhD WJones, Bryan Duration: 8/15/12– Duration: Activity Acquisition Research Medical Army Trauma Blast Ocular of Mechanisms Characterization ofMolecular 12/1/12–11/30/16 Duration: Health of Institutes Nation Retina the in Mechanosensation of Role 7/1/10–6/30/15 Duration: Health of Institutes National Grant Research Vision Core Duration: 2012-2013 Duration: Commercialization Technology Utah of University Glaucoma Treatment of for Prodrug TRPV4 Antagonist Novel 7/1/12–6/30/13 Duration: Foundation Research Utah of University Neuroprotection inGlaucoma and Transduction Pressure 7/1/11–6/30/12 Duration: Templar Knights Eye Foundation Glia Muller Retinal in Channels by TRPC Modulated are RetinalInflammation and Degeneration

8/31/13 8/31/16 8/14/2016

$321,829 $93,635 $718,099 $440,990 $827,185 $250,000 $269,406 $249,652 $85,254 $10,000 $18,500 $40,000 Duration: 3/1/06–Present 3/1/06–Present Duration: Inc. Vision, Calhoun Liliana Werner Mamalis, Nick Investigators: Principal Model aRabbit in Lens Adjustable Light the of Biocompatibility and Adjustment Power the of Evaluation 2/2/06–Present Duration: TreatPhaco Liliana Werner Mamalis, Nick Investigators: Principal Eyes Cadaver Human in Cells Epithelial Lens Remove to of EpiLoop Evaluation 3/1/05–Present Duration: Advanced Medical Optics Liliana Werner Mamalis, Nick Investigators: Principal Lens Intraocular aNew with Implanted been had Eyes that Rabbit Explanted of Gross and Histopathologic Evaluation 3/1/05–Present Duration: Ltd. Research Alcon Extraction Cataract During Cells Epithelial Lens Residual of Removal for AquaLase 1/1/05–Present Duration: Ltd. Research Alcon Eye aPig in Cells Epithelial Lens of Removal of Evaluation 1/1/05–Present Duration: Inc. Visiogen Liliana Werner Mamalis, Nick Investigators: Principal IOL IOL’s Back Piggy aDual-optic and of Implantation after Opacification Bag Capsular of Assessment 5/5/07–4/30/12 Duration: Inc. Vision Calhoun Liliana Werner Mamalis, Nick Investigators: Principal #21 Amend Biocompatibility, and Adjustment Power MD Mamalis, Nick 7/1/11–6/30/12 Duration: Foundation Research Utah of University Pathologies TreatingRetinal-related for Models Mouse of &Evaluation Development Duration: 7/1/10–6/30/15 Duration: Health of Institutes National Grant Research Vision Core 12/1/08– Duration: Health of Institutes National Cells Retinal Embryonic CCX10 PhD MLevine, Edward TA-NMT-0810-0502-UUT Degeneration, Macular Age-related Dry and Dominant Stargardt Disease (STGD3) in (VLC-PUFAs) Acids Polyunsaturated Chain Long Very of Role The Duration: 8/1/10– Duration: Foundation Fighting Blindness SBernstein Paul Krizaj, David Investigators: Principle

7/31/13 11/30/12

NA NA NA NA NA NA NA $28,000 $112,354 $344,178 $195,000 75 F      76 F      of Neurochemistry Structural PhD E Marc, Robert 8/1/99–7/31/13Duration: EyeInstitute National Outcome Transplant Cornea on Age of Effect the Study to Investigation Multicenter National Study: Donor Cornea 1/1/09–Present Duration: Inc. Allergan, Duration: 3/1/93– Duration: Health of Institutes National Circuits Retinal 12/01/08– Duration: EyeInstitute National Remodeling Retinal 12/15/09– Duration: Foundation Memorial LThome N&Della Edward EMarc Robert WJones, Bryan Hageman, S Gregory Investigators: Principal AMD Late-stage vs Aging Normal 7/1/11–6/30/12 Duration: Foundation Research Retinal International Plasticity Acid Retinoic 10/1/09– Duration: Foundation Science National Subcontract UCSB (ARRA) Imaging in Challenges 7/1/12–6/30/13 Duration: EyeInstitute National (Supplement) Grant Research Vision Core Retinal Circuits Injection Intravitreal with Endophthalmitis of Antibiotics/Risk of Topical Evaluation 03/1/12–6/30/17 Duration: Research Health for Center Jaeb CPTS 7/1/12– Duration: Research Health for Center Jaeb CPTS MD DMifflin, Mark Duration: 7/1/10–6/30/15 Duration: EyeInstitute National (Main) Grant Research Vision Core Duration: 12/1/11–11/30/16 Duration: EyeInstitute National Duration: 7/1/10–6/30/15 Duration: EyeInstitute National Grant Research Vision Core 4/1/12–3/31/13 Duration: EyeInstitute National Retinal Remodeling Retinal

12/31/12 6/30/17

9/30/13

12/14/12 11/30/13

$27,134 $1,569,456 $874,688 $691,825 $35,000 $300,000 $89,932 $20,000 $109,350 $51,800 $41,974 $614,251 $166,840 $627,106

of AcrySof ofGlistenings AcrySof Study Multi-centered A Prospective MD Jolson, Randall 9/1/11–8/31/13 Duration: Foundation Science National Intrafascicular Microstimulation with Activity Nerve Peripheral and Afferent Efferent of Control PhD ANormann, Richard Duration: 12/2/11–12/31/16 Inc. Technologies, Ophthalmic VisionCare IMT 9/1/12–6/30/13 Duration: Avedro, Inc. Kxl-001 ACOS MD Moshirfar, Majid Allergan, Inc. Allergan, BAK +/- Gatifloxacin to Response MRSA Visualizing 05/1/08–Present Duration: &Lomb Bausch Systems Flow Vacuum in Surge Post-occlusion Assessing 6/1/08–Present Duration: Inc. Optics, Medical Advanced Generation Fluoroquinolonesagainst MRSA 4th and of BAK Effect the Differentiating 8/1/07–Present Duration: Inc. Allergan, Eyes Cadaver in Injection Intraocular from Bacteria of Recovery 4/1/08–Present Duration: Advanced Medical Optics, Inc. OVDs Dispersive with Damage Endothelial Corneal of Comparison Eyebank An 5/1/08–Present Duration: Allergan, Inc. Allergan, Duration: 4/1/07–Present Duration:

$198,458 $71,090 NA $8,000 $10,000 $25,000 $25,000 $6,000 $12,000 Duration: 7/1/10–6/30/15 Duration: Health of Institutes National Experimental Glaucoma in Microglia of Role EY020878 1 R01 Duration: 7/1/08–6/30/13 Health of Institutes National Factors by bHLH Neurogenesis Retinal EY012274of 2 R01 Regulation 1/1/10–12/31/12 Duration: Foundation Research Glaucoma aCure for Catalyst Duration: 7/1/09– NEI Health, of Institutes National Vasculature Hyaloid Vitreous the of Development Regulating Signals 1 R21Retina-derived EY019390 Vetter,Monica PhD 4/1/12–3/31/13 Duration: Health of Institutes National Retina (Supplement) in Pathways Synaptic of Development 4/1/11–3/31/16 Duration: Health of Institutes National Retina in Development of Synaptic Pathways Pathways Synaptic of Development PhD Tian, Ning 1/1/87–Present Duration: EyeInstitute National Study Melanoma Ocular Collaborative the of Section California Northern 10/14/08–Present Duration: Inc. Macusight, investigator Sub Retinopathy Diabetic to Secondary Edema Macular Diabetic with Patients Injections Subconjunctival of Sirolimus in of Efficacy and Safety the Assess to Study Clinical Dose-ranging Placebo-controlled, Double-masked, Randomized, 2, A Phase 4/1/07–Present Duration: Inc. Pharmaceuticals, Regeneron 3) 3 (CLEAR-IT Trial Retina–Intravitreal the in Anti-angiogenesis of Evaluation Clinical Degeneration Macular Age-related Neovascular with Trap VEGF Subjects in Intravitreal of Doses Repeated of Tolerability and Safety, Efficacy, the of Study III Phase Controlled Active Double-masked, A Randomized, 4/15/09–6/30/12 Duration: Ltd Research Alcon GATE 1/31/08–Present Duration: Ltd Research Alcon (GAP) Study Progression Atrophy Geographic of History Natural The PTeske, MD Michael

6/30/12

$984,465 $2,740,163 $1,101,250 $413,771 $263,900 $374,375 NA NA NA $75,900 $312,860 $312,860

Duration: 7/1/10–12/31/12 Duration: Laboratories Abbott M10-877 Adalimumab 7/1/10–12/31/12 Duration: Laboratories Abbott M10-880 Adalimumab 12/1/10–12/31/12 Duration: Ltd Research Alcon Uveitis Durazol C-10-034 5/1/12–4/30/13 Duration: University Hopkins Johns Study Follow-up MUST 9/21/11–PresentDuration: Glaxosmithkline Sub-Investigator Degeneration Macular Age-related to Secondary Atrophy Geographic with Patients GSK933776 Adult of in Pharmacodynamics and Pharmacokinetics, Efficacy, Tolerability, Safety, the Investigate to Study Parallel-group Placebo-controlled, Double-masked, Randomized, Multi-center, 2, A Phase 3/16/12–12/31/13 Duration: Foundation ALSAM Vitale T Albert Hartnett, Elizabeth Mary DeAngelis, Margaret SBernstein, Paul Investigators: Principal Genetic Epidemiology 12/1/05–Present Duration: Initiative Neuro-education University Hopkins Johns Trial(MUST) Steroid Treatment Uveitis Multicenter 4/1/07–Present Duration: Inc. USA, Neurotech Outcome Primary as Acuity Visual Using Pigmentosa Retinitis with Participants (CNTF) for Factor Neurotrophic Ciliary Releasing Implants NTC-201 Cell Human Encapsulated of Study II/III Phase 8/18/09–Present Duration: Ltd Research Alcon Sub-Investigator Degeneration Macular Age-related to (GA) Secondary Atrophy Geographic of the for Treatment Solution Ophthalmic of AL-8309B Efficacy and Safety The 8/17/10–PresentDuration: Corporation Ophthotech Sub-Investigator Degeneration Macular Age-related Neovascular with Subjects in Lucentis with Combination in Given Aptamer) Pegylated (Anti-PDGF E10030 of Injections Intravitreous of Efficacy and Safety the Trial Establish to Controlled Double-masked, Randomized, 2, A Phase MD TVitale, Albert

$95,771 $93,537 $32,733 $7,731 $281,000 NA NA NA $963,100 NA 77 F      78 F o c u s 2 0 1 3 Duration: Duration: 11/30/09– Consortium Investigator Investigator Sub Disease Research Ophthalmology Neuro- Loss Visual Mild with Hypertension Intracranial Idiopathic with Subjects in Placebo plus Diet Acetazolamidevs Plus Diet and/or Low-sodium reduction Study of Weight-Placebo-controlled A Randomized, Multicenter,Double-blind, E A Warner, Judith MD 4/1/02–Present Duration: &Lomb Bausch Co-Investigator Eye the of Segment Posterior the Affecting Uveitis Non-infectious with Patients in Therapy Standard to Compared (0.5mg)Implant Acetonide Flucinolone Intravitreal an of Efficacy and Safety the Evaluate to Study Controlled Randomized A Multicenter, Duration:1/1/03–Present &Lomb Bausch Study Eye, American the of Segment Posterior the Affecting Uveitis Noninfectious with Patients in 2mg) or Implant (0.5 Acetonide Fluocinolone Intravitreal an of Efficacy and Safety the Evaluate to Study Controlled Double-masked Randomized Trial: AMulticenter Clinical II Phase Duration: 3/1/03–Present Inc. Genentech Unmasked Physician Treating Sub-Investigator (MARINA) Degeneration Macular Age-related Neovascular Subfoveal Occult or Classic Minimally with Subjects In (Ranibizumab) RhufabV2 of Safety and Efficacy the of Study III A Phase 4/1/07–Present Duration: Institute Eye Corporation/National Emmes Trial (CATT)–Lucentis–Avastin TreatmentTrial AMD of Comparison 4/1/07–Present Duration: Lux Biosciences, Inc. Sight-threatening, UveitisNon-infectious Quiescent Clinically Therapy LX211 as of Safety and Efficacy the Assess to Study Dose-ranging Multi-centered, Placebo-controlled, Double-mass, 7/1/10–12/31/12 Duration: Laboratories Abbott M11-327Adalimumab MD TVitale, Albert 11/30/15

$80,500 na na na na na $63,014 Research Disease Disease Research IOL New of a Evaluation 10/1/10–9/30/13 Duration: Advanced Vision Science, Inc. Werner Liliana Mamalis, Nick Investigators: Principal IOL New of a Evaluation Duration: 8/1/10–7/31/13 Duration: Foundation Fighting Blindness Type Syndrome 2 Usher in Pigmentosa Retinitis for Therapy Gene 1/1/11– Duration: Foundation Ziegler E Matilda Photorecptors in Complex Protein 2 Usher the of Function(s) and Formation 4/1/11– Duration: Health of Institutes National Visual Loss Neuro-ophthalmology Mild with Hypertension Intracranial Idiopathic with Subjects in Placebo plus Diet vs Acetazolamide Plus Diet and/or Low-sodium Weight-reduction of study 2Placebo-controlled Usher the of Components New and Formation Jun 1/15/09–12/15/12 Duration: Inc. Visiogen, Werner Liliana Mamalis, Nick Investigators: Principal Evaluation of IOL aDual-optic 3/30/09–Present Duration: Inc. PowerVision, Werner Liliana Mamalis, Nick Investigators: Principal Eye the in Oil Silicone 5/1/10–4/30/13 Duration: Inc. Optics, Anew Werner Liliana Mamalis, Nick Investigators: Principal Duration: 9/19/11– Duration: LLC Innovia Werner Liliana Mamalis, Nick Investigators: Principal Material Lens Intraocular New 2/10/12– Duration: Optics Medical Abbott Werner Liliana Mamalis, Nick Investigators: Principal IOL New of a Evaluation 11/1/12– Duration: PhysIOL Werner Liliana Mamalis, Nick Investigators: Principal IOL New of a Evaluation Werner, MD,Liliana PhD y ang, PhD ang, 12/31/13 3/31/16 7/31/12 1/31/13 4/30/13

$50,000 $80,000 $336,937 $48,650 $201,211 $43,323 $10,986 $20,374 $66,537 $8,529 Paul SBernstein, MD, PhD Wolfgang BBaehr, PhD Alessandra Angelucci, MD, PhD P RESENTER RESENTER N ATI o NAL Invited Speaker, FloridaInternational University Invited Speaker, Bascom Palmer Eye Institute Invited Lecturer, Ophthalmic Photographers Society a Invited Speaker, Retina Sub-specialty Day, Thomas Age-related MacularDegeneration Symposium Invited Speaker, Royal Ophthalmological Society, Elizabeth related MacularDegeneration on theValue ofNutritionalSupplements for Age- Invited Speaker, to Educate Russian Ophthalmologists c Invited Speaker andPanelist, Hohenheim on OcularPharmacology andTherapeutics Invited Speaker andModerator, International Symposium MPI for Biochemistry Membrane Protein Transport inPhotoreceptors. Vanderbuilt The FunctionofPDE6DandUNC119 inPhotoreceptors Membrane Protein Transport inPhotoreceptors. and Retina Ciliopathies: From Genes to Mechanisms Organizer of14thVisionResearch Conference Department ofBiochemistry, University ofUtah Membrane Protein Transport inPhotoreceptors. To Invited Speaker Seminar, Rewiring theBrain: Role of Department ofMathematics, University ofChicago Computational Neuroscience SeminarSeries, Physiology, ConsiglioNazionaledelleRicerche and Patterned Connections.Department of Afferents and Targets intheGeneration ofSpecific V3, andV5/MToftheMacaque VisualCortex. Seminar, TheSpatial LogicofIntra-areal andInter- and Neuroscience, UMIST Honorary Lectureship, Department ofOptometry University Laboratory ofPhysiology, Oxford University areal Connectionswithinandbetween Areas V1,V2, and Patterned Connections.Departmental Lecture, Afferents and Targets intheGeneration ofSpecific Invited Speaker Seminar, Rewiring theBrain: Role of Department ofMathematics Invited Speaker Seminar, Circuits for Spatial Cerebral Cortex. Math BiologySeminarSeries, Integration ofInformation inthePrimate Visual This isapartiallist ofMoranNationaland International Presentations onsensus merican

t AND PIC reatment a o c cademy of onference I R T NTERNATI ITLE o phthalmology o NAL P RESENTATI Miami, FL Miami, FL San Francisco, CA San Francisco, CA Nottingham, England and Moscow, Russia Saint Petersburg Stuttgart, Germany Rome, Italy Muenchen, Germany Berlin, Germany Nashville, TN Ft. Lauderdale, FL Salt Lake City, UT Pisa, Italy Chicago, IL Manchester, England England Salt Lake City, UT o L CATI D N o o NS 2010–present 2009–present 2012 2012 2010–present 2010–present 2008–present 2010–present 2012 2012 2012 2012 2012 1998–present 2001–present 1999–present 1998–present 2002–present ATE

79 F o c u s 2 0 1 3 80 F o c u s 2 0 1 3 Alan SCrandall, MD P RESENTER RESENTER N ATI o NAL

22nd AnnualMeeting Surgeon intheGroup. Why theGlaucoma Specialist ShouldBetheBest Glaucoma Surgery: New Variations and Techniques. Including Femtosecond Laser andNucleus Chopper. Merging Complex Anterior Segment Surgery and Glaucoma: Masters inOphthalmology 2012 Advanced UsesofCapsule SupportSystem Introperatively. Monitoring Glaucoma. Nuclear DisassemblyTechnique Invited Speaker, TheRole ofAdjunctive Testing in Nichamin LD, et al.American Academy ofOphthalmology Hoffer J, Rowen S, Tabin GC, GillsJP, MichelsonMA, of Cataract andIOLSurgery. ArbisserLB, Crandall AS, Clinical Decisions intheManagement ofComplications Chop Squad.American Academy ofOphthalmology Intraoperative and Postoperative Complications. One-stop Ocular ComorbiditiesandHigh-risk Features for Malpositioned IOL.Cataract Surgeryof intheSetting Schlemm Cataract Surgery andAnterior Segment Reconstruction. making WithCataract Complications. Advanced Refractive IOL Exchange. Spotlight onCataracts: Clinical Decision- American Society ofCataract andRefractive Surgery in PXF. 2-HIntraocular Surgery: Challenging Cases. Repositioning Techniques. Risk Factors ofCataract Surgery Prechop Symposium. Intraocular LensExchange and Glaucoma: Tips for theUneasy Relationship. International Strategies andSurgical Techniques. Coexisting Cataract and Zonules andUsingCapsular Tension Devices. FixingtheIris: Syndrome Following Cataract Surgery. Tackling Weak Techniques, New Instrumentation. Toxic Anterior Segment Challenging Situations. Finer Points inIOLFixation: New Intraocular Lenses. Management ofDifficult Cataracts and Surgical Management ofSubluxated Crystalline and Symposium, University ofChile Filtration Lab.Seventh International Ophthalmology Express Shunts andCanaloplasty). Express Shunt Glaucoma Combined Glaucoma andCataract (Trabeculectomy, ltrachopper and Pseudoexfoliation (IncludingUse ofCapsular Devices). Malpositioned IOL.The XXXCongress oftheEuropean The Surgical Management ofLens Exchange andthe Glaucoma Surgeons. New Surgical Procedures. ManagingLate Subluxation. Society ofCataract &Refractive Surgeons penetrating Glaucoma Surgery andCanaloplasty for New penetrating Malpositioned Lenses: Techniques for Surgical Cataract andGlaucoma: Surgical Challenges. Non- New Instrumentation. Management ofCo-existing Management. Finer Points inIOLFixation: New Techniques, Management ofCataract inChallengingCases. Invited Lecturer, Ophthalmic Photographers Society Invited Speaker, American Optometric Association To AND PIC c anal Surgery. o I NTERNATI R m T anaging Hard o ITLE verview ofSuprachoroidal Devices. a t merican Glaucoma Society he Surgical c ataracts. m anagement of the anagement ofthe o m NAL anaging anaging P RESENTATI New York, NY Orlando, FL New York, NY Chicago, IL Chicago, IL Santiago, Chile Milan, Italy Chicago, IL Orlando, FL o L CATI D N o o NS 2012 2012 2012 2012 2012 2012 2012 2011–present 2010–present

ATE

Kathleen BDigre, MD Margaret DeAngelis, PhD Donnell JCreel, PhD P RESENTER RESENTER N ATI o NAL Digre KB, Schwedt TJ. American HeadacheSociety Episodic to Chronic Migraine and BackAgain. Coalition Meeting of Pregnancy. TheCarol ZimmermanLecture, University Photophobia inBlepharospasm. Dystonia Caring for Two: Neuro-ophthalmic Disorders in University of Idiopathic Intracranial Hypertension: Current Concepts. for Macular Degeneration. International Society Nuclear Receptors asDruggable Targets for Age-related Queen’s University Degeneration. Ninth Alumniand Research Day Meeting, Pathways/Mechanisms UnderlyingAge-related Macular Genomic Convergent Approach to Characterizing Foundation Fighting BlindnessConference. Curing Age-related MacularDegeneration inourLifetime. Eye &Ear Infirmary An Overview. The AMDSymposium, Massachusetts The Genetics ofAge-related MacularDegeneration: Medical School,SchepensEye Institute Degeneration. TheAMD Symposium, Harvard for aRole ofCVDandLipidsinAge-related Macular Genomic Convergent Approach Provides Evidence Electroretinograms. West ChinaHospital Invited Speaker, VisuallyEvoked Potentials. of Retina andGlaucoma Conference. Tilganga Institute Invited Speaker, VisuallyEvoked Potentials. International Society ofCataract andRefractive Surgery in PXE Case Presentation. Winter Update 2010, American The ABCs of CTRs. HardThe ABCsofCTRs. LenseswithLooseZonules Society ofCataract andRefractive Surgery Cataract Surgery: Experience andResults. European Cataract andGlaucoma: Surgical Challenges. The Future of Management. Course: IC-14Management ofCo-existing Malpositioned Lenses- Techniques ofSurgical of Congress. TheXXX111International Congress Moderator, New Horizons inGlaucoma Devices. Staged Procedures, Surgery. World Ophthalmology Update, WillsEye Institute with Subluxed IOLs.Advanced Anterior Segment Complex Cataract CasesandManagement ofPatients Glaucoma 360-New Horizons Forum To t o o

e exas Southwestern phthalmology phthalmology ye ye AND PIC r esearch o m I R aryland aryland T NTERNATI ITLE o NAL P RESENTATI Scottsdale, AZ Chicago, IL Dallas, TX College Park, MD Berlin, Germany Belfast, Ireland Salt Lake City, UT Boston, MA Boston, MA Chengdu, China Kathmandu, Nepal Mexico Playa delCarmen, Vienna, Austria Emirates San Francisco, CA Abu Dhabi,United Arab Philadelphia, PA o L CATI D N o o NS 2012 2012 2012 2012 2012 2012 2012 2003–present 2012 2012 2012 2012 2012 2012 2012–present 2012–present ATE

81 F o c u s 2 0 1 3 82 F o c u s 2 0 1 3 Gregory SHageman, PhD P RESENTER RESENTER N ATI o NAL

Invited Speaker, Hope inSight, JohnMoran Eye Center American Society ofHumanGenetics Biological Data. Sixty-second AnnualMeeting ofthe Degeneration Basedupon Available Genetic and Development andProgression ofAge-related Macular Invited Speaker, AnIntegrated Hypothesisofthe Eleventh MacularVisionResearch Foundation Conference Degeneration: Therapeutic &Diagnostic Implications. of theBiologyandGenetics of Age-related Macular Invited Speaker, Toward aRefined Understanding Mabel BeckmanInitiative forMacular Research Phenotype. Clinical-pathological Correlation in Patients with aHistory ofReticular Pseudodrusen. Arnoldand Innovations Symposium Moderator, Invited Speaker. GenotypeCorrelation-Biology- Annual FFB&Gavin HerbertEye Institute Ophthalmic Age-related MacularDegeneration: ANew Era. Fifth Invited Speaker, Diagnostics &Therapeutics for Atlantic Coast Retina Club Age-related MacularDegeneration. Macula2012, Invited Speaker, TheGenetics ofNon-exudative Macula ofParis Macular Degeneration-associated Pathways andGenes. Invited Speaker, Drusen-Harbingers ofAge-related Alumni Day, University ofNebraska Medical Center Gifford Lecturer, Gifford-Truhlsen Residents and of Age-related MacularDegeneration: ANew Era. Keynote Speaker, Toward aRefined Understanding Research Institute, Massachusetts Eye and Ear Infirmary Degeneration. Distinguished Lecture, Schepens Eye Genetics, Biology, and Treatment ofAge-related Macular Keynote Lecture, Toward aRefined Understanding ofthe Lighthouse International PisartVisionAward Macular Degeneration: Entering aNew Era. Genetics, Diagnosis,and Treatment ofAge-related Invited Speaker andAward Recipient, ThePathogenesis a Associated withAge-related MacularDegeneration: Invited Speaker, Biology, Genetics, and Pathways Scottsdale Headache Symposium Silverstein SD. American Headache Society, Moderator: Treatment. Digre KB, DodickDW, a Neuro-ophthalmology. All-day Course, American a Common Important Neuro-ophthalmoscopic Findings. Headache Society Oral Contraceptives andMigraine. American To AND cademy of merican n ew ew PIC e ra. a o I c cademy of n hallenge in eurology. NTERNATI R T ITLE n eurology am D Study o NAL P RESENTATI Sun Valley, ID San Francisco, CA Chicago, IL Newport Beach, CA Newport Beach,CA New York, NY Paris, France Omaha, NE Boston, MA New York City, NY Beijing, China Beijing, Scottsdale, AZ New Orleans,LA New Orleans,LA Scottsdale, AZ o L CATI D N o o NS 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012

ATE

P Bryan WJones,PhD Robert Mary ElizabethMary Hartnett, MD

RESENTER RESENTER o Hoffman,MD N ATI o NAL To Society for Invited Speaker, Neural Retina. International Clinical Faculty Day, University ofUtah Ophthalmology Black HillsRegional Eye Institute Visiting Professor Lecture, Retinoblastoma. ChildrensPrimary Medical Center Neonatal/Perinatal Conference, University ofUtah, Invited Speaker, Evidence for useofAvastin in ROP. Vision and Generation inRPE.TheAssociation for Research in The SmallGTPase Rap1Regulates Intracellular ROS Retinal Vascular Meeting Downregulation ofErythropoltin. Pediatric Delayed Retinal Angiogenesis by VEGF-mediated Distinguished SeminarSeries Macular Degeneration. VisionDiscovery Institute Mechanisms involved inNeovascular Age-related MoranJohn A. Eye Center, University ofUtah Treatments in Severe Retinopathy ofPrematurity. of Prematurity. Considerations Regarding Anti-VEGF (non-diabetic) II.Diabetic Retinopathy. Retinopathy Retina Lecture: Vascular andChoroidal Disease The Association for Research inVisionandOphthalmology ROS Generation inRPE. ME. Wang H,Wittchen E, Hartnett Lacks Story. TheSmallGTPase Rap1Regulates Intracellular Personal andHistorical Insights into theHenrietta Initiative forMacular Research Age-related MacularDegeneration. Beckman Invited Speaker, Concepts Relating to the Biologyof Conference, Centre for Eye Research Australia Associated withReticular Psuedodrusen. Fluorescein Invited Speaker, UniqueAngiographic Characteristics Invited Speaker, Royal Victoria Hospital United States a Congressional HouseRayburn, Briefing, Research’s Decade ofVision,2010-2020Initiative: Co-segregating Diseases.Alliance for Eye andVision Targeting Age-related MacularDegeneration andIts Invited Speaker, ANew Era: Diagnostics andTherapeutics - Degeneration. National Eye Institute of theGenetics andBiologyofAge-related Macular Invited Speaker, Toward aRefined Understanding School of Medical Center, Sungkyunkwan University Era. Fifteenth SamsungMacula Symposium, Samsung Degeneration andItsCo-segregating Diseases:A New and Therapeutics Targeting Age-related Macular Invited Speaker, Toward theDevelopment ofDiagnostcs

AND PIC m o o e edicine ye ye phthalmology c I R r ongress esearch T NTERNATI ITLE o NAL P RESENTATI o L Berlin, Germany Salt Lake City, UT Rapid City, SD Salt Lake City, UT Ft. Lauderdale, FL San Francisco, CA Augusta, GA Salt Lake City, UT Ft. Lauderdale, FL Irvine, CA Irvine, Melbourne, Australia Belfast, Northern Ireland Washington, DC Washington, DC Seoul, SouthKorea CATI D N o o NS 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 ATE

83 F o c u s 2 0 1 3 84 F o c u s 2 0 1 3 Nick Mamalis,MD David Krizaj, PhD Bradley JKatz, MD, PhD P RESENTER RESENTER N ATI o NAL

Cataract andRefractive Surgeons 2011 XXIXCongress oftheEuropean Society of Mamalis N,FullerS,Kavoussi S,McIntyre J. Vienna. Explantation orSecondary Intervention, 2010Update. Congress oftheHellenicSociety ofIntraocular Brunescent Cataract. Twenty-sixth International The ASCRS/ESCRS Survey onFoldable IOLs Requiring Implant andRefractive Surgery Correction of Postoperative Refractive Surprises after Sciences University Visual Behavior, andDisease.Georgia Health Nonconventional CalciumSignalsinMechanosensation, Invited Seminar, TRPingtheRetina: Role of Vision and Annual Meeting of theAssociation for Research in and Neurodegeneration intheMammalian Retina. SIG Presentation, Mechanosensation, TRPV4 Signaling Presented by D. Ryskamp. JaneliaFarms Consequences ofMechanosensation inthe Retina. Research Presentation, The Roles, Properties, and Federation ofAmerican Societies forExperimental Biology Summer Research Conference onCalciumSignaling, TRPV4’s Polymodal Responses. Presented by D. Ryskamp. Platform Presentation, Diverse MechanismsMediate e Retinal Ganglion Neurons. International Society for Platform Presentation, TRPV4 Polymodal Signalsin on Retinal Processing Experimental Biology, SummerResearch Conference Neurons. Federation ofAmerican Societies for Platform Presentation, Trpv4 ChannelsModulate on Cognitive Sciences, Jozef Stefan Institute Retinal Signalingand Polymodal Integration of Sensory Information. Fifteenth International Multiconference Keynote Presentation, From Watching to Seeing: and Mischief Makers. Neurobiology andGliaSymposium Invited Speaker, Retinal Glia:Glue, Feeders, Protectors, KSL andKUTV. TheKSL piecewas distributed nationally Featured Speaker, ZionBank’s “SpeakingonBusiness,” Cognitive Sciences, Jozef Stefan Institute Information. Fifteenth International Multiconference on Retinal Signalingand Polymodal Integration of Sensory Keynote Presentation, From Watching to Seeing: of theNorth American Neuro-Ophthalmology Society Strain Treated withSteroids andAntibiotics. AnnualMeeting Arteritis: Infection withaBurkholderia Pseudomallei-like Arteritis withAntibiotics. AMurineModelofGiant Cell Presentation: Treatment ofSubjectswithGiant Cell Retinal Remodeling SessionXXBiennialMeeting Moderator: International Society for Eye Research, To AND ye ye r PIC esearch o o I phthalmolog NTERNATI R T ITLE o NAL P RESENTATI Vienna, Austria Athens, Greece Augusta, GA Ft. Lauderdale, FL Ashburn, VA Snowmass, CO Berlin, Germany Steamboat, CO Ljubljana, Slovenia Snowbird, UT Salt Lake City, UT Surabaya, Indonesia San Antonio, TX Berlin, Germany o L CATI D N o o NS 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012

ATE

Majid Moshirfar, MD P RESENTER RESENTER N ATI o NAL SCS-core Meeting Dry Eye:Dry ADiseasethat May Progress. ALLERGAN- SCS-core Meeting Dry Eye:Dry ADiseasethat May Progress. ALLERGAN- Blepharitis. ALCON Meeting Ocular Surface Complications Associated withAcute of Affected? Spotlight on Pseudoexfoliation. Pathology ofExfoiliation: Are the CanalandCollectors with Cataract Complications. One-stop ChopSquad.The (Case 7inSpotlight onCataract: Clinical Decision-making Academy ofOphthalmology/Asia Pacific Academy Phacoemulsification andAdvanced Techniques. American Astigmatism inthe Cataract Patient. IFIS:Clinical Update Intraoperative and Postoperative Complications. Setting ofOcularComorbidities andHigh-risk Featuresfor Surgery, Roundtable Moderator. Cataract Surgery inthe a vs. Round Anterior Optic Edges (Original Paper). Toxic Asymmetric orSulcusFixation of3-pieceIOLs withSquare (Best Paper ofSession).Pathologic Comparisonof Anterior Optic Edges. Effective Communication Skills Sulcus Fixation of3-pieceIOLswithSquare or Round Hydrophobic IOLs.Pathological Acrylic Comparisonof Asymmetric orSulcusFixation ofSquare-edged Risk Factors for Toxic Anterior Segment Syndrome, Cataract andRefractive Surgery (Tips for American PublicSpeaking/Writing. Society of Pathological Assessment ofComplications with Evaluation of CapsularEvaluation BagOpacification With NewDisc- shaped Hydrophilic Foldable Acrylic IOLinRabbitModel. Piggyback FixationPiggyback in Pseudophakic Cadaver Eyes. piece Hydrophilic andSilicone Acrylic IOLsfor Sulcus/ Update onMost CommonCauses. Assessment ofSingle- Secondary Intervention. Toxic Anterior Segment Syndrome: ESCRS Survey ofFoldable IOLsRequiring Explaintation or Surprises: Lens-based Versus LaserCorrection. TheASCRS- in Cataract andRefractive Surgery. Correction of Refractive Symposium/Moderator, Cataract. Controversies in Ophthalmology Symposium, Olmsted Center for Sight Toxic Anterior Segment Syndrome. Buffalo Hawaiian Eye 2012,Grand Wailea Resort Cataract Surgery inPseudoexfoliation Patients. Tassignon MJ, Auffarth G, Mamalis N, Tetz M, Masket S Strategies andTechniques for IOLExchange (A). Cataract andRefractive Surgeons Werner Ollerton Michelson J, Leishman L, A, L, Strenk S. Versus Round Anterior Optic Edges. Mamalis N, BodnarZ, Fixation ofThree-piece Intraocular LenseswithSquare Milan 2012XXXCongress ofthe European Society of Pathologic ComparisonofAsymmetric orSulcus To nterior Segment Syndrome Following o

phthalmology AND PIC o I R T NTERNATI ITLE a nterior Segment o NAL P Salt Lake City, UT Boise, ID Salt Lake City, UT Chicago, IL Chicago, IL Buffalo, NY Maui, HI Vienna, Austria Milan, Italy RESENTATI o L CATI D N o o NS 2012 2012 2012 2012 2012 2012 2012 2012 2012 ATE

85 F o c u s 2 0 1 3 86 F o c u s 2 0 1 3 Jeff Pettey, MD Bhupendra C KPatel, MD, FRCS, FRC Randall J P RESENTER RESENTER o lson, MD N ATI o NAL

Resident Lecture. Moran JohnA. Eye Center Effective Communication during Patient Encounters. Cosmetic Surgery Forum. Facial Cosmetic Surgery Meeting Refractive Error. Hawaiian Eye Conference Non-surgical MeansofCorrecting Post-surgical Concerns aboutRelying onIntraoperative Aberrometry. Speaker, Surgical Management ofIFIS.Some Aberrometry. Hawaiian Eye Nursing Meeting Chair Tenure. Top Ten Management Problems. Caucus onTranslational Research. ABusinessPlan for University Professors ofOphthalmology Meetings Speaker, OtherConcernsSurrounding Intraoperative Meeting Association ofUniversity Professors ofOphthalmology Speaker, Fundraising: Key to theFuture. Innovation. HiltonMeeting, Conference Center, University ofFlorida Ophthalmology Anniversary Meeting andScientific Fiftieth University ofFloridaDepartment of Speaker, What We Know AboutPBKPrevention. in Twenty-ninth AnnualJohnsHopkinsCurrent Concepts Presentation, Wound Burn:Causation and Prevention. and Refractive Surgery Eyeworld Symposium, American Society ofCataract Personal ExperiencewiththeCatalys System. American Society ofCataract andRefractive Surgery Instructor, LearningPhaco Chop:Pearls andPitfalls. Session Moderator, Advanced Phaco Skills.Senior Refractive Surgery Surgery. a Intraocular Surgery, Surgical Techniques. Toxic a Annual Spotlight onCataract Symposium, American Session Moderator, White Lens+Uveitis. Eleventh of Phacoemulsification Session.American Academy Learning Phaco Chop.Latest onPOE,Advanced Senior Instructor, Advanced Phaco Labs. American of Complications. American AnnualMeeting, Academy High-risk Features for Intraoperative and Postoperative Talk Title:Cataract Surgery intheFace ofaPKP. and Refractive Surgery and Refractive Surgery. American Society ofCataract to Optical Perfection? Symposiumon Cataract, IOL, Cataract Surgeryand intheSetting ofOcularComorbidities 2012 Binkhorst Lecturer, Where Are We ontheRoad To AND nterior Segment Syndrome Following cademy of o o o phthalmology phthalmology phthalmology PIC a merican Society of o I o phthalmology NTERNATI R T c onference ITLE c ataract and o c ataract NAL P RESENTATI Salt Lake City, UT Las Vegas, NV Maui, HI Maui, HI Miami, FL Gainesville, FL Vail, CO Chicago, IL Chicago, IL Chicago, IL Chicago, IL Chicago, IL Chicago, IL Chicago, IL o L CATI D N o o NS 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2003–present 2012

ATE

P Judith EAWarner, MD Albert TVitale, MD Monica Vetter, PhD Geoffrey Tabin, MD RESENTER RESENTER N ATI o NAL To Stroke Conference, University ofUtah CSVT: Acute andChronic Management andConcerns. Vision Project: Occipital Cortical Implants for Blindness Neuro-ophthalmology Fall Festival WINO HotTopics inNeurology, NMO:What’s New? Vision and NANOS: HotTopics inNeuro-ophthalmology, Utah Artificial Vasudevan V, Moorthy Association R. for Research in Granulomatosis: Case Series. Vitale AT, LimLT, Shelton J, and Choroiditis Associated with Wegener's Poster Presentation: Macular Retinal Vasculitis Uveitis. Cal Pacific Invited Speaker: Diagnostic andTherapeutic Vitrectomy in of Diagnosis andTreatment ofUveitis. American Academy Invited Speaker: MultimodalImaginginUveitis, and of Ophthalmology, Uveitis Sub-specialty Day Panel Discussion:Uveitis Potpourri. American Academy of Ophthalmology, Uveitis Sub-specialtyDay and IfSo, How ShouldITreat It?American Academy Invited Speaker: IsItBirdshot Retinochoroidopathy, International Symposium ofUveitis (IUSG) Combined PPV andPhaco-IOL for Uveitis. Eighth Stroke Conference, University ofUtah CSVT -Acute andChronic Management andConcerns. Development, Colby-Sawyer College Gordon Research Conference onVisualSystem Cell Biology, Neurobiology &Anatomy Medical College ofWisconsin, Department of Ear Infirmary Harvard Medical School,Massachusetts Eye and Genentech, Neuroscience Research Department Staff Education. World BlindnessProgram. The33rd AnnualTechnical Impossible Dreams—The Ascent ofEverest andEradicating o Life LongVisionFoundation. The Eye Ball American Academy ofOphthalmology Techniques. Extraction (ECCE/SICS). Surgery: Indications and Cataract andIOLSurgery. ManualExtracapsular Cataract Clinical Decisionsinthe Management ofComplications of International Ophthalmology. Canadian International Opportunities for YoungOphthalmologists. phthalmology Society o

phthalmology AND PIC o o phthalmology I R T NTERNATI ITLE o NAL P RESENTATI o L Salt Lake City, UT Boston, MA Salt Lake City, UT San Antonio, TX Fort Lauderdale, FL. San Francisco, CA Orlando, FL Chicago, IL Chicago, IL Halkidiki, Greece Salt Lake City, UT New London,NH Milwaukee, WI Boston, MA Palo Alto, CA Salt Lake City, UT St. Louis,MO Canada Chicago, IL CATI D N o o NS 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 ATE

87 F o c u s 2 0 1 3 88 F o c u s 2 0 1 3 Marielle Barbara MWirostko, MD Jun Liliana Werner, MD, PhD P RESENTER RESENTER y ang, PhD ang, y oung, MD oung, N ATI o NAL

John A. MoranJohn A. Eye Center, University ofUtah. Infantile Cataracts. NorthStar Optometry Seminar, Diagnosis andManagement ofOcularTorsion Disorders. MoranJohn A. Eye Center, University ofUtah Bilateral Infantile Cataracts. Clinical Faculty Day, Chemistry ofContact Lenses Timing ofSurgery andNystagmus inPatients with forDivision ofServices theBlindandVisuallyImpaired and Rehabilitation oftheBlindandVisuallyImpaired. University ofUtah Sixteenth Symposium onthe Reiver S,MessierK,ThiesJ, Wirostko B, Rafii MJ. Complex. Membrane Trafficking Minisymposium, Pediatric Ophthalmology, Association for the Education Keynote Speaker, AnnualCataract Course Refraktive Chirurgie (DGII) Gesellschaft fürIntraokularlinsen-Implantation und Julien Bérard, Hecka Kemp A, MullerM,Mihov G, A, Functional Exploration oftheUsher Syndrome Type2 Association for Research inOtolaryngology Actin-regulatory FunctionofEspin.Midwinter Meeting, r Kengatharan M. Abstract #.5079.Association for Inhibitor ATS8535 InVivo. Wirostko B, UmenoH, HsuH, The 26thCongress oftheDeutschsprachige on Cataract andRefractive Surgery ARVO Education Course Strategies for for theTreatment ofCornealWounds. JohnZupancich, Human Growth HormoneDelivery from PEA Fibers Annual BioInterface Conference, University College S, Messier K, Thies J, Wirostko B, Rafii MJ. Twenty-second Kemp Muller M, MihovA, A, G, Reiver Hecka Bérard, Julien Podium Presentation, WhirlinModulates the Treatment. Elsevier: 14thVisionResearch Conference Retina Ciliopathies: From Genes to Mechanismsand a Afonso Fatorelli Lecture, TheXIIInternational Congress Sustained Delivery for Glaucoma. March Meeting, Safety andEfficacy ofa Novel Topical Rho Kinase Invited Speaker, Early for theTreatment ofCornealWounds. JohnZupancich, Human Growth HormoneDelivery from PEA Fibers and Refractive Surgery Winter Update. Current Understanding oftheUsher2Complex, To AND esearch inVisionand merican Glaucoma Society PIC o I e NTERNATI R ntrepreneurship in a merican Society of T - ITLE stage Startup Companies: o phthalmology m aterial Scienceand o phthalmology. c ataract and o NAL P RESENTATI Salt Lake City, UT Salt Lake City, UT Salt Lake City, UT Ayr, Scotland Salt Lake City, UT Berlin, Germany San Diego, CA Ft. Lauderdale, FL São Paulo, Brazil Ft. Lauderdale, FL Playa delCarmen,Mexico New Orleans,LA Fort Lauderdale, FL New York, NY Dublin, Ireland o L CATI D N o o NS 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012

ATE

John A.Moran Eye Center 65 Mario Capecchi Drive Salt Lake City, UT 84132 801.581.2352

Visit our website www.moraneyecenter.org